WO2024020592A1 - Cosmetic or personal care composition comprising recombinant milk protein - Google Patents
Cosmetic or personal care composition comprising recombinant milk protein Download PDFInfo
- Publication number
- WO2024020592A1 WO2024020592A1 PCT/US2023/070793 US2023070793W WO2024020592A1 WO 2024020592 A1 WO2024020592 A1 WO 2024020592A1 US 2023070793 W US2023070793 W US 2023070793W WO 2024020592 A1 WO2024020592 A1 WO 2024020592A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- recombinant
- cosmetic
- personal care
- care composition
- casein
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 553
- 102000014171 Milk Proteins Human genes 0.000 title claims abstract description 331
- 108010011756 Milk Proteins Proteins 0.000 title claims abstract description 331
- 235000021239 milk protein Nutrition 0.000 title claims abstract description 331
- 239000002537 cosmetic Substances 0.000 title claims abstract description 325
- 238000000034 method Methods 0.000 claims abstract description 38
- 239000005018 casein Substances 0.000 claims description 311
- 108010076119 Caseins Proteins 0.000 claims description 122
- 102000011632 Caseins Human genes 0.000 claims description 122
- 108010063045 Lactoferrin Proteins 0.000 claims description 99
- 108010023244 Lactoperoxidase Proteins 0.000 claims description 99
- 102000045576 Lactoperoxidases Human genes 0.000 claims description 99
- 102000012174 Lactotransferrin Human genes 0.000 claims description 99
- 229940057428 lactoperoxidase Drugs 0.000 claims description 97
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 95
- 229940098773 bovine serum albumin Drugs 0.000 claims description 95
- 102000008192 Lactoglobulins Human genes 0.000 claims description 57
- 108010060630 Lactoglobulins Proteins 0.000 claims description 57
- 239000003795 chemical substances by application Substances 0.000 claims description 36
- 235000013336 milk Nutrition 0.000 claims description 32
- 210000004080 milk Anatomy 0.000 claims description 32
- 239000000843 powder Substances 0.000 claims description 31
- 235000021240 caseins Nutrition 0.000 claims description 29
- 239000008267 milk Substances 0.000 claims description 29
- 241000196324 Embryophyta Species 0.000 claims description 22
- 102000004407 Lactalbumin Human genes 0.000 claims description 22
- 108090000942 Lactalbumin Proteins 0.000 claims description 22
- 241001465754 Metazoa Species 0.000 claims description 21
- 150000002632 lipids Chemical class 0.000 claims description 20
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 20
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 19
- 241000123346 Chrysosporium Species 0.000 claims description 18
- 108010046377 Whey Proteins Proteins 0.000 claims description 16
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 16
- 230000002538 fungal effect Effects 0.000 claims description 16
- 235000021119 whey protein Nutrition 0.000 claims description 16
- 241000235648 Pichia Species 0.000 claims description 13
- 102000007544 Whey Proteins Human genes 0.000 claims description 12
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 12
- 239000000194 fatty acid Substances 0.000 claims description 12
- 229930195729 fatty acid Natural products 0.000 claims description 12
- 150000004665 fatty acids Chemical class 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 229920001282 polysaccharide Polymers 0.000 claims description 11
- 239000005017 polysaccharide Substances 0.000 claims description 11
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 10
- 241000223218 Fusarium Species 0.000 claims description 8
- 241000235070 Saccharomyces Species 0.000 claims description 8
- 239000013543 active substance Substances 0.000 claims description 8
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 7
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims description 6
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 6
- 150000001412 amines Chemical class 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 6
- 150000002191 fatty alcohols Chemical class 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- 241000228212 Aspergillus Species 0.000 claims description 5
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 5
- 241000223892 Tetrahymena Species 0.000 claims description 5
- 241000223259 Trichoderma Species 0.000 claims description 5
- 238000000149 argon plasma sintering Methods 0.000 claims description 5
- 239000003086 colorant Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000000178 monomer Substances 0.000 claims description 5
- 241000159601 Blastobotrys Species 0.000 claims description 4
- 241000235035 Debaryomyces Species 0.000 claims description 4
- 241000235649 Kluyveromyces Species 0.000 claims description 4
- 241000235013 Yarrowia Species 0.000 claims description 4
- 241000235017 Zygosaccharomyces Species 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 4
- 229960002446 octanoic acid Drugs 0.000 claims description 4
- 230000000379 polymerizing effect Effects 0.000 claims description 4
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 3
- 239000005639 Lauric acid Substances 0.000 claims description 3
- 241000221960 Neurospora Species 0.000 claims description 3
- 241000195888 Physcomitrella Species 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 229960004488 linolenic acid Drugs 0.000 claims description 3
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 2
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 claims description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 2
- AWQSAIIDOMEEOD-UHFFFAOYSA-N 5,5-Dimethyl-4-(3-oxobutyl)dihydro-2(3H)-furanone Chemical compound CC(=O)CCC1CC(=O)OC1(C)C AWQSAIIDOMEEOD-UHFFFAOYSA-N 0.000 claims description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims description 2
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 2
- 239000005642 Oleic acid Substances 0.000 claims description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000021314 Palmitic acid Nutrition 0.000 claims description 2
- 239000000443 aerosol Substances 0.000 claims description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 claims description 2
- 239000011247 coating layer Substances 0.000 claims description 2
- 150000002190 fatty acyls Chemical class 0.000 claims description 2
- 230000000774 hypoallergenic effect Effects 0.000 claims description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- 235000021313 oleic acid Nutrition 0.000 claims description 2
- 230000001580 bacterial effect Effects 0.000 claims 2
- 150000004676 glycans Chemical class 0.000 claims 2
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 claims 1
- 229960003656 ricinoleic acid Drugs 0.000 claims 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 claims 1
- -1 masks Substances 0.000 description 74
- 108010067454 caseinomacropeptide Proteins 0.000 description 54
- 150000001413 amino acids Chemical class 0.000 description 46
- 229940024606 amino acid Drugs 0.000 description 44
- 235000001014 amino acid Nutrition 0.000 description 44
- 210000004027 cell Anatomy 0.000 description 37
- 210000003491 skin Anatomy 0.000 description 24
- 239000000047 product Substances 0.000 description 23
- 239000003921 oil Substances 0.000 description 21
- 235000019198 oils Nutrition 0.000 description 21
- 150000001875 compounds Chemical class 0.000 description 20
- 239000006071 cream Substances 0.000 description 17
- 229920001184 polypeptide Polymers 0.000 description 17
- 210000004209 hair Anatomy 0.000 description 15
- 239000004615 ingredient Substances 0.000 description 15
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- 102000040430 polynucleotide Human genes 0.000 description 14
- 108091033319 polynucleotide Proteins 0.000 description 14
- 239000002157 polynucleotide Substances 0.000 description 14
- 241000233866 Fungi Species 0.000 description 13
- 239000002253 acid Substances 0.000 description 13
- 239000000344 soap Substances 0.000 description 13
- 238000011282 treatment Methods 0.000 description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 12
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 11
- FGVVTMRZYROCTH-UHFFFAOYSA-N pyridine-2-thiol N-oxide Chemical class [O-][N+]1=CC=CC=C1S FGVVTMRZYROCTH-UHFFFAOYSA-N 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 11
- 125000000217 alkyl group Chemical group 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000006210 lotion Substances 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 239000013641 positive control Substances 0.000 description 10
- 229960002026 pyrithione Drugs 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000001993 wax Substances 0.000 description 9
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 125000003729 nucleotide group Chemical group 0.000 description 8
- 235000010987 pectin Nutrition 0.000 description 8
- 239000001814 pectin Substances 0.000 description 8
- 229920001277 pectin Polymers 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 7
- 239000006096 absorbing agent Substances 0.000 description 7
- 229920002678 cellulose Polymers 0.000 description 7
- 239000001913 cellulose Substances 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 235000019388 lanolin Nutrition 0.000 description 7
- 229910052618 mica group Inorganic materials 0.000 description 7
- 239000013642 negative control Substances 0.000 description 7
- 150000004804 polysaccharides Chemical class 0.000 description 7
- 239000004166 Lanolin Substances 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- 230000003712 anti-aging effect Effects 0.000 description 6
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 6
- 239000000975 dye Substances 0.000 description 6
- 239000006260 foam Substances 0.000 description 6
- 229940039717 lanolin Drugs 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- 241000754533 Bettsia alvei Species 0.000 description 5
- 208000001840 Dandruff Diseases 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 241000282414 Homo sapiens Species 0.000 description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 235000012730 carminic acid Nutrition 0.000 description 5
- 229960001484 edetic acid Drugs 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 241001453604 Bettsia fastidia Species 0.000 description 4
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 101800004361 Lactoferricin-B Proteins 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 108010071390 Serum Albumin Proteins 0.000 description 4
- 102000007562 Serum Albumin Human genes 0.000 description 4
- 206010040829 Skin discolouration Diseases 0.000 description 4
- 244000057717 Streptococcus lactis Species 0.000 description 4
- 235000014897 Streptococcus lactis Nutrition 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 235000011399 aloe vera Nutrition 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 230000027455 binding Effects 0.000 description 4
- 229940073609 bismuth oxychloride Drugs 0.000 description 4
- 229960000846 camphor Drugs 0.000 description 4
- 229920001525 carrageenan Polymers 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- OSOIQJGOYGSIMF-UHFFFAOYSA-N cyclopentadecanone Chemical compound O=C1CCCCCCCCCCCCCC1 OSOIQJGOYGSIMF-UHFFFAOYSA-N 0.000 description 4
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 229920000591 gum Polymers 0.000 description 4
- 230000000887 hydrating effect Effects 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- CFFMZOZGXDAXHP-HOKBLYKWSA-N lactoferricin Chemical compound C([C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CSSC[C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)C(=O)N[C@H](C(N[C@H](C(=O)N1)[C@@H](C)O)=O)[C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CFFMZOZGXDAXHP-HOKBLYKWSA-N 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000010445 mica Substances 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 4
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 229960004889 salicylic acid Drugs 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 239000011787 zinc oxide Substances 0.000 description 4
- 235000014692 zinc oxide Nutrition 0.000 description 4
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 241001116389 Aloe Species 0.000 description 3
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 3
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 3
- 241000207199 Citrus Species 0.000 description 3
- 241001672694 Citrus reticulata Species 0.000 description 3
- 241000195493 Cryptophyta Species 0.000 description 3
- 244000008991 Curcuma longa Species 0.000 description 3
- FKUPPRZPSYCDRS-UHFFFAOYSA-N Cyclopentadecanolide Chemical compound O=C1CCCCCCCCCCCCCCO1 FKUPPRZPSYCDRS-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 241000283074 Equus asinus Species 0.000 description 3
- 241000283073 Equus caballus Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- NGEWQZIDQIYUNV-UHFFFAOYSA-N L-valinic acid Natural products CC(C)C(O)C(O)=O NGEWQZIDQIYUNV-UHFFFAOYSA-N 0.000 description 3
- 244000246386 Mentha pulegium Species 0.000 description 3
- 235000016257 Mentha pulegium Nutrition 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 240000004713 Pisum sativum Species 0.000 description 3
- 108010009736 Protein Hydrolysates Proteins 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 239000003429 antifungal agent Substances 0.000 description 3
- 229940030999 antipsoriatics Drugs 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 235000021302 avocado oil Nutrition 0.000 description 3
- 239000008163 avocado oil Substances 0.000 description 3
- 238000004061 bleaching Methods 0.000 description 3
- 235000012745 brilliant blue FCF Nutrition 0.000 description 3
- 239000004161 brilliant blue FCF Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000001465 calcium Nutrition 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 229940021722 caseins Drugs 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 3
- CEZCCHQBSQPRMU-UHFFFAOYSA-L chembl174821 Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-UHFFFAOYSA-L 0.000 description 3
- 229940099898 chlorophyllin Drugs 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 235000020971 citrus fruits Nutrition 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 229940109262 curcumin Drugs 0.000 description 3
- 235000012754 curcumin Nutrition 0.000 description 3
- 239000004148 curcumin Substances 0.000 description 3
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000005187 foaming Methods 0.000 description 3
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 3
- 229960004275 glycolic acid Drugs 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 3
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 3
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 3
- 229960004705 kojic acid Drugs 0.000 description 3
- 229930007503 menthone Natural products 0.000 description 3
- 239000004005 microsphere Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 239000006072 paste Substances 0.000 description 3
- 235000019271 petrolatum Nutrition 0.000 description 3
- 229950001046 piroctone Drugs 0.000 description 3
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 3
- 230000004481 post-translational protein modification Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 229960004063 propylene glycol Drugs 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- 239000003531 protein hydrolysate Substances 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 229920002050 silicone resin Polymers 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- DSSYKIVIOFKYAU-OIBJUYFYSA-N (S)-camphor Chemical compound C1C[C@]2(C)C(=O)C[C@H]1C2(C)C DSSYKIVIOFKYAU-OIBJUYFYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- PUKWIVZFEZFVAT-UHFFFAOYSA-N 2,2,5-trimethyl-5-pentylcyclopentan-1-one Chemical compound CCCCCC1(C)CCC(C)(C)C1=O PUKWIVZFEZFVAT-UHFFFAOYSA-N 0.000 description 2
- RBPXWEAXSBRZBU-UHFFFAOYSA-N 2-hexylsulfanylethanamine;hydrochloride Chemical compound Cl.CCCCCCSCCN RBPXWEAXSBRZBU-UHFFFAOYSA-N 0.000 description 2
- AFENDNXGAFYKQO-UHFFFAOYSA-N 2-hydroxybutyric acid Chemical compound CCC(O)C(O)=O AFENDNXGAFYKQO-UHFFFAOYSA-N 0.000 description 2
- XOUQAVYLRNOXDO-UHFFFAOYSA-N 2-tert-butyl-5-methylphenol Chemical compound CC1=CC=C(C(C)(C)C)C(O)=C1 XOUQAVYLRNOXDO-UHFFFAOYSA-N 0.000 description 2
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- 240000004507 Abelmoschus esculentus Species 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 241000187844 Actinoplanes Species 0.000 description 2
- 244000291564 Allium cepa Species 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- 235000011437 Amygdalus communis Nutrition 0.000 description 2
- 244000061520 Angelica archangelica Species 0.000 description 2
- 241000439392 Apiotrichum cacaoliposimilis Species 0.000 description 2
- 241000205585 Aquilegia canadensis Species 0.000 description 2
- 241000203069 Archaea Species 0.000 description 2
- 240000001851 Artemisia dracunculus Species 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 235000016425 Arthrospira platensis Nutrition 0.000 description 2
- 240000002900 Arthrospira platensis Species 0.000 description 2
- 241001513093 Aspergillus awamori Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 241000209763 Avena sativa Species 0.000 description 2
- 235000007558 Avena sp Nutrition 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- 208000035985 Body Odor Diseases 0.000 description 2
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 2
- 240000002791 Brassica napus Species 0.000 description 2
- 235000006008 Brassica napus var napus Nutrition 0.000 description 2
- 240000000385 Brassica napus var. napus Species 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 2
- 241000195940 Bryophyta Species 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 240000001432 Calendula officinalis Species 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 241001674013 Chrysosporium lucknowense Species 0.000 description 2
- 235000010523 Cicer arietinum Nutrition 0.000 description 2
- 244000045195 Cicer arietinum Species 0.000 description 2
- 244000183685 Citrus aurantium Species 0.000 description 2
- 235000007716 Citrus aurantium Nutrition 0.000 description 2
- 240000000560 Citrus x paradisi Species 0.000 description 2
- 240000007154 Coffea arabica Species 0.000 description 2
- 108010078777 Colistin Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 244000018436 Coriandrum sativum Species 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 description 2
- 240000001980 Cucurbita pepo Species 0.000 description 2
- 241000235555 Cunninghamella Species 0.000 description 2
- 235000003392 Curcuma domestica Nutrition 0.000 description 2
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 2
- 241000192700 Cyanobacteria Species 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 241000228138 Emericella Species 0.000 description 2
- 241000178951 Endomyces Species 0.000 description 2
- 241001465321 Eremothecium Species 0.000 description 2
- 241000588722 Escherichia Species 0.000 description 2
- VUNOFAIHSALQQH-UHFFFAOYSA-N Ethyl menthane carboxamide Chemical compound CCNC(=O)C1CC(C)CCC1C(C)C VUNOFAIHSALQQH-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 2
- 241001138401 Kluyveromyces lactis Species 0.000 description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 2
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 241000192132 Leuconostoc Species 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 241000555676 Malassezia Species 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 240000003183 Manihot esculenta Species 0.000 description 2
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 2
- 244000062730 Melissa officinalis Species 0.000 description 2
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 235000009421 Myristica fragrans Nutrition 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- 241001489174 Ogataea minuta Species 0.000 description 2
- 241000233654 Oomycetes Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 240000008474 Pimenta dioica Species 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 241000235403 Rhizomucor miehei Species 0.000 description 2
- 241000223252 Rhodotorula Species 0.000 description 2
- 241000221523 Rhodotorula toruloides Species 0.000 description 2
- 244000253911 Saccharomyces fragilis Species 0.000 description 2
- 235000018368 Saccharomyces fragilis Nutrition 0.000 description 2
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 206010040904 Skin odour abnormal Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 206010064127 Solar lentigo Diseases 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- 235000009337 Spinacia oleracea Nutrition 0.000 description 2
- 244000300264 Spinacia oleracea Species 0.000 description 2
- 241001085826 Sporotrichum Species 0.000 description 2
- 241000187747 Streptomyces Species 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 241001495429 Thielavia terrestris Species 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 241000223238 Trichophyton Species 0.000 description 2
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 2
- 244000078534 Vaccinium myrtillus Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 241000589634 Xanthomonas Species 0.000 description 2
- 241000235015 Yarrowia lipolytica Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229920001586 anionic polysaccharide Polymers 0.000 description 2
- 150000004836 anionic polysaccharides Chemical class 0.000 description 2
- 239000000058 anti acne agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 229940124340 antiacne agent Drugs 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000012867 bioactive agent Substances 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 239000003876 biosurfactant Substances 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 239000001511 capsicum annuum Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 239000004106 carminic acid Substances 0.000 description 2
- DGQLVPJVXFOQEV-JNVSTXMASA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-JNVSTXMASA-N 0.000 description 2
- 239000004203 carnauba wax Substances 0.000 description 2
- 235000013869 carnauba wax Nutrition 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- JQXXHWHPUNPDRT-BQVAUQFYSA-N chembl1523493 Chemical compound O([C@](C1=O)(C)O\C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2C=NN1CCN(C)CC1 JQXXHWHPUNPDRT-BQVAUQFYSA-N 0.000 description 2
- 229940106705 chlorophyll Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229910000423 chromium oxide Inorganic materials 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 229960002227 clindamycin Drugs 0.000 description 2
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 2
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 2
- 235000016213 coffee Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 235000003373 curcuma longa Nutrition 0.000 description 2
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- GGQQNYXPYWCUHG-UHFFFAOYSA-N deca-3,6-diene Chemical compound CCCC=CCC=CCC GGQQNYXPYWCUHG-UHFFFAOYSA-N 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 239000007854 depigmenting agent Substances 0.000 description 2
- 229940120503 dihydroxyacetone Drugs 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 2
- 235000012732 erythrosine Nutrition 0.000 description 2
- 229940011411 erythrosine Drugs 0.000 description 2
- 239000004174 erythrosine Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- XIRNKXNNONJFQO-UHFFFAOYSA-N ethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC XIRNKXNNONJFQO-UHFFFAOYSA-N 0.000 description 2
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
- 238000009313 farming Methods 0.000 description 2
- 235000019240 fast green FCF Nutrition 0.000 description 2
- 229940051147 fd&c yellow no. 6 Drugs 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 2
- 229960004884 fluconazole Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000021472 generally recognized as safe Nutrition 0.000 description 2
- 235000012209 glucono delta-lactone Nutrition 0.000 description 2
- 229960003681 gluconolactone Drugs 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 230000009422 growth inhibiting effect Effects 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 239000008266 hair spray Substances 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 235000012738 indigotine Nutrition 0.000 description 2
- 239000004179 indigotine Substances 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- YJSUCBQWLKRPDL-UHFFFAOYSA-N isocyclocitral Chemical compound CC1CC(C)=CC(C)C1C=O YJSUCBQWLKRPDL-UHFFFAOYSA-N 0.000 description 2
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 229960004125 ketoconazole Drugs 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 229960000448 lactic acid Drugs 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 229940099690 malic acid Drugs 0.000 description 2
- 229960001929 meloxicam Drugs 0.000 description 2
- UODXCYZDMHPIJE-UHFFFAOYSA-N menthanol Chemical compound CC1CCC(C(C)(C)O)CC1 UODXCYZDMHPIJE-UHFFFAOYSA-N 0.000 description 2
- SMJXJPQSPQXVMU-UHFFFAOYSA-N methyl 2,2-dimethyl-6-methylidenecyclohexane-1-carboxylate Chemical compound COC(=O)C1C(=C)CCCC1(C)C SMJXJPQSPQXVMU-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 229960002509 miconazole Drugs 0.000 description 2
- 235000011929 mousse Nutrition 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000012860 organic pigment Substances 0.000 description 2
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- SSZBUIDZHHWXNJ-UHFFFAOYSA-N palmityl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 2
- 235000012658 paprika extract Nutrition 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229960000969 phenyl salicylate Drugs 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 230000008832 photodamage Effects 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 229960005205 prednisolone Drugs 0.000 description 2
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 229960001225 rifampicin Drugs 0.000 description 2
- RZJQGNCSTQAWON-UHFFFAOYSA-N rofecoxib Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=C(C=2C=CC=CC=2)C(=O)OC1 RZJQGNCSTQAWON-UHFFFAOYSA-N 0.000 description 2
- CZCBTSFUTPZVKJ-UHFFFAOYSA-N rose oxide Chemical compound CC1CCOC(C=C(C)C)C1 CZCBTSFUTPZVKJ-UHFFFAOYSA-N 0.000 description 2
- VBIZUNYMJSPHBH-OQLLNIDSSA-N salinazid Chemical compound OC1=CC=CC=C1\C=N\NC(=O)C1=CC=NC=C1 VBIZUNYMJSPHBH-OQLLNIDSSA-N 0.000 description 2
- 229950007671 salinazid Drugs 0.000 description 2
- 208000008742 seborrheic dermatitis Diseases 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- VIDTVPHHDGRGAF-UHFFFAOYSA-N selenium sulfide Chemical compound [Se]=S VIDTVPHHDGRGAF-UHFFFAOYSA-N 0.000 description 2
- 229960005265 selenium sulfide Drugs 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- ACTRVOBWPAIOHC-UHFFFAOYSA-N succimer Chemical compound OC(=O)C(S)C(S)C(O)=O ACTRVOBWPAIOHC-UHFFFAOYSA-N 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 230000037072 sun protection Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- ULSUXBXHSYSGDT-UHFFFAOYSA-N tangeretin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 ULSUXBXHSYSGDT-UHFFFAOYSA-N 0.000 description 2
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 2
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 235000010215 titanium dioxide Nutrition 0.000 description 2
- 210000000515 tooth Anatomy 0.000 description 2
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 2
- 235000013976 turmeric Nutrition 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 230000009105 vegetative growth Effects 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000007762 w/o emulsion Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229940043810 zinc pyrithione Drugs 0.000 description 2
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical class [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 2
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- PSQYTAPXSHCGMF-BQYQJAHWSA-N β-ionone Chemical compound CC(=O)\C=C\C1=C(C)CCCC1(C)C PSQYTAPXSHCGMF-BQYQJAHWSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- SFEOKXHPFMOVRM-UHFFFAOYSA-N (+)-(S)-gamma-ionone Natural products CC(=O)C=CC1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- NFLGAXVYCFJBMK-IUCAKERBSA-N (-)-isomenthone Chemical compound CC(C)[C@@H]1CC[C@H](C)CC1=O NFLGAXVYCFJBMK-IUCAKERBSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- NDTYTMIUWGWIMO-SNVBAGLBSA-N (-)-perillyl alcohol Chemical compound CC(=C)[C@H]1CCC(CO)=CC1 NDTYTMIUWGWIMO-SNVBAGLBSA-N 0.000 description 1
- BXJYLJLZLMXRSH-UHFFFAOYSA-N (1-methyl-4-propan-2-ylcyclohexyl) 3-hydroxybutanoate Chemical compound CC(O)CC(=O)OC1(C)CCC(C(C)C)CC1 BXJYLJLZLMXRSH-UHFFFAOYSA-N 0.000 description 1
- QILMAYXCYBTEDM-HNQUOIGGSA-N (10e)-1-oxacycloheptadec-10-en-2-one Chemical compound O=C1CCCCCCC\C=C\CCCCCCO1 QILMAYXCYBTEDM-HNQUOIGGSA-N 0.000 description 1
- 239000001871 (1R,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol Substances 0.000 description 1
- WQFGPARDTSBVLU-UHFFFAOYSA-N (1R,2S,3S,4R)-p-Menthane-2,3-diol Chemical compound CC(C)C1CCC(C)C(O)C1O WQFGPARDTSBVLU-UHFFFAOYSA-N 0.000 description 1
- HJIAMFHSAAEUKR-UHFFFAOYSA-N (2-hydroxyphenyl)-phenylmethanone Chemical class OC1=CC=CC=C1C(=O)C1=CC=CC=C1 HJIAMFHSAAEUKR-UHFFFAOYSA-N 0.000 description 1
- FINOAUDUYKVGDS-UHFFFAOYSA-N (2-tert-butylcyclohexyl) acetate Chemical compound CC(=O)OC1CCCCC1C(C)(C)C FINOAUDUYKVGDS-UHFFFAOYSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- WWJFFVUVFNBJTN-UIBIZFFUSA-N (2S)-2-[[(2S,3S,4S)-2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutanoyl]amino]-2-[(2R,3S,4S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]acetic acid Chemical class C[C@@H]([C@H](N)C(=O)N[C@@H]([C@H]1O[C@H]([C@@H](O)[C@@H]1O)n1ccc(=O)[nH]c1=O)C(O)=O)[C@H](O)c1ccc(O)cn1 WWJFFVUVFNBJTN-UIBIZFFUSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- RYAUSSKQMZRMAI-ALOPSCKCSA-N (2S,6R)-4-[3-(4-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1C[C@H](C)O[C@H](C)C1 RYAUSSKQMZRMAI-ALOPSCKCSA-N 0.000 description 1
- NDDLLTAIKYHPOD-ISLYRVAYSA-N (2e)-6-chloro-2-(6-chloro-4-methyl-3-oxo-1-benzothiophen-2-ylidene)-4-methyl-1-benzothiophen-3-one Chemical compound S/1C2=CC(Cl)=CC(C)=C2C(=O)C\1=C1/SC(C=C(Cl)C=C2C)=C2C1=O NDDLLTAIKYHPOD-ISLYRVAYSA-N 0.000 description 1
- CIDUJQMULVCIBT-MQDUPKMGSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4-amino-3-[[(2s,3r)-3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](NC)[C@@](C)(O)CO1)O)NCC)[C@H]1OC(CN)=CC[C@H]1N CIDUJQMULVCIBT-MQDUPKMGSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- RDJGLLICXDHJDY-NSHDSACASA-N (2s)-2-(3-phenoxyphenyl)propanoic acid Chemical compound OC(=O)[C@@H](C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-NSHDSACASA-N 0.000 description 1
- LDQAVQLJHUEMEY-JTQLQIEISA-N (2s)-2-(ethylamino)-3-(4-hydroxyphenyl)propanoic acid Chemical compound CCN[C@H](C(O)=O)CC1=CC=C(O)C=C1 LDQAVQLJHUEMEY-JTQLQIEISA-N 0.000 description 1
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 1
- HJTAPPMVLVVDGZ-UWVGGRQHSA-N (3S)-4-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]amino]-3-hydroxy-4-oxobutanoic acid Chemical compound OC(=O)C[C@H](O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HJTAPPMVLVVDGZ-UWVGGRQHSA-N 0.000 description 1
- KHLFMZDGADSQGR-ACCUITESSA-N (3e)-1-oxacyclohexadec-3-en-2-one Chemical compound O=C/1OCCCCCCCCCCCC\C=C\1 KHLFMZDGADSQGR-ACCUITESSA-N 0.000 description 1
- PAZWFUGWOAQBJJ-SWZPTJTJSA-N (4e,8e)-4,8,12-trimethyl-13-oxabicyclo[10.1.0]trideca-4,8-diene Chemical compound C1C\C(C)=C\CCC(/C)=C/CCC2(C)OC21 PAZWFUGWOAQBJJ-SWZPTJTJSA-N 0.000 description 1
- XIYOPDCBBDCGOE-IWVLMIASSA-N (4s,4ar,5s,5ar,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C=C1C2=CC=CC(O)=C2C(O)=C2[C@@H]1[C@H](O)[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O XIYOPDCBBDCGOE-IWVLMIASSA-N 0.000 description 1
- RNIADBXQDMCFEN-IWVLMIASSA-N (4s,4ar,5s,5ar,12ar)-7-chloro-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C=C1C2=C(Cl)C=CC(O)=C2C(O)=C2[C@@H]1[C@H](O)[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O RNIADBXQDMCFEN-IWVLMIASSA-N 0.000 description 1
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 1
- GUXHBMASAHGULD-SEYHBJAFSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1([C@H]2O)=C(Cl)C=CC(O)=C1C(O)=C1[C@@H]2C[C@H]2[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]2(O)C1=O GUXHBMASAHGULD-SEYHBJAFSA-N 0.000 description 1
- MTDHILKWIRSIHB-UHFFFAOYSA-N (5-azaniumyl-3,4,6-trihydroxyoxan-2-yl)methyl sulfate Chemical compound NC1C(O)OC(COS(O)(=O)=O)C(O)C1O MTDHILKWIRSIHB-UHFFFAOYSA-N 0.000 description 1
- URJOWNUVTORLNY-UHFFFAOYSA-N (5-hexadecanoyloxy-4-oxopyran-2-yl) hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC1=CC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=CO1 URJOWNUVTORLNY-UHFFFAOYSA-N 0.000 description 1
- FGDINYRLQOKVQS-LJSVPSOQSA-N (6r)-3,6-dimethyl-3a,4,5,6,7,7a-hexahydro-3h-1-benzofuran-2-one Chemical compound C1C[C@@H](C)CC2OC(=O)C(C)C21 FGDINYRLQOKVQS-LJSVPSOQSA-N 0.000 description 1
- WDLWHQDACQUCJR-ZAMMOSSLSA-N (6r,7r)-7-[[(2r)-2-azaniumyl-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(e)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)/C=C/C)C(O)=O)=CC=C(O)C=C1 WDLWHQDACQUCJR-ZAMMOSSLSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- JXNPEDYJTDQORS-HZJYTTRNSA-N (9Z,12Z)-octadecadien-1-ol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCO JXNPEDYJTDQORS-HZJYTTRNSA-N 0.000 description 1
- IKYKEVDKGZYRMQ-PDBXOOCHSA-N (9Z,12Z,15Z)-octadecatrien-1-ol Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCCO IKYKEVDKGZYRMQ-PDBXOOCHSA-N 0.000 description 1
- ZTOKUMPYMPKCFX-CZNUEWPDSA-N (E)-17-[(2R,3R,4S,5S,6R)-6-(acetyloxymethyl)-3-[(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxyoctadec-9-enoic acid Chemical compound OC(=O)CCCCCCC/C=C/CCCCCCC(C)O[C@@H]1O[C@H](COC(C)=O)[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](COC(C)=O)O1 ZTOKUMPYMPKCFX-CZNUEWPDSA-N 0.000 description 1
- NVIPUOMWGQAOIT-UHFFFAOYSA-N (E)-7-Hexadecen-16-olide Natural products O=C1CCCCCC=CCCCCCCCCO1 NVIPUOMWGQAOIT-UHFFFAOYSA-N 0.000 description 1
- LVRFTAZAXQPQHI-RXMQYKEDSA-N (R)-2-hydroxy-4-methylpentanoic acid Chemical compound CC(C)C[C@@H](O)C(O)=O LVRFTAZAXQPQHI-RXMQYKEDSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- IZFHEQBZOYJLPK-SSDOTTSWSA-N (R)-dihydrolipoic acid Chemical compound OC(=O)CCCC[C@@H](S)CCS IZFHEQBZOYJLPK-SSDOTTSWSA-N 0.000 description 1
- QKDHBVNJCZBTMR-LLVKDONJSA-N (R)-temafloxacin Chemical compound C1CN[C@H](C)CN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1=CC=C(F)C=C1F QKDHBVNJCZBTMR-LLVKDONJSA-N 0.000 description 1
- XUBOMFCQGDBHNK-JTQLQIEISA-N (S)-gatifloxacin Chemical compound FC1=CC(C(C(C(O)=O)=CN2C3CC3)=O)=C2C(OC)=C1N1CCN[C@@H](C)C1 XUBOMFCQGDBHNK-JTQLQIEISA-N 0.000 description 1
- RNLHVODSMDJCBR-SOFGYWHQSA-N (e)-3-methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pent-4-en-2-ol Chemical compound CC(O)C(C)\C=C\C1CC=C(C)C1(C)C RNLHVODSMDJCBR-SOFGYWHQSA-N 0.000 description 1
- YYMCVDNIIFNDJK-XFQWXJFMSA-N (z)-1-(3-fluorophenyl)-n-[(z)-(3-fluorophenyl)methylideneamino]methanimine Chemical compound FC1=CC=CC(\C=N/N=C\C=2C=C(F)C=CC=2)=C1 YYMCVDNIIFNDJK-XFQWXJFMSA-N 0.000 description 1
- UENOQWSWMYJKIW-UHFFFAOYSA-N 1,2,2-trimethylcyclohexan-1-ol Chemical compound CC1(C)CCCCC1(C)O UENOQWSWMYJKIW-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- NAOLWIGVYRIGTP-UHFFFAOYSA-N 1,3,5-trihydroxyanthracene-9,10-dione Chemical compound C1=CC(O)=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 NAOLWIGVYRIGTP-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- DZSVIVLGBJKQAP-UHFFFAOYSA-N 1-(2-methyl-5-propan-2-ylcyclohex-2-en-1-yl)propan-1-one Chemical compound CCC(=O)C1CC(C(C)C)CC=C1C DZSVIVLGBJKQAP-UHFFFAOYSA-N 0.000 description 1
- KZOSFTIGNZAWQS-UHFFFAOYSA-N 1-(3,3-dimethylcyclohexyl)ethyl 2-acetyloxyacetate Chemical compound CC(OC(=O)COC(C)=O)C1CCCC(C)(C)C1 KZOSFTIGNZAWQS-UHFFFAOYSA-N 0.000 description 1
- OWEGWHBOCFMBLP-UHFFFAOYSA-N 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one Chemical compound C1=CN=CN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 OWEGWHBOCFMBLP-UHFFFAOYSA-N 0.000 description 1
- BVDMQAQCEBGIJR-YIOYIWSBSA-N 1-[(1s,6r)-2,2,6-trimethylcyclohexyl]hexan-3-ol Chemical compound CCCC(O)CC[C@H]1[C@H](C)CCCC1(C)C BVDMQAQCEBGIJR-YIOYIWSBSA-N 0.000 description 1
- XLTMWFMRJZDFFD-UHFFFAOYSA-N 1-[(2-chloro-4-nitrophenyl)diazenyl]naphthalen-2-ol Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C([N+]([O-])=O)C=C1Cl XLTMWFMRJZDFFD-UHFFFAOYSA-N 0.000 description 1
- AFNXATANNDIXLG-SFHVURJKSA-N 1-[(2r)-2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound C1=CC(Cl)=CC=C1CS[C@H](C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 AFNXATANNDIXLG-SFHVURJKSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- BSIMZHVOQZIAOY-SCSAIBSYSA-N 1-carbapenem-3-carboxylic acid Chemical compound OC(=O)C1=CC[C@@H]2CC(=O)N12 BSIMZHVOQZIAOY-SCSAIBSYSA-N 0.000 description 1
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- CNANHJLQJZEVPS-UHFFFAOYSA-N 1-ethoxyethoxycyclododecane Chemical compound CCOC(C)OC1CCCCCCCCCCC1 CNANHJLQJZEVPS-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- KHLFMZDGADSQGR-UHFFFAOYSA-N 1-oxacyclohexadec-3-en-2-one Chemical compound O=C1OCCCCCCCCCCCCC=C1 KHLFMZDGADSQGR-UHFFFAOYSA-N 0.000 description 1
- OAAZUWWNSYWWHG-UHFFFAOYSA-N 1-phenoxypropan-1-ol Chemical compound CCC(O)OC1=CC=CC=C1 OAAZUWWNSYWWHG-UHFFFAOYSA-N 0.000 description 1
- QXHHHPZILQDDPS-UHFFFAOYSA-N 1-{2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound S1C=CC(COC(CN2C=NC=C2)C=2C(=CC(Cl)=CC=2)Cl)=C1Cl QXHHHPZILQDDPS-UHFFFAOYSA-N 0.000 description 1
- MGWGNGWZAQWPAD-UHFFFAOYSA-N 10-ethylidene-3-oxatricyclo[6.2.1.02,7]undecan-4-one Chemical compound C12OC(=O)CCC2C2CC(=CC)C1C2 MGWGNGWZAQWPAD-UHFFFAOYSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- SXNBVULTHKFMNO-UHFFFAOYSA-N 2,2-dihydroxyoctadecanoic acid Chemical class CCCCCCCCCCCCCCCCC(O)(O)C(O)=O SXNBVULTHKFMNO-UHFFFAOYSA-N 0.000 description 1
- JLVSRWOIZZXQAD-UHFFFAOYSA-N 2,3-disulfanylpropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(S)CS JLVSRWOIZZXQAD-UHFFFAOYSA-N 0.000 description 1
- MZZRKEIUNOYYDF-UHFFFAOYSA-N 2,4-dimethylcyclohex-3-ene-1-carbaldehyde Chemical compound CC1C=C(C)CCC1C=O MZZRKEIUNOYYDF-UHFFFAOYSA-N 0.000 description 1
- VHTFHZGAMYUZEP-UHFFFAOYSA-N 2,6,6-Trimethyl-1-cyclohexen-1-acetaldehyde Chemical compound CC1=C(CC=O)C(C)(C)CCC1 VHTFHZGAMYUZEP-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 1
- FEBUJFMRSBAMES-UHFFFAOYSA-N 2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(OC2C(C(OP)C(O)C(CO)O2)O)C(O)C(OC2C(C(CO)OC(P)C2O)O)O1 FEBUJFMRSBAMES-UHFFFAOYSA-N 0.000 description 1
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- MSWZFWKMSRAUBD-CBPJZXOFSA-N 2-amino-2-deoxy-D-mannopyranose Chemical compound N[C@@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-CBPJZXOFSA-N 0.000 description 1
- MBRHNTMUYWQHMR-UHFFFAOYSA-N 2-aminoethanol;6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one Chemical compound NCCO.ON1C(=O)C=C(C)C=C1C1CCCCC1 MBRHNTMUYWQHMR-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- OYINQIKIQCNQOX-UHFFFAOYSA-M 2-hydroxybutyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCC(O)C[N+](C)(C)C OYINQIKIQCNQOX-UHFFFAOYSA-M 0.000 description 1
- BWLBGMIXKSTLSX-UHFFFAOYSA-N 2-hydroxyisobutyric acid Chemical compound CC(C)(O)C(O)=O BWLBGMIXKSTLSX-UHFFFAOYSA-N 0.000 description 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 1
- 229940006193 2-mercaptoethanesulfonic acid Drugs 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- HZGTYCFBIJQZMA-UHFFFAOYSA-N 2-sulfanylbenzimidazole-2-sulfonic acid Chemical compound C1=CC=CC2=NC(S(=O)(=O)O)(S)N=C21 HZGTYCFBIJQZMA-UHFFFAOYSA-N 0.000 description 1
- IMOYOUMVYICGCA-UHFFFAOYSA-N 2-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C=C1C(C)(C)C IMOYOUMVYICGCA-UHFFFAOYSA-N 0.000 description 1
- IKEHOXWJQXIQAG-UHFFFAOYSA-N 2-tert-butyl-4-methylphenol Chemical compound CC1=CC=C(O)C(C(C)(C)C)=C1 IKEHOXWJQXIQAG-UHFFFAOYSA-N 0.000 description 1
- BKZXZGWHTRCFPX-UHFFFAOYSA-N 2-tert-butyl-6-methylphenol Chemical compound CC1=CC=CC(C(C)(C)C)=C1O BKZXZGWHTRCFPX-UHFFFAOYSA-N 0.000 description 1
- DSVUBXQDJGJGIC-UHFFFAOYSA-N 3',6'-dihydroxy-4',5'-diiodospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C(I)=C1OC1=C(I)C(O)=CC=C21 DSVUBXQDJGJGIC-UHFFFAOYSA-N 0.000 description 1
- QZFSNJAQFWEXEA-UHFFFAOYSA-N 3,3-dimethyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pent-4-en-2-ol Chemical compound CC(O)C(C)(C)C=CC1CC=C(C)C1(C)C QZFSNJAQFWEXEA-UHFFFAOYSA-N 0.000 description 1
- VKPRTBDRPNWOGL-UHFFFAOYSA-N 3,4,4a,5,8,8a-hexahydro-3',7-dimethyl-spiro(1,4-methanonaphthalene-2(1h),2'-oxirane) Chemical compound CC1OC11C(C2C3CC=C(C)C2)CC3C1 VKPRTBDRPNWOGL-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- FGDINYRLQOKVQS-UHFFFAOYSA-N 3,6-dimethyl-3a,4,5,6,7,7a-hexahydro-3h-benzofuran-2-one Chemical compound C1CC(C)CC2OC(=O)C(C)C21 FGDINYRLQOKVQS-UHFFFAOYSA-N 0.000 description 1
- QPNXWGRYYRSVET-UHFFFAOYSA-N 3,7,11-trimethyl-13-oxabicyclo[10.1.0]trideca-4,8-diene Chemical compound CC1CC=CC(C)CC=CC(C)CC2OC21 QPNXWGRYYRSVET-UHFFFAOYSA-N 0.000 description 1
- AYERSDHOTKHEDA-UHFFFAOYSA-N 3-(1-methyl-4-propan-2-ylcyclohexyl)oxybutan-1-ol Chemical compound CC(C)C1CCC(C)(OC(C)CCO)CC1 AYERSDHOTKHEDA-UHFFFAOYSA-N 0.000 description 1
- DCNFPFNLHFFBFM-UHFFFAOYSA-N 3-(1-methyl-4-propan-2-ylcyclohexyl)oxypropan-1-ol Chemical compound CC(C)C1CCC(C)(OCCCO)CC1 DCNFPFNLHFFBFM-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- GEPCDOWRWODJEY-UHFFFAOYSA-N 3-(3,3-dimethyl-1,2-dihydroinden-5-yl)propanal Chemical compound C1=C(CCC=O)C=C2C(C)(C)CCC2=C1 GEPCDOWRWODJEY-UHFFFAOYSA-N 0.000 description 1
- JRJBVWJSTHECJK-PKNBQFBNSA-N 3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one Chemical compound CC(=O)C(\C)=C\C1C(C)=CCCC1(C)C JRJBVWJSTHECJK-PKNBQFBNSA-N 0.000 description 1
- PWUSHZPXYOALFZ-UHFFFAOYSA-N 3-hydroxy-4-[(1-sulfonaphthalen-2-yl)diazenyl]naphthalene-2-carboxylic acid Chemical compound OC(=O)c1cc2ccccc2c(N=Nc2ccc3ccccc3c2S(O)(=O)=O)c1O PWUSHZPXYOALFZ-UHFFFAOYSA-N 0.000 description 1
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 description 1
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 1
- FKLSTTWRGDCXOK-UHFFFAOYSA-N 3-methoxy-7,7-dimethyl-10-methylidenebicyclo[4.3.1]decane Chemical compound C1C(OC)CCC2C(C)(C)CCC1C2=C FKLSTTWRGDCXOK-UHFFFAOYSA-N 0.000 description 1
- NGYMOTOXXHCHOC-UHFFFAOYSA-N 3-methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pentan-2-ol Chemical compound CC(O)C(C)CCC1CC=C(C)C1(C)C NGYMOTOXXHCHOC-UHFFFAOYSA-N 0.000 description 1
- VBVHHAXCYHWVKK-UHFFFAOYSA-N 3-methyl-6-propan-2-ylcyclohex-2-ene-1-thiol Chemical compound CC(C)C1CCC(C)=CC1S VBVHHAXCYHWVKK-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- VOXXWSYKYCBWHO-UHFFFAOYSA-N 3-phenyllactic acid Chemical compound OC(=O)C(O)CC1=CC=CC=C1 VOXXWSYKYCBWHO-UHFFFAOYSA-N 0.000 description 1
- MRBKEAMVRSLQPH-UHFFFAOYSA-N 3-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1 MRBKEAMVRSLQPH-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- ZDTNHRWWURISAA-UHFFFAOYSA-N 4',5'-dibromo-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C(Br)=C1OC1=C(Br)C(O)=CC=C21 ZDTNHRWWURISAA-UHFFFAOYSA-N 0.000 description 1
- NDHNBHXAALUAAJ-UHFFFAOYSA-N 4,5-dimorpholin-4-yl-1h-pyridazin-6-one Chemical compound C1COCCN1C=1C(O)=NN=CC=1N1CCOCC1 NDHNBHXAALUAAJ-UHFFFAOYSA-N 0.000 description 1
- YWJHQHJWHJRTAB-UHFFFAOYSA-N 4-(2-Methoxypropan-2-yl)-1-methylcyclohex-1-ene Chemical compound COC(C)(C)C1CCC(C)=CC1 YWJHQHJWHJRTAB-UHFFFAOYSA-N 0.000 description 1
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical class NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 1
- GVTFIGQDTWPFTA-UHFFFAOYSA-N 4-bromo-2-chloro-1-isothiocyanatobenzene Chemical compound ClC1=CC(Br)=CC=C1N=C=S GVTFIGQDTWPFTA-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- GDAVABNCFOTAOD-UHFFFAOYSA-N 4-methyl-2-phenyloxane Chemical compound C1C(C)CCOC1C1=CC=CC=C1 GDAVABNCFOTAOD-UHFFFAOYSA-N 0.000 description 1
- WYVMDJWLFVQZAL-UHFFFAOYSA-N 4-propan-2-ylbenzene-1,2-diol Chemical compound CC(C)C1=CC=C(O)C(O)=C1 WYVMDJWLFVQZAL-UHFFFAOYSA-N 0.000 description 1
- PJJGZPJJTHBVMX-UHFFFAOYSA-N 5,7-Dihydroxyisoflavone Chemical compound C=1C(O)=CC(O)=C(C2=O)C=1OC=C2C1=CC=CC=C1 PJJGZPJJTHBVMX-UHFFFAOYSA-N 0.000 description 1
- RDBLNMQDEWOUIB-UHFFFAOYSA-N 5-methyl-2-phenyl-1,3-benzoxazole Chemical compound N=1C2=CC(C)=CC=C2OC=1C1=CC=CC=C1 RDBLNMQDEWOUIB-UHFFFAOYSA-N 0.000 description 1
- OWFZJSXGDOTWSH-UHFFFAOYSA-N 5-methyl-2-propan-2-ylbicyclo[2.2.2]oct-5-ene-8-carbaldehyde Chemical compound O=CC1CC2C(C(C)C)CC1C(C)=C2 OWFZJSXGDOTWSH-UHFFFAOYSA-N 0.000 description 1
- DIPHJTHZUWDJIK-JPLAUYQNSA-N 5beta-scymnol Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CC[C@@H](O)C(CO)CO)C)[C@@]2(C)[C@@H](O)C1 DIPHJTHZUWDJIK-JPLAUYQNSA-N 0.000 description 1
- ZPFJBPIFMMENKC-UHFFFAOYSA-N 67634-24-6 Chemical compound C12C=CCC2C2CC(OC(=O)CC)C1C2 ZPFJBPIFMMENKC-UHFFFAOYSA-N 0.000 description 1
- LLVFKEOMLYDSGT-UHFFFAOYSA-N 69486-14-2 Chemical compound C12CCC(=O)OC2C2CC(=CC)C1C2 LLVFKEOMLYDSGT-UHFFFAOYSA-N 0.000 description 1
- MYYIMZRZXIQBGI-HVIRSNARSA-N 6alpha-Fluoroprednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3C[C@H](F)C2=C1 MYYIMZRZXIQBGI-HVIRSNARSA-N 0.000 description 1
- MPORYQCGWFQFLA-ONPDANIMSA-N 7-[(7s)-7-amino-5-azaspiro[2.4]heptan-5-yl]-8-chloro-6-fluoro-1-[(1r,2s)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid;trihydrate Chemical compound O.O.O.C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1.C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 MPORYQCGWFQFLA-ONPDANIMSA-N 0.000 description 1
- NVIPUOMWGQAOIT-DUXPYHPUSA-N 7-hexadecen-1,16-olide Chemical compound O=C1CCCCC\C=C\CCCCCCCCO1 NVIPUOMWGQAOIT-DUXPYHPUSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000589220 Acetobacter Species 0.000 description 1
- 244000235858 Acetobacter xylinum Species 0.000 description 1
- 235000002837 Acetobacter xylinum Nutrition 0.000 description 1
- 241000589291 Acinetobacter Species 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 235000003320 Adansonia digitata Nutrition 0.000 description 1
- 244000056971 Adansonia gregorii Species 0.000 description 1
- 235000003319 Adansonia gregorii Nutrition 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 240000006054 Agastache cana Species 0.000 description 1
- 244000152526 Agathosma crenulata Species 0.000 description 1
- 235000013388 Agathosma crenulata Nutrition 0.000 description 1
- 235000010167 Allium cepa var aggregatum Nutrition 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001280436 Allium schoenoprasum Species 0.000 description 1
- 235000001270 Allium sibiricum Nutrition 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000013668 Aloysia triphylla Nutrition 0.000 description 1
- 240000008554 Aloysia triphylla Species 0.000 description 1
- 241000710929 Alphavirus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- YPZUZOLGGMJZJO-UHFFFAOYSA-N Ambronide Chemical compound C1CC2C(C)(C)CCCC2(C)C2C1(C)OCC2 YPZUZOLGGMJZJO-UHFFFAOYSA-N 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 240000000662 Anethum graveolens Species 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 244000303258 Annona diversifolia Species 0.000 description 1
- 235000002198 Annona diversifolia Nutrition 0.000 description 1
- 235000007258 Anthriscus cerefolium Nutrition 0.000 description 1
- 240000002022 Anthriscus cerefolium Species 0.000 description 1
- 240000001436 Antirrhinum majus Species 0.000 description 1
- 241001634944 Apiotrichum dulcitum Species 0.000 description 1
- 241001634941 Apiotrichum gracile Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241001444063 Aronia Species 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 235000010576 Artemisia cina Nutrition 0.000 description 1
- 235000003092 Artemisia dracunculus Nutrition 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241001313476 Arthroderma ciferrii Species 0.000 description 1
- 241001336563 Arthroderma vespertilii Species 0.000 description 1
- 241001495180 Arthrospira Species 0.000 description 1
- 241000620196 Arthrospira maxima Species 0.000 description 1
- 235000002672 Artocarpus altilis Nutrition 0.000 description 1
- 240000004161 Artocarpus altilis Species 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 241000228215 Aspergillus aculeatus Species 0.000 description 1
- 241000228193 Aspergillus clavatus Species 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 241000892910 Aspergillus foetidus Species 0.000 description 1
- 241001225321 Aspergillus fumigatus Species 0.000 description 1
- 241001480052 Aspergillus japonicus Species 0.000 description 1
- 241000351920 Aspergillus nidulans Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000122824 Aspergillus ochraceus Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241000131386 Aspergillus sojae Species 0.000 description 1
- 241001465318 Aspergillus terreus Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000223651 Aureobasidium Species 0.000 description 1
- 241001465294 Auxarthron filamentosum Species 0.000 description 1
- 241000700663 Avipoxvirus Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 240000005343 Azadirachta indica Species 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 241001112741 Bacillaceae Species 0.000 description 1
- 241000193833 Bacillales Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 108010062877 Bacteriocins Proteins 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000151861 Barnettozyma salicaria Species 0.000 description 1
- 235000009269 Barosma crenulata Nutrition 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 239000004604 Blowing Agent Substances 0.000 description 1
- 241000283725 Bos Species 0.000 description 1
- 241001416153 Bos grunniens Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000003717 Boswellia sacra Nutrition 0.000 description 1
- 235000012035 Boswellia serrata Nutrition 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000011297 Brassica napobrassica Nutrition 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 241000219192 Brassica napus subsp. rapifera Species 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000004221 Brassica oleracea var gemmifera Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 1
- 244000308368 Brassica oleracea var. gemmifera Species 0.000 description 1
- 244000221633 Brassica rapa subsp chinensis Species 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
- MUAOHYJGHYFDSA-YZMLMZOASA-N CCCCC1C\C=C\C=C\C=C\C=C\[C@@H](C[C@@H]2O[C@@](O)(C[C@H](O)[C@H]2C(O)=O)C[C@@H](O)C[C@H]2O[C@@H]2\C=C\C(=O)O1)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](N)[C@@H]1O Chemical compound CCCCC1C\C=C\C=C\C=C\C=C\[C@@H](C[C@@H]2O[C@@](O)(C[C@H](O)[C@H]2C(O)=O)C[C@@H](O)C[C@H]2O[C@@H]2\C=C\C(=O)O1)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](N)[C@@H]1O MUAOHYJGHYFDSA-YZMLMZOASA-N 0.000 description 1
- QCMYYKRYFNMIEC-UHFFFAOYSA-N COP(O)=O Chemical class COP(O)=O QCMYYKRYFNMIEC-UHFFFAOYSA-N 0.000 description 1
- 229940124638 COX inhibitor Drugs 0.000 description 1
- 241000219357 Cactaceae Species 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 241001246270 Calophyllum Species 0.000 description 1
- 235000016401 Camelina Nutrition 0.000 description 1
- 244000197813 Camelina sativa Species 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 240000007436 Cananga odorata Species 0.000 description 1
- 241000626645 Canariomyces Species 0.000 description 1
- 240000005209 Canarium indicum Species 0.000 description 1
- 244000045232 Canavalia ensiformis Species 0.000 description 1
- 244000206911 Candida holmii Species 0.000 description 1
- 235000002965 Candida holmii Nutrition 0.000 description 1
- 241000436311 Candida orthopsilosis Species 0.000 description 1
- 241001123652 Candida versatilis Species 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 235000005273 Canna coccinea Nutrition 0.000 description 1
- 240000008555 Canna flaccida Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000283705 Capra hircus Species 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 108010020326 Caspofungin Proteins 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 108050004290 Cecropin Proteins 0.000 description 1
- 101800003223 Cecropin-A Proteins 0.000 description 1
- UQLLWWBDSUHNEB-CZUORRHYSA-N Cefaprin Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C(O)=O)C(=O)CSC1=CC=NC=C1 UQLLWWBDSUHNEB-CZUORRHYSA-N 0.000 description 1
- GNWUOVJNSFPWDD-XMZRARIVSA-M Cefoxitin sodium Chemical compound [Na+].N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)CC1=CC=CS1 GNWUOVJNSFPWDD-XMZRARIVSA-M 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 241000259840 Chaetomidium Species 0.000 description 1
- 241000221955 Chaetomium Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 235000021538 Chard Nutrition 0.000 description 1
- 235000000509 Chenopodium ambrosioides Nutrition 0.000 description 1
- 240000006162 Chenopodium quinoa Species 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 239000004099 Chlortetracycline Substances 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 1
- 241001336578 Chrysosporium europae Species 0.000 description 1
- 241001313448 Chrysosporium indicum Species 0.000 description 1
- 241000985909 Chrysosporium keratinophilum Species 0.000 description 1
- 241001674010 Chrysosporium mephiticum Species 0.000 description 1
- 241001556045 Chrysosporium merdarium Species 0.000 description 1
- 241000393428 Chrysosporium merdarium var. roseum Species 0.000 description 1
- 241000131962 Chrysosporium parvum Species 0.000 description 1
- 241001556043 Chrysosporium pilosum Species 0.000 description 1
- 241001154026 Chrysosporium pseudomerdarium Species 0.000 description 1
- 241000080524 Chrysosporium queenslandicum Species 0.000 description 1
- 241001556041 Chrysosporium sulfureum Species 0.000 description 1
- 241001674001 Chrysosporium tropicum Species 0.000 description 1
- 241001336565 Chrysosporium undulatum Species 0.000 description 1
- 241001556036 Chrysosporium vallenarense Species 0.000 description 1
- 241000355696 Chrysosporium zonatum Species 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000222290 Cladosporium Species 0.000 description 1
- 241001112696 Clostridia Species 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 102100033601 Collagen alpha-1(I) chain Human genes 0.000 description 1
- 102100031611 Collagen alpha-1(III) chain Human genes 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 240000004270 Colocasia esculenta var. antiquorum Species 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 241000218631 Coniferophyta Species 0.000 description 1
- 244000180278 Copernicia prunifera Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 240000009226 Corylus americana Species 0.000 description 1
- 235000001543 Corylus americana Nutrition 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 241001252397 Corynascus Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 241001527609 Cryptococcus Species 0.000 description 1
- 241000223935 Cryptosporidium Species 0.000 description 1
- 235000015001 Cucumis melo var inodorus Nutrition 0.000 description 1
- 240000002495 Cucumis melo var. inodorus Species 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 description 1
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 description 1
- 235000007129 Cuminum cyminum Nutrition 0.000 description 1
- 244000304337 Cuminum cyminum Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 235000003398 Curcuma aromatica Nutrition 0.000 description 1
- 241000580885 Cutaneotrichosporon curvatus Species 0.000 description 1
- 241001634939 Cutaneotrichosporon jirovecii Species 0.000 description 1
- 241000439394 Cutaneotrichosporon oleaginosum Species 0.000 description 1
- 241000235646 Cyberlindnera jadinii Species 0.000 description 1
- 241000592295 Cycadophyta Species 0.000 description 1
- YYLLIJHXUHJATK-UHFFFAOYSA-N Cyclohexyl acetate Chemical compound CC(=O)OC1CCCCC1 YYLLIJHXUHJATK-UHFFFAOYSA-N 0.000 description 1
- 240000004784 Cymbopogon citratus Species 0.000 description 1
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 1
- 244000166675 Cymbopogon nardus Species 0.000 description 1
- 235000018791 Cymbopogon nardus Nutrition 0.000 description 1
- 241001649011 Cypselea Species 0.000 description 1
- 102100028717 Cytosolic 5'-nucleotidase 3A Human genes 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 241000235036 Debaryomyces hansenii Species 0.000 description 1
- 108010002069 Defensins Proteins 0.000 description 1
- 102000000541 Defensins Human genes 0.000 description 1
- FMTDIUIBLCQGJB-UHFFFAOYSA-N Demethylchlortetracyclin Natural products C1C2C(O)C3=C(Cl)C=CC(O)=C3C(=O)C2=C(O)C2(O)C1C(N(C)C)C(O)=C(C(N)=O)C2=O FMTDIUIBLCQGJB-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000289427 Didelphidae Species 0.000 description 1
- WYQPLTPSGFELIB-JTQPXKBDSA-N Difluprednate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2CC[C@@](C(=O)COC(C)=O)(OC(=O)CCC)[C@@]2(C)C[C@@H]1O WYQPLTPSGFELIB-JTQPXKBDSA-N 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 235000002723 Dioscorea alata Nutrition 0.000 description 1
- 235000007056 Dioscorea composita Nutrition 0.000 description 1
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 description 1
- 235000005362 Dioscorea floribunda Nutrition 0.000 description 1
- 235000004868 Dioscorea macrostachya Nutrition 0.000 description 1
- 235000005361 Dioscorea nummularia Nutrition 0.000 description 1
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241001144268 Echidna Species 0.000 description 1
- 108010049047 Echinocandins Proteins 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 241001262649 Emmonsia crescens Species 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 241000224432 Entamoeba histolytica Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 231100000948 EpiDerm Skin Irritation Test Toxicity 0.000 description 1
- 102400001368 Epidermal growth factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- GDSYPXWUHMRTHT-UHFFFAOYSA-N Epidermin Natural products N#CCC(C)(C)OC1OC(CO)C(O)C(O)C1O GDSYPXWUHMRTHT-UHFFFAOYSA-N 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- XXRCUYVCPSWGCC-UHFFFAOYSA-N Ethyl pyruvate Chemical compound CCOC(=O)C(C)=O XXRCUYVCPSWGCC-UHFFFAOYSA-N 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 235000012601 Euterpe oleracea Nutrition 0.000 description 1
- 244000207620 Euterpe oleracea Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 239000001653 FEMA 3120 Substances 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000005778 Fenpropimorph Substances 0.000 description 1
- 102100028314 Filaggrin Human genes 0.000 description 1
- 101710088660 Filaggrin Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000710831 Flavivirus Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- WJOHZNCJWYWUJD-IUGZLZTKSA-N Fluocinonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)C)[C@@]2(C)C[C@@H]1O WJOHZNCJWYWUJD-IUGZLZTKSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- POPFMWWJOGLOIF-XWCQMRHXSA-N Flurandrenolide Chemical compound C1([C@@H](F)C2)=CC(=O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O POPFMWWJOGLOIF-XWCQMRHXSA-N 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 241000567163 Fusarium cerealis Species 0.000 description 1
- 241000223194 Fusarium culmorum Species 0.000 description 1
- 241000223195 Fusarium graminearum Species 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 241001489200 Fusarium poae Species 0.000 description 1
- 241000690372 Fusarium proliferatum Species 0.000 description 1
- 241000223192 Fusarium sporotrichioides Species 0.000 description 1
- 241001465753 Fusarium torulosum Species 0.000 description 1
- 241000567178 Fusarium venenatum Species 0.000 description 1
- 241000233732 Fusarium verticillioides Species 0.000 description 1
- DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Natural products OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 241000224467 Giardia intestinalis Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 241001583499 Glomeromycotina Species 0.000 description 1
- 241000589232 Gluconobacter oxydans Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 241000282575 Gorilla Species 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- AIJTTZAVMXIJGM-UHFFFAOYSA-N Grepafloxacin Chemical compound C1CNC(C)CN1C(C(=C1C)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 AIJTTZAVMXIJGM-UHFFFAOYSA-N 0.000 description 1
- 241001091440 Grossulariaceae Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- MUQNGPZZQDCDFT-JNQJZLCISA-N Halcinonide Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@@H]2O MUQNGPZZQDCDFT-JNQJZLCISA-N 0.000 description 1
- YCISZOVUHXIOFY-HKXOFBAYSA-N Halopredone acetate Chemical compound C1([C@H](F)C2)=CC(=O)C(Br)=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2CC[C@](OC(C)=O)(C(=O)COC(=O)C)[C@@]2(C)C[C@@H]1O YCISZOVUHXIOFY-HKXOFBAYSA-N 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- 235000008418 Hedeoma Nutrition 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 244000308760 Helichrysum petiolatum Species 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 241000700586 Herpesviridae Species 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 241001456088 Hesperocnide Species 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 241000167881 Hirundo Species 0.000 description 1
- 108010019494 Histatins Proteins 0.000 description 1
- 102000006492 Histatins Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000993285 Homo sapiens Collagen alpha-1(III) chain Proteins 0.000 description 1
- 241000384507 Hoplostethus Species 0.000 description 1
- 241000223198 Humicola Species 0.000 description 1
- 241000282596 Hylobatidae Species 0.000 description 1
- 235000010650 Hyssopus officinalis Nutrition 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 description 1
- 240000001549 Ipomoea eriocarpa Species 0.000 description 1
- 235000005146 Ipomoea eriocarpa Nutrition 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 235000013421 Kaempferia galanga Nutrition 0.000 description 1
- 244000062241 Kaempferia galanga Species 0.000 description 1
- 241000512931 Kazachstania humilis Species 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- 240000007839 Kleinhovia hospita Species 0.000 description 1
- 244000285963 Kluyveromyces fragilis Species 0.000 description 1
- 241000170280 Kluyveromyces sp. Species 0.000 description 1
- 241000235058 Komagataella pastoris Species 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 1
- XAGMUUZPGZWTRP-ZETCQYMHSA-N LSM-5745 Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1C1(N)CC1 XAGMUUZPGZWTRP-ZETCQYMHSA-N 0.000 description 1
- 241000481961 Lachancea thermotolerans Species 0.000 description 1
- 241001468155 Lactobacillaceae Species 0.000 description 1
- 241001112724 Lactobacillales Species 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 241000186604 Lactobacillus reuteri Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 235000013628 Lantana involucrata Nutrition 0.000 description 1
- 240000005183 Lantana involucrata Species 0.000 description 1
- 241000712902 Lassa mammarenavirus Species 0.000 description 1
- 241000219730 Lathyrus aphaca Species 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 244000147568 Laurus nobilis Species 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 241000288904 Lemur Species 0.000 description 1
- 240000004322 Lens culinaris Species 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- 241000222435 Lentinula Species 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 241000522169 Lespedeza Species 0.000 description 1
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 1
- 241001468194 Leuconostoc mesenteroides subsp. dextranicum Species 0.000 description 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 1
- 241000234269 Liliales Species 0.000 description 1
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 1
- 235000004520 Lindera benzoin Nutrition 0.000 description 1
- 244000148992 Lindera benzoin Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 241001149698 Lipomyces Species 0.000 description 1
- 241001149691 Lipomyces starkeyi Species 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- MUAOHYJGHYFDSA-UHFFFAOYSA-N Lucensomycin Natural products C1C(C(C(O)C2)C(O)=O)OC2(O)CC(O)CC2OC2C=CC(=O)OC(CCCC)CC=CC=CC=CC=CC1OC1OC(C)C(O)C(N)C1O MUAOHYJGHYFDSA-UHFFFAOYSA-N 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241000711828 Lyssavirus Species 0.000 description 1
- 241000282553 Macaca Species 0.000 description 1
- 241000208467 Macadamia Species 0.000 description 1
- 241000289619 Macropodidae Species 0.000 description 1
- 108060003100 Magainin Proteins 0.000 description 1
- 241001344133 Magnaporthe Species 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 241000228423 Malbranchea Species 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 241001503471 Mammuthus primigenius Species 0.000 description 1
- 241000282537 Mandrillus sphinx Species 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 241001595840 Margarites Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- GZENKSODFLBBHQ-ILSZZQPISA-N Medrysone Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@H](C(C)=O)CC[C@H]21 GZENKSODFLBBHQ-ILSZZQPISA-N 0.000 description 1
- 244000304222 Melaleuca cajuputi Species 0.000 description 1
- 235000001167 Melaleuca cajuputi Nutrition 0.000 description 1
- 241000378544 Melaleuca quinquenervia Species 0.000 description 1
- 235000017710 Melaleuca viridiflora Nutrition 0.000 description 1
- 241000183011 Melanocarpus Species 0.000 description 1
- 241000997826 Melanocetus johnsonii Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 235000013500 Melia azadirachta Nutrition 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 235000016278 Mentha canadensis Nutrition 0.000 description 1
- 244000245214 Mentha canadensis Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000078639 Mentha spicata Species 0.000 description 1
- KNVPMEZIMFVWMD-UHFFFAOYSA-N Menthyl pyrrolidone carboxylate Chemical compound CC(C)C1CCC(C)CC1OC(=O)N1C(=O)CCC1 KNVPMEZIMFVWMD-UHFFFAOYSA-N 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- FQISKWAFAHGMGT-SGJOWKDISA-M Methylprednisolone sodium succinate Chemical compound [Na+].C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(=O)CCC([O-])=O)CC[C@H]21 FQISKWAFAHGMGT-SGJOWKDISA-M 0.000 description 1
- 241000235048 Meyerozyma guilliermondii Species 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 241000712045 Morbillivirus Species 0.000 description 1
- 235000011347 Moringa oleifera Nutrition 0.000 description 1
- 244000179886 Moringa oleifera Species 0.000 description 1
- 241000235575 Mortierella Species 0.000 description 1
- 241000907999 Mortierella alpina Species 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 241000306281 Mucor ambiguus Species 0.000 description 1
- 241001149951 Mucor mucedo Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- ALHUZKCOMYUFRB-OAHLLOKOSA-N Muscone Chemical compound C[C@@H]1CCCCCCCCCCCCC(=O)C1 ALHUZKCOMYUFRB-OAHLLOKOSA-N 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 241000223251 Myrothecium Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- RWAXQWRDVUOOGG-UHFFFAOYSA-N N,2,3-Trimethyl-2-(1-methylethyl)butanamide Chemical compound CNC(=O)C(C)(C(C)C)C(C)C RWAXQWRDVUOOGG-UHFFFAOYSA-N 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- OTGQIQQTPXJQRG-UHFFFAOYSA-N N-(octadecanoyl)ethanolamine Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCO OTGQIQQTPXJQRG-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- OVRNDRQMDRJTHS-OZRXBMAMSA-N N-acetyl-beta-D-mannosamine Chemical compound CC(=O)N[C@@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-OZRXBMAMSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- UBQYURCVBFRUQT-UHFFFAOYSA-N N-benzoyl-Ferrioxamine B Chemical compound CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN UBQYURCVBFRUQT-UHFFFAOYSA-N 0.000 description 1
- BLXXJMDCKKHMKV-UHFFFAOYSA-N Nabumetone Chemical compound C1=C(CCC(C)=O)C=CC2=CC(OC)=CC=C21 BLXXJMDCKKHMKV-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 241000233892 Neocallimastix Species 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 241001507755 Neosartorya Species 0.000 description 1
- 241000221961 Neurospora crassa Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 229930184499 Nikkomycin Natural products 0.000 description 1
- UDTWZFJEMMUFLC-UHFFFAOYSA-N Nirvanol Chemical compound C=1C=CC=CC=1C1(CC)NC(=O)NC1=O UDTWZFJEMMUFLC-UHFFFAOYSA-N 0.000 description 1
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 1
- 108010053775 Nisin Proteins 0.000 description 1
- 235000010676 Ocimum basilicum Nutrition 0.000 description 1
- 240000007926 Ocimum gratissimum Species 0.000 description 1
- 244000227633 Ocotea pretiosa Species 0.000 description 1
- 235000004263 Ocotea pretiosa Nutrition 0.000 description 1
- 241001112159 Ogataea Species 0.000 description 1
- 241000320412 Ogataea angusta Species 0.000 description 1
- 241001452677 Ogataea methanolica Species 0.000 description 1
- 241000489470 Ogataea trehalophila Species 0.000 description 1
- 241000826199 Ogataea wickerhamii Species 0.000 description 1
- 241000902235 Oides Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 241001482592 Oreamnos americanus Species 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 241000700629 Orthopoxvirus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000192494 Oscillatoriales Species 0.000 description 1
- 241000283903 Ovis aries Species 0.000 description 1
- KYGZCKSPAKDVKC-UHFFFAOYSA-N Oxolinic acid Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC2=C1OCO2 KYGZCKSPAKDVKC-UHFFFAOYSA-N 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 208000025174 PANDAS Diseases 0.000 description 1
- 241001236817 Paecilomyces <Clavicipitaceae> Species 0.000 description 1
- 208000021155 Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection Diseases 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 241000282577 Pan troglodytes Species 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 241000282520 Papio Species 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 229930195708 Penicillin V Natural products 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 241000228150 Penicillium chrysogenum Species 0.000 description 1
- 240000000064 Penicillium roqueforti Species 0.000 description 1
- 235000002233 Penicillium roqueforti Nutrition 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 241000710778 Pestivirus Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 244000062780 Petroselinum sativum Species 0.000 description 1
- 240000007377 Petunia x hybrida Species 0.000 description 1
- 241000530350 Phaffomyces opuntiae Species 0.000 description 1
- 241000529953 Phaffomyces thermotolerans Species 0.000 description 1
- 235000010617 Phaseolus lunatus Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000222395 Phlebia Species 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- 241000425347 Phyla <beetle> Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241000195887 Physcomitrella patens Species 0.000 description 1
- 241000235062 Pichia membranifaciens Species 0.000 description 1
- 241000235061 Pichia sp. Species 0.000 description 1
- 235000006990 Pimenta dioica Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 241000235379 Piromyces Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 235000016816 Pisum sativum subsp sativum Nutrition 0.000 description 1
- 235000015622 Pisum sativum var macrocarpon Nutrition 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 241000711902 Pneumovirus Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 235000011751 Pogostemon cablin Nutrition 0.000 description 1
- 240000002505 Pogostemon cablin Species 0.000 description 1
- 235000016067 Polianthes tuberosa Nutrition 0.000 description 1
- 244000014047 Polianthes tuberosa Species 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001273 Polyhydroxy acid Polymers 0.000 description 1
- 108010040201 Polymyxins Proteins 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000282405 Pongo abelii Species 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- 241000700625 Poxviridae Species 0.000 description 1
- 235000000497 Primula Nutrition 0.000 description 1
- 241000208476 Primulaceae Species 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 241001494501 Prosopis <angiosperm> Species 0.000 description 1
- 235000001560 Prosopis chilensis Nutrition 0.000 description 1
- 235000014460 Prosopis juliflora var juliflora Nutrition 0.000 description 1
- 102100038277 Prostaglandin G/H synthase 1 Human genes 0.000 description 1
- 108050003243 Prostaglandin G/H synthase 1 Proteins 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 244000141353 Prunus domestica Species 0.000 description 1
- 235000006029 Prunus persica var nucipersica Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 244000017714 Prunus persica var. nucipersica Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 244000179750 Psoralea glandulosa Species 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 241000233639 Pythium Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 241000235525 Rhizomucor pusillus Species 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 241000235545 Rhizopus niveus Species 0.000 description 1
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 1
- 241001524101 Rhodococcus opacus Species 0.000 description 1
- 241000119319 Rhodococcus opacus PD630 Species 0.000 description 1
- 241000223253 Rhodotorula glutinis Species 0.000 description 1
- 241001149408 Rhodotorula graminis Species 0.000 description 1
- 241001030146 Rhodotorula sp. Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 235000002357 Ribes grossularia Nutrition 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- URWAJWIAIPFPJE-UHFFFAOYSA-N Rickamicin Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(CC=C(CN)O2)N)C(N)CC1N URWAJWIAIPFPJE-UHFFFAOYSA-N 0.000 description 1
- 229930189077 Rifamycin Natural products 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 241000710801 Rubivirus Species 0.000 description 1
- 235000017848 Rubus fruticosus Nutrition 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 241000235072 Saccharomyces bayanus Species 0.000 description 1
- 235000001006 Saccharomyces cerevisiae var diastaticus Nutrition 0.000 description 1
- 244000206963 Saccharomyces cerevisiae var. diastaticus Species 0.000 description 1
- 241000877399 Saccharomyces chevalieri Species 0.000 description 1
- 241000877401 Saccharomyces ellipsoideus Species 0.000 description 1
- 241001123227 Saccharomyces pastorianus Species 0.000 description 1
- 241000235088 Saccharomyces sp. Species 0.000 description 1
- 241000582914 Saccharomyces uvarum Species 0.000 description 1
- 241000235343 Saccharomycetales Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 241001072909 Salvia Species 0.000 description 1
- 244000151637 Sambucus canadensis Species 0.000 description 1
- 235000018735 Sambucus canadensis Nutrition 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 235000008406 SarachaNachtschatten Nutrition 0.000 description 1
- 229920002305 Schizophyllan Polymers 0.000 description 1
- 241000222480 Schizophyllum Species 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 240000003935 Sclerocarya birrea Species 0.000 description 1
- 235000001836 Sclerocarya caffra Nutrition 0.000 description 1
- DIPHJTHZUWDJIK-UHFFFAOYSA-N Scymnol Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)C(CO)CO)C)C1(C)C(O)C2 DIPHJTHZUWDJIK-UHFFFAOYSA-N 0.000 description 1
- 241000223255 Scytalidium Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 108010013296 Sericins Proteins 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241000320380 Silybum Species 0.000 description 1
- 235000010841 Silybum marianum Nutrition 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 229930192786 Sisomicin Natural products 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 235000004790 Solanum aculeatissimum Nutrition 0.000 description 1
- 235000008424 Solanum demissum Nutrition 0.000 description 1
- 235000018253 Solanum ferox Nutrition 0.000 description 1
- 235000000208 Solanum incanum Nutrition 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000013131 Solanum macrocarpon Nutrition 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000009869 Solanum phureja Nutrition 0.000 description 1
- 235000000341 Solanum ptychanthum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 235000017622 Solanum xanthocarpum Nutrition 0.000 description 1
- 241001491964 Solicoccozyma terricola Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 241000228389 Sporidiobolus Species 0.000 description 1
- 241000228393 Sporidiobolus salmonicolor Species 0.000 description 1
- 241000222068 Sporobolomyces <Sporidiobolaceae> Species 0.000 description 1
- 241000228390 Sporobolomyces johnsonii Species 0.000 description 1
- 241000123675 Sporobolomyces roseus Species 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 241000222646 Stereum Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 235000014962 Streptococcus cremoris Nutrition 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 108010034396 Streptogramins Proteins 0.000 description 1
- 241000936794 Streptomyces chattanoogensis Species 0.000 description 1
- 241000970906 Streptomyces natalensis Species 0.000 description 1
- 241000218589 Streptomyces olivaceus Species 0.000 description 1
- 241000187134 Streptomyces olivochromogenes Species 0.000 description 1
- 241000187417 Streptomyces rubiginosus Species 0.000 description 1
- FHNINJWBTRXEBC-UHFFFAOYSA-N Sudan III Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC(C=C1)=CC=C1N=NC1=CC=CC=C1 FHNINJWBTRXEBC-UHFFFAOYSA-N 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 235000004338 Syringa vulgaris Nutrition 0.000 description 1
- 244000297179 Syringa vulgaris Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 241000736851 Tagetes Species 0.000 description 1
- 235000012308 Tagetes Nutrition 0.000 description 1
- 241000228341 Talaromyces Species 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 108010053950 Teicoplanin Proteins 0.000 description 1
- 241000248392 Tetrahymena hegewischi Species 0.000 description 1
- 241000223891 Tetrahymena hyperangularis Species 0.000 description 1
- 241000248419 Tetrahymena malaccensis Species 0.000 description 1
- 241000248424 Tetrahymena pigmentosa Species 0.000 description 1
- 241000248418 Tetrahymena pyriformis Species 0.000 description 1
- 241000248381 Tetrahymena vorax Species 0.000 description 1
- 241000228178 Thermoascus Species 0.000 description 1
- 241000223257 Thermomyces Species 0.000 description 1
- 241001313536 Thermothelomyces thermophila Species 0.000 description 1
- 241001494489 Thielavia Species 0.000 description 1
- WKDDRNSBRWANNC-UHFFFAOYSA-N Thienamycin Natural products C1C(SCCN)=C(C(O)=O)N2C(=O)C(C(O)C)C21 WKDDRNSBRWANNC-UHFFFAOYSA-N 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 241000218636 Thuja Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 241000710924 Togaviridae Species 0.000 description 1
- 241001149964 Tolypocladium Species 0.000 description 1
- TZIZWYVVGLXXFV-FLRHRWPCSA-N Triamcinolone hexacetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@@H]2O TZIZWYVVGLXXFV-FLRHRWPCSA-N 0.000 description 1
- 241000894120 Trichoderma atroviride Species 0.000 description 1
- 241000596490 Trichoderma citrinoviride Species 0.000 description 1
- 241000223260 Trichoderma harzianum Species 0.000 description 1
- 241000378866 Trichoderma koningii Species 0.000 description 1
- 241000223262 Trichoderma longibrachiatum Species 0.000 description 1
- 241000499912 Trichoderma reesei Species 0.000 description 1
- 241001149558 Trichoderma virens Species 0.000 description 1
- 241000223261 Trichoderma viride Species 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 241000223230 Trichosporon Species 0.000 description 1
- 241000886095 Trichosporon insectorum Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 241000282458 Ursus sp. Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 235000007769 Vetiveria zizanioides Nutrition 0.000 description 1
- 244000284012 Vetiveria zizanioides Species 0.000 description 1
- 235000010749 Vicia faba Nutrition 0.000 description 1
- 240000006677 Vicia faba Species 0.000 description 1
- 235000002098 Vicia faba var. major Nutrition 0.000 description 1
- 241001416177 Vicugna pacos Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 241000282485 Vulpes vulpes Species 0.000 description 1
- 229920002310 Welan gum Polymers 0.000 description 1
- 241000370136 Wickerhamomyces pijperi Species 0.000 description 1
- 241000219995 Wisteria Species 0.000 description 1
- 241001000247 Xanthophyllomyces Species 0.000 description 1
- 241000222057 Xanthophyllomyces dendrorhous Species 0.000 description 1
- 235000004552 Yucca aloifolia Nutrition 0.000 description 1
- 235000012044 Yucca brevifolia Nutrition 0.000 description 1
- 235000017049 Yucca glauca Nutrition 0.000 description 1
- 240000005780 Yucca gloriosa Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 241000758405 Zoopagomycotina Species 0.000 description 1
- OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 description 1
- 241000235033 Zygosaccharomyces rouxii Species 0.000 description 1
- MKWSZTVOJKTLPX-HZSPNIEDSA-N [(1r,2s,5r)-2-isopropyl-5-methyl-cyclohexyl] 4-(dimethylamino)-4-oxo-butanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)CCC(=O)N(C)C MKWSZTVOJKTLPX-HZSPNIEDSA-N 0.000 description 1
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 description 1
- KGEKLUUHTZCSIP-UMNHJUIQSA-N [(1s,3r,4r)-4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-UMNHJUIQSA-N 0.000 description 1
- ZWBTYMGEBZUQTK-PVLSIAFMSA-N [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1'-(2-methylpropyl)-6,23-dioxospiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(32),2,4,9,19,21,24,26,30-nonaene-28,4'-piperidine]-13-yl] acetate Chemical compound CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c4NC5(CCN(CC(C)C)CC5)N=c4c(=NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C ZWBTYMGEBZUQTK-PVLSIAFMSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 241000192393 [Candida] etchellsii Species 0.000 description 1
- 241000192348 [Candida] palmioleophila Species 0.000 description 1
- 241001674017 [Chrysosporium] filiforme Species 0.000 description 1
- 241001556033 [Chrysosporium] synchronum Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000003650 acai Nutrition 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- PDODBKYPSUYQGT-UHFFFAOYSA-N acetic acid;1h-indene Chemical class CC(O)=O.C1=CC=C2CC=CC2=C1 PDODBKYPSUYQGT-UHFFFAOYSA-N 0.000 description 1
- BOIZHGCLUSQNLD-UHFFFAOYSA-N acetic acid;1h-indole Chemical class CC(O)=O.C1=CC=C2NC=CC2=C1 BOIZHGCLUSQNLD-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- CQPFMGBJSMSXLP-UHFFFAOYSA-M acid orange 7 Chemical compound [Na+].OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 CQPFMGBJSMSXLP-UHFFFAOYSA-M 0.000 description 1
- LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 description 1
- 229960002916 adapalene Drugs 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical class OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 1
- 229960000552 alclometasone Drugs 0.000 description 1
- DJHCCTTVDRAMEH-DUUJBDRPSA-N alclometasone dipropionate Chemical compound C([C@H]1Cl)C2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O DJHCCTTVDRAMEH-DUUJBDRPSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 229960001900 algestone Drugs 0.000 description 1
- CXDWHYOBSJTRJU-SRWWVFQWSA-N algestone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@@H](O)[C@@](C(=O)C)(O)[C@@]1(C)CC2 CXDWHYOBSJTRJU-SRWWVFQWSA-N 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 125000005157 alkyl carboxy group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 235000012741 allura red AC Nutrition 0.000 description 1
- 239000004191 allura red AC Substances 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 239000001140 aloe barbadensis leaf extract Substances 0.000 description 1
- 108010029483 alpha 1 Chain Collagen Type I Proteins 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- LVRFTAZAXQPQHI-UHFFFAOYSA-N alpha-hydroxyisocaproic acid Natural products CC(C)CC(O)C(O)=O LVRFTAZAXQPQHI-UHFFFAOYSA-N 0.000 description 1
- UZFLPKAIBPNNCA-BQYQJAHWSA-N alpha-ionone Chemical compound CC(=O)\C=C\C1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-BQYQJAHWSA-N 0.000 description 1
- UZFLPKAIBPNNCA-UHFFFAOYSA-N alpha-ionone Natural products CC(=O)C=CC1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-UHFFFAOYSA-N 0.000 description 1
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 229960003099 amcinonide Drugs 0.000 description 1
- ILKJAFIWWBXGDU-MOGDOJJUSA-N amcinonide Chemical compound O([C@@]1([C@H](O2)C[C@@H]3[C@@]1(C[C@H](O)[C@]1(F)[C@@]4(C)C=CC(=O)C=C4CC[C@H]13)C)C(=O)COC(=O)C)C12CCCC1 ILKJAFIWWBXGDU-MOGDOJJUSA-N 0.000 description 1
- 229960004821 amikacin Drugs 0.000 description 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000010407 ammonium alginate Nutrition 0.000 description 1
- 239000000728 ammonium alginate Substances 0.000 description 1
- KPGABFJTMYCRHJ-YZOKENDUSA-N ammonium alginate Chemical compound [NH4+].[NH4+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O KPGABFJTMYCRHJ-YZOKENDUSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 239000010868 animal carcass Substances 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940105969 annatto extract Drugs 0.000 description 1
- 239000000420 anogeissus latifolia wall. gum Substances 0.000 description 1
- NUZWLKWWNNJHPT-UHFFFAOYSA-N anthralin Chemical compound C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O NUZWLKWWNNJHPT-UHFFFAOYSA-N 0.000 description 1
- 239000001000 anthraquinone dye Substances 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 229940111136 antiinflammatory and antirheumatic drug fenamates Drugs 0.000 description 1
- 229940111133 antiinflammatory and antirheumatic drug oxicams Drugs 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000010477 apricot oil Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 229940011019 arthrospira platensis Drugs 0.000 description 1
- MDJRZSNPHZEMJH-MTMZYOSNSA-N artisone acetate Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)COC(=O)C)[C@@]1(C)CC2 MDJRZSNPHZEMJH-MTMZYOSNSA-N 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 229940091771 aspergillus fumigatus Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- UHHXUPJJDHEMGX-UHFFFAOYSA-K azanium;manganese(3+);phosphonato phosphate Chemical compound [NH4+].[Mn+3].[O-]P([O-])(=O)OP([O-])([O-])=O UHHXUPJJDHEMGX-UHFFFAOYSA-K 0.000 description 1
- 229960002255 azelaic acid Drugs 0.000 description 1
- 229960004099 azithromycin Drugs 0.000 description 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
- 229960003623 azlocillin Drugs 0.000 description 1
- JTWOMNBEOCYFNV-NFFDBFGFSA-N azlocillin Chemical compound N([C@@H](C(=O)N[C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C=1C=CC=CC=1)C(=O)N1CCNC1=O JTWOMNBEOCYFNV-NFFDBFGFSA-N 0.000 description 1
- 239000000987 azo dye Substances 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 229940092705 beclomethasone Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 235000015191 beet juice Nutrition 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- BJFLSHMHTPAZHO-UHFFFAOYSA-N benzotriazole Chemical compound [CH]1C=CC=C2N=NN=C21 BJFLSHMHTPAZHO-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 229960004024 besifloxacin Drugs 0.000 description 1
- QFFGVLORLPOAEC-SNVBAGLBSA-N besifloxacin Chemical compound C1[C@H](N)CCCCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C3CC3)C2=C1Cl QFFGVLORLPOAEC-SNVBAGLBSA-N 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- POIARNZEYGURDG-FNORWQNLSA-N beta-damascenone Chemical compound C\C=C\C(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-FNORWQNLSA-N 0.000 description 1
- 229960002537 betamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- YZXZAUAIVAZWFN-UHFFFAOYSA-N bis(5-methyl-2-propan-2-ylcyclohexyl) butanedioate Chemical compound CC(C)C1CCC(C)CC1OC(=O)CCC(=O)OC1C(C(C)C)CCC(C)C1 YZXZAUAIVAZWFN-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 235000019481 bixa orellana extract Nutrition 0.000 description 1
- 235000021029 blackberry Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000007123 blue elder Nutrition 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- DBZJJPROPLPMSN-UHFFFAOYSA-N bromoeosin Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 DBZJJPROPLPMSN-UHFFFAOYSA-N 0.000 description 1
- 229940062650 buchu Drugs 0.000 description 1
- 229960004436 budesonide Drugs 0.000 description 1
- 229960005074 butoconazole Drugs 0.000 description 1
- SWLMUYACZKCSHZ-UHFFFAOYSA-N butoconazole Chemical compound C1=CC(Cl)=CC=C1CCC(SC=1C(=CC=CC=1Cl)Cl)CN1C=NC=C1 SWLMUYACZKCSHZ-UHFFFAOYSA-N 0.000 description 1
- DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 229940105847 calamine Drugs 0.000 description 1
- CYHOWEBNQPOWEI-UHFFFAOYSA-L calcium 3-carboxy-1-phenyldiazenylnaphthalen-2-olate Chemical compound OC=1C(=CC2=CC=CC=C2C1N=NC1=CC=CC=C1)C(=O)[O-].OC=1C(=CC2=CC=CC=C2C1N=NC1=CC=CC=C1)C(=O)[O-].[Ca+2] CYHOWEBNQPOWEI-UHFFFAOYSA-L 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229940080858 cancidas Drugs 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 239000001325 capsicum annuum l. var. longum oleoresin Substances 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 229940041011 carbapenems Drugs 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 229940114118 carminic acid Drugs 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 235000013709 carrot oil Nutrition 0.000 description 1
- 108010079058 casein hydrolysate Proteins 0.000 description 1
- 229940071162 caseinate Drugs 0.000 description 1
- OGUJBRYAAJYXQP-LLXMLGLCSA-N caspofungin acetate Chemical compound CC(O)=O.CC(O)=O.C1([C@H](O)[C@@H](O)[C@H]2C(=O)N[C@H](C(=O)N3CC[C@H](O)[C@H]3C(=O)N[C@H](NCCN)[C@H](O)C[C@@H](C(N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N2)[C@@H](C)O)=O)NC(=O)CCCCCCCCC(C)CC(C)CC)[C@H](O)CCN)=CC=C(O)C=C1 OGUJBRYAAJYXQP-LLXMLGLCSA-N 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- HCQPHKMLKXOJSR-IRCPFGJUSA-N cecropin-a Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](N)CCCCN)C1=CC=CC=C1 HCQPHKMLKXOJSR-IRCPFGJUSA-N 0.000 description 1
- DJYWGTBEZVORGE-CVWWDKSYSA-N cedr-8(15)-en-9-ol Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1C(=C)C(O)C2 DJYWGTBEZVORGE-CVWWDKSYSA-N 0.000 description 1
- IRAQOCYXUMOFCW-CXTNEJHOSA-N cedrene Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@H]1C(C)=CC2 IRAQOCYXUMOFCW-CXTNEJHOSA-N 0.000 description 1
- SVURIXNDRWRAFU-OGMFBOKVSA-N cedrol Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1[C@@](O)(C)CC2 SVURIXNDRWRAFU-OGMFBOKVSA-N 0.000 description 1
- 229940026455 cedrol Drugs 0.000 description 1
- PCROEXHGMUJCDB-UHFFFAOYSA-N cedrol Natural products CC1CCC2C(C)(C)C3CC(C)(O)CC12C3 PCROEXHGMUJCDB-UHFFFAOYSA-N 0.000 description 1
- HRGPYCVTDOECMG-UHFFFAOYSA-N cedrol methyl ether Chemical compound COC1(C)CCC2(C(CC3)C)C3C(C)(C)C1C2 HRGPYCVTDOECMG-UHFFFAOYSA-N 0.000 description 1
- QYIYFLOTGYLRGG-GPCCPHFNSA-N cefaclor Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CS[C@@H]32)C(O)=O)=O)N)=CC=CC=C1 QYIYFLOTGYLRGG-GPCCPHFNSA-N 0.000 description 1
- 229960005361 cefaclor Drugs 0.000 description 1
- CZTQZXZIADLWOZ-CRAIPNDOSA-N cefaloridine Chemical compound O=C([C@@H](NC(=O)CC=1SC=CC=1)[C@H]1SC2)N1C(C(=O)[O-])=C2C[N+]1=CC=CC=C1 CZTQZXZIADLWOZ-CRAIPNDOSA-N 0.000 description 1
- 229960003866 cefaloridine Drugs 0.000 description 1
- OLVCFLKTBJRLHI-AXAPSJFSSA-N cefamandole Chemical compound CN1N=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)[C@H](O)C=3C=CC=CC=3)[C@H]2SC1 OLVCFLKTBJRLHI-AXAPSJFSSA-N 0.000 description 1
- 229960003012 cefamandole Drugs 0.000 description 1
- 229960004350 cefapirin Drugs 0.000 description 1
- 229960001139 cefazolin Drugs 0.000 description 1
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 1
- 229960003719 cefdinir Drugs 0.000 description 1
- RTXOFQZKPXMALH-GHXIOONMSA-N cefdinir Chemical compound S1C(N)=NC(C(=N\O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 RTXOFQZKPXMALH-GHXIOONMSA-N 0.000 description 1
- 229960002100 cefepime Drugs 0.000 description 1
- HVFLCNVBZFFHBT-ZKDACBOMSA-O cefepime(1+) Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1C[N+]1(C)CCCC1 HVFLCNVBZFFHBT-ZKDACBOMSA-O 0.000 description 1
- 229960002129 cefixime Drugs 0.000 description 1
- OKBVVJOGVLARMR-QSWIMTSFSA-N cefixime Chemical compound S1C(N)=NC(C(=N\OCC(O)=O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 OKBVVJOGVLARMR-QSWIMTSFSA-N 0.000 description 1
- SNBUBQHDYVFSQF-HIFRSBDPSA-N cefmetazole Chemical compound S([C@@H]1[C@@](C(N1C=1C(O)=O)=O)(NC(=O)CSCC#N)OC)CC=1CSC1=NN=NN1C SNBUBQHDYVFSQF-HIFRSBDPSA-N 0.000 description 1
- 229960003585 cefmetazole Drugs 0.000 description 1
- GCFBRXLSHGKWDP-XCGNWRKASA-N cefoperazone Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 GCFBRXLSHGKWDP-XCGNWRKASA-N 0.000 description 1
- 229960004682 cefoperazone Drugs 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 1
- 229960002682 cefoxitin Drugs 0.000 description 1
- 229960000466 cefpirome Drugs 0.000 description 1
- DKOQGJHPHLTOJR-WHRDSVKCSA-N cefpirome Chemical compound N([C@@H]1C(N2C(=C(C[N+]=3C=4CCCC=4C=CC=3)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 DKOQGJHPHLTOJR-WHRDSVKCSA-N 0.000 description 1
- WYUSVOMTXWRGEK-HBWVYFAYSA-N cefpodoxime Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC)C(O)=O)C(=O)C(=N/OC)\C1=CSC(N)=N1 WYUSVOMTXWRGEK-HBWVYFAYSA-N 0.000 description 1
- 229960005090 cefpodoxime Drugs 0.000 description 1
- 229960002580 cefprozil Drugs 0.000 description 1
- 229960002588 cefradine Drugs 0.000 description 1
- 229960000484 ceftazidime Drugs 0.000 description 1
- ORFOPKXBNMVMKC-DWVKKRMSSA-N ceftazidime Chemical compound S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 ORFOPKXBNMVMKC-DWVKKRMSSA-N 0.000 description 1
- 229960004086 ceftibuten Drugs 0.000 description 1
- UNJFKXSSGBWRBZ-BJCIPQKHSA-N ceftibuten Chemical compound S1C(N)=NC(C(=C\CC(O)=O)\C(=O)N[C@@H]2C(N3C(=CCS[C@@H]32)C(O)=O)=O)=C1 UNJFKXSSGBWRBZ-BJCIPQKHSA-N 0.000 description 1
- 229960001991 ceftizoxime Drugs 0.000 description 1
- NNULBSISHYWZJU-LLKWHZGFSA-N ceftizoxime Chemical compound N([C@@H]1C(N2C(=CCS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 NNULBSISHYWZJU-LLKWHZGFSA-N 0.000 description 1
- 229960004755 ceftriaxone Drugs 0.000 description 1
- VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 description 1
- 229960001668 cefuroxime Drugs 0.000 description 1
- JFPVXVDWJQMJEE-IZRZKJBUSA-N cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 JFPVXVDWJQMJEE-IZRZKJBUSA-N 0.000 description 1
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 description 1
- 229960000590 celecoxib Drugs 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229940106164 cephalexin Drugs 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- RDLPVSKMFDYCOR-UEKVPHQBSA-N cephradine Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CCC=CC1 RDLPVSKMFDYCOR-UEKVPHQBSA-N 0.000 description 1
- 229940044927 ceric oxide Drugs 0.000 description 1
- CETPSERCERDGAM-UHFFFAOYSA-N ceric oxide Chemical compound O=[Ce]=O CETPSERCERDGAM-UHFFFAOYSA-N 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 229910000422 cerium(IV) oxide Inorganic materials 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940048851 cetyl ricinoleate Drugs 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- PZTQVMXMKVTIRC-UHFFFAOYSA-L chembl2028348 Chemical compound [Ca+2].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 PZTQVMXMKVTIRC-UHFFFAOYSA-L 0.000 description 1
- DDTDNCYHLGRFBM-YZEKDTGTSA-N chembl2367892 Chemical compound CC(=O)N[C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O[C@@H]([C@H]1C(N[C@@H](C2=CC(O)=CC(O[C@@H]3[C@H]([C@H](O)[C@H](O)[C@@H](CO)O3)O)=C2C=2C(O)=CC=C(C=2)[C@@H](NC(=O)[C@@H]2NC(=O)[C@@H]3C=4C=C(O)C=C(C=4)OC=4C(O)=CC=C(C=4)[C@@H](N)C(=O)N[C@H](CC=4C=C(Cl)C(O5)=CC=4)C(=O)N3)C(=O)N1)C(O)=O)=O)C(C=C1Cl)=CC=C1OC1=C(O[C@H]3[C@H]([C@@H](O)[C@H](O)[C@H](CO)O3)NC(C)=O)C5=CC2=C1 DDTDNCYHLGRFBM-YZEKDTGTSA-N 0.000 description 1
- RKLXDNHNLPUQRB-TVJUEJKUSA-N chembl564271 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]2C(C)SC[C@H](N[C@@H](CC(N)=O)C(=O)NC(=O)[C@@H](NC2=O)CSC1C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NC(=C)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H]1NC(=O)C(=C\C)/NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@@H](NC(=O)[C@H]3N[C@@H](CC(C)C)C(=O)NC(=O)C(=C)NC(=O)CC[C@H](NC(=O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC=4C5=CC=CC=C5NC=4)CSC3)C(O)=O)C(C)SC2)C(C)C)C(C)SC1)C1=CC=CC=C1 RKLXDNHNLPUQRB-TVJUEJKUSA-N 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000020235 chia seed Nutrition 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000019805 chlorophyllin Nutrition 0.000 description 1
- NPSLCOWKFFNQKK-ZPSUVKRCSA-N chloroprednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3C[C@H](Cl)C2=C1 NPSLCOWKFFNQKK-ZPSUVKRCSA-N 0.000 description 1
- 229950006229 chloroprednisone Drugs 0.000 description 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
- 229960004475 chlortetracycline Drugs 0.000 description 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-M cholate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-M 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- QFSKIUZTIHBWFR-UHFFFAOYSA-N chromium;hydrate Chemical compound O.[Cr] QFSKIUZTIHBWFR-UHFFFAOYSA-N 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 229960003749 ciclopirox Drugs 0.000 description 1
- SCKYRAXSEDYPSA-UHFFFAOYSA-N ciclopirox Chemical compound ON1C(=O)C=C(C)C=C1C1CCCCC1 SCKYRAXSEDYPSA-UHFFFAOYSA-N 0.000 description 1
- 229960004375 ciclopirox olamine Drugs 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 229960002626 clarithromycin Drugs 0.000 description 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 229960003344 climbazole Drugs 0.000 description 1
- QGPKADBNRMWEQR-UHFFFAOYSA-N clinafloxacin Chemical compound C1C(N)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C3CC3)C2=C1Cl QGPKADBNRMWEQR-UHFFFAOYSA-N 0.000 description 1
- 229950001320 clinafloxacin Drugs 0.000 description 1
- 229960002842 clobetasol Drugs 0.000 description 1
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 description 1
- 229960004299 clocortolone Drugs 0.000 description 1
- YMTMADLUXIRMGX-RFPWEZLHSA-N clocortolone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(Cl)[C@@H]2[C@@H]2C[C@@H](C)[C@H](C(=O)CO)[C@@]2(C)C[C@@H]1O YMTMADLUXIRMGX-RFPWEZLHSA-N 0.000 description 1
- 229960002219 cloprednol Drugs 0.000 description 1
- YTJIBEDMAQUYSZ-FDNPDPBUSA-N cloprednol Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3C=C(Cl)C2=C1 YTJIBEDMAQUYSZ-FDNPDPBUSA-N 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- 239000011280 coal tar Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940080423 cochineal Drugs 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- ZNEWHQLOPFWXOF-UHFFFAOYSA-N coenzyme M Chemical compound OS(=O)(=O)CCS ZNEWHQLOPFWXOF-UHFFFAOYSA-N 0.000 description 1
- 229960003346 colistin Drugs 0.000 description 1
- 229940052366 colloidal oatmeal Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- QHNCWVQDOPICKC-UHFFFAOYSA-N copper;1-hydroxypyridine-2-thione Chemical compound [Cu].ON1C=CC=CC1=S.ON1C=CC=CC1=S QHNCWVQDOPICKC-UHFFFAOYSA-N 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 229960003840 cortivazol Drugs 0.000 description 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
- 229940111134 coxibs Drugs 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 231100000429 cutaneous necrosis Toxicity 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- YKFKEYKJGVSEIX-UHFFFAOYSA-N cyclohexanone, 4-(1,1-dimethylethyl)- Chemical compound CC(C)(C)C1CCC(=O)CC1 YKFKEYKJGVSEIX-UHFFFAOYSA-N 0.000 description 1
- FGEUKKGODAGXOD-FMIVXFBMSA-N cyclohexyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound C1=CC(OC)=CC=C1\C=C\C(=O)OC1CCCCC1 FGEUKKGODAGXOD-FMIVXFBMSA-N 0.000 description 1
- NUQDJSMHGCTKNL-UHFFFAOYSA-N cyclohexyl 2-hydroxybenzoate Chemical compound OC1=CC=CC=C1C(=O)OC1CCCCC1 NUQDJSMHGCTKNL-UHFFFAOYSA-N 0.000 description 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229940075482 d & c green 5 Drugs 0.000 description 1
- 229940075479 d & c red no. 27 Drugs 0.000 description 1
- 229940099441 d&c blue no. 4 Drugs 0.000 description 1
- 229940106008 d&c brown no. 1 Drugs 0.000 description 1
- 229940086624 d&c orange no. 10 Drugs 0.000 description 1
- 229940099449 d&c orange no. 4 Drugs 0.000 description 1
- 229940090962 d&c orange no. 5 Drugs 0.000 description 1
- 229940058010 d&c red no. 21 Drugs 0.000 description 1
- 229940056316 d&c red no. 28 Drugs 0.000 description 1
- 229940075484 d&c red no. 30 Drugs 0.000 description 1
- 229940047180 d&c red no. 34 Drugs 0.000 description 1
- 229940075493 d&c red no. 6 Drugs 0.000 description 1
- 229940057946 d&c red no. 7 Drugs 0.000 description 1
- 229940096890 d&c violet no. 2 Drugs 0.000 description 1
- 229940051157 d&c yellow no. 11 Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229960000958 deferoxamine Drugs 0.000 description 1
- 229960001145 deflazacort Drugs 0.000 description 1
- FBHSPRKOSMHSIF-GRMWVWQJSA-N deflazacort Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(C)=N[C@@]3(C(=O)COC(=O)C)[C@@]1(C)C[C@@H]2O FBHSPRKOSMHSIF-GRMWVWQJSA-N 0.000 description 1
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 1
- 229960002398 demeclocycline Drugs 0.000 description 1
- 229940009976 deoxycholate Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-M deoxycholate Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-M 0.000 description 1
- 229960003662 desonide Drugs 0.000 description 1
- WBGKWQHBNHJJPZ-LECWWXJVSA-N desonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O WBGKWQHBNHJJPZ-LECWWXJVSA-N 0.000 description 1
- 229960002593 desoximetasone Drugs 0.000 description 1
- VWVSBHGCDBMOOT-IIEHVVJPSA-N desoximetasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@@H]2O VWVSBHGCDBMOOT-IIEHVVJPSA-N 0.000 description 1
- 230000003745 detangling effect Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- IRAQOCYXUMOFCW-UHFFFAOYSA-N di-epi-alpha-cedrene Natural products C1C23C(C)CCC3C(C)(C)C1C(C)=CC2 IRAQOCYXUMOFCW-UHFFFAOYSA-N 0.000 description 1
- TVCBMJCHKADLEE-UHFFFAOYSA-N diazanium;2-[[4-[ethyl-[(4-sulfonatophenyl)methyl]amino]phenyl]-[4-[ethyl-[(4-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]benzenesulfonate Chemical compound [NH4+].[NH4+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=CC(=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=C(S([O-])(=O)=O)C=C1 TVCBMJCHKADLEE-UHFFFAOYSA-N 0.000 description 1
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 1
- 229960001083 diazolidinylurea Drugs 0.000 description 1
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical group C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 1
- 125000004188 dichlorophenyl group Chemical group 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 229960001585 dicloxacillin Drugs 0.000 description 1
- YFAGHNZHGGCZAX-JKIFEVAISA-N dicloxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl YFAGHNZHGGCZAX-JKIFEVAISA-N 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 229960004154 diflorasone Drugs 0.000 description 1
- WXURHACBFYSXBI-XHIJKXOTSA-N diflorasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H](C)[C@@](C(=O)CO)(O)[C@@]2(C)C[C@@H]1O WXURHACBFYSXBI-XHIJKXOTSA-N 0.000 description 1
- 229960004091 diflucortolone Drugs 0.000 description 1
- OGPWIDANBSLJPC-RFPWEZLHSA-N diflucortolone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@H](C(=O)CO)[C@@]2(C)C[C@@H]1O OGPWIDANBSLJPC-RFPWEZLHSA-N 0.000 description 1
- HUPFGZXOMWLGNK-UHFFFAOYSA-N diflunisal Chemical compound C1=C(O)C(C(=O)O)=CC(C=2C(=CC(F)=CC=2)F)=C1 HUPFGZXOMWLGNK-UHFFFAOYSA-N 0.000 description 1
- 229960000616 diflunisal Drugs 0.000 description 1
- 229960004875 difluprednate Drugs 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 description 1
- JFVXEJADITYJHK-UHFFFAOYSA-L disodium 2-(3-hydroxy-5-sulfonato-1H-indol-2-yl)-3-oxoindole-5-sulfonate Chemical compound [Na+].[Na+].Oc1c([nH]c2ccc(cc12)S([O-])(=O)=O)C1=Nc2ccc(cc2C1=O)S([O-])(=O)=O JFVXEJADITYJHK-UHFFFAOYSA-L 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- LQJVOKWHGUAUHK-UHFFFAOYSA-L disodium 5-amino-4-hydroxy-3-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].OC1=C2C(N)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 LQJVOKWHGUAUHK-UHFFFAOYSA-L 0.000 description 1
- NJDNXYGOVLYJHP-UHFFFAOYSA-L disodium;2-(3-oxido-6-oxoxanthen-9-yl)benzoate Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC([O-])=CC=C21 NJDNXYGOVLYJHP-UHFFFAOYSA-L 0.000 description 1
- AHSJNHONMVUMLK-UHFFFAOYSA-L disodium;4',5'-diiodo-3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate Chemical compound [Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC=C([O-])C(I)=C1OC1=C(I)C([O-])=CC=C21 AHSJNHONMVUMLK-UHFFFAOYSA-L 0.000 description 1
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
- 150000002019 disulfides Chemical class 0.000 description 1
- NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical class OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 1
- 229960002311 dithranol Drugs 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- 235000021038 drupes Nutrition 0.000 description 1
- 239000002706 dry binder Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 235000007124 elderberry Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000004862 elemi Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 229960002549 enoxacin Drugs 0.000 description 1
- IDYZIJYBMGIQMJ-UHFFFAOYSA-N enoxacin Chemical compound N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 IDYZIJYBMGIQMJ-UHFFFAOYSA-N 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229940007078 entamoeba histolytica Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 1
- 229940057841 eosine yellowish Drugs 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 108010064962 epidermin Proteins 0.000 description 1
- CXTXHTVXPMOOSW-JUEJINBGSA-N epidermin Chemical compound C([C@H]1C(=O)N[C@H](C(=O)N[C@@H](CSC[C@H](C(N[C@@H](CCCCN)C(=O)N1)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@H]1C(N2CCC[C@H]2C(=O)NCC(=O)N[C@@H](CS[C@H]1C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N\C(=C/C)C(=O)NCC(=O)N[C@H]1C(N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@H](C(N\C=C/SC2)=O)CSC1)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 CXTXHTVXPMOOSW-JUEJINBGSA-N 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- XRLCQRMNGQRGOC-MDZDMXLPSA-N ethyl (e)-3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(C(C)C)C=C1C(C)C XRLCQRMNGQRGOC-MDZDMXLPSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- XCRHYAQWBYDRGV-UHFFFAOYSA-N ethyl 3-(4-propan-2-ylphenyl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C(C(C)C)C=C1 XCRHYAQWBYDRGV-UHFFFAOYSA-N 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 229940067592 ethyl palmitate Drugs 0.000 description 1
- 229940117360 ethyl pyruvate Drugs 0.000 description 1
- JUOXYWXXPHUSAI-UHFFFAOYSA-N ethylamino acetate Chemical compound CCNOC(C)=O JUOXYWXXPHUSAI-UHFFFAOYSA-N 0.000 description 1
- 229960005293 etodolac Drugs 0.000 description 1
- XFBVBWWRPKNWHW-UHFFFAOYSA-N etodolac Chemical compound C1COC(CC)(CC(O)=O)C2=N[C]3C(CC)=CC=CC3=C21 XFBVBWWRPKNWHW-UHFFFAOYSA-N 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- 229960001419 fenoprofen Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 229960003306 fleroxacin Drugs 0.000 description 1
- XBJBPGROQZJDOJ-UHFFFAOYSA-N fleroxacin Chemical compound C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(CCF)C2=C1F XBJBPGROQZJDOJ-UHFFFAOYSA-N 0.000 description 1
- 229950002335 fluazacort Drugs 0.000 description 1
- BYZCJOHDXLROEC-RBWIMXSLSA-N fluazacort Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)=N[C@@]3(C(=O)COC(=O)C)[C@@]1(C)C[C@@H]2O BYZCJOHDXLROEC-RBWIMXSLSA-N 0.000 description 1
- NJNWEGFJCGYWQT-VSXGLTOVSA-N fluclorolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(Cl)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1Cl NJNWEGFJCGYWQT-VSXGLTOVSA-N 0.000 description 1
- 229940094766 flucloronide Drugs 0.000 description 1
- 229960004511 fludroxycortide Drugs 0.000 description 1
- 229960003469 flumetasone Drugs 0.000 description 1
- WXURHACBFYSXBI-GQKYHHCASA-N flumethasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]2(C)C[C@@H]1O WXURHACBFYSXBI-GQKYHHCASA-N 0.000 description 1
- 229960000676 flunisolide Drugs 0.000 description 1
- 229960001347 fluocinolone acetonide Drugs 0.000 description 1
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 1
- 229960000785 fluocinonide Drugs 0.000 description 1
- 229950008509 fluocortin butyl Drugs 0.000 description 1
- XWTIDFOGTCVGQB-FHIVUSPVSA-N fluocortin butyl Chemical group C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@@H](C)[C@H](C(=O)C(=O)OCCCC)[C@@]2(C)C[C@@H]1O XWTIDFOGTCVGQB-FHIVUSPVSA-N 0.000 description 1
- 229960003973 fluocortolone Drugs 0.000 description 1
- GAKMQHDJQHZUTJ-ULHLPKEOSA-N fluocortolone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@@H](C)[C@H](C(=O)CO)[C@@]2(C)C[C@@H]1O GAKMQHDJQHZUTJ-ULHLPKEOSA-N 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 229960003590 fluperolone Drugs 0.000 description 1
- HHPZZKDXAFJLOH-QZIXMDIESA-N fluperolone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1CC[C@@](C(=O)[C@@H](OC(C)=O)C)(O)[C@@]1(C)C[C@@H]2O HHPZZKDXAFJLOH-QZIXMDIESA-N 0.000 description 1
- 229960002650 fluprednidene acetate Drugs 0.000 description 1
- DEFOZIFYUBUHHU-IYQKUMFPSA-N fluprednidene acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1CC(=C)[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O DEFOZIFYUBUHHU-IYQKUMFPSA-N 0.000 description 1
- 229960000618 fluprednisolone Drugs 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 229960000289 fluticasone propionate Drugs 0.000 description 1
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 description 1
- 229960000671 formocortal Drugs 0.000 description 1
- QNXUUBBKHBYRFW-QWAPGEGQSA-N formocortal Chemical compound C1C(C=O)=C2C=C(OCCCl)CC[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)C)[C@@]1(C)C[C@@H]2O QNXUUBBKHBYRFW-QWAPGEGQSA-N 0.000 description 1
- YMDXZJFXQJVXBF-STHAYSLISA-N fosfomycin Chemical compound C[C@@H]1O[C@@H]1P(O)(O)=O YMDXZJFXQJVXBF-STHAYSLISA-N 0.000 description 1
- YNDMEEULGSTYJT-LURJTMIESA-N foslevodopa Chemical compound OC(=O)[C@@H](N)CC1=CC=C(OP(O)(O)=O)C(O)=C1 YNDMEEULGSTYJT-LURJTMIESA-N 0.000 description 1
- 150000002241 furanones Chemical class 0.000 description 1
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 description 1
- 108010047651 gallidermin Proteins 0.000 description 1
- AHMZTHYNOXWCBS-PCUVAHMGSA-N gallidermin Chemical compound C([C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CSC[C@H](C(N[C@@H](CCCCN)C(=O)N1)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@H]1C(N2CCC[C@H]2C(=O)NCC(=O)N[C@H](CS[C@H]1C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N\C(=C\C)C(=O)NCC(=O)N[C@H]1C(N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](C(N/C=C/SC2)=O)CSC1)=O)=O)C1=CC=CC=C1 AHMZTHYNOXWCBS-PCUVAHMGSA-N 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 229960001430 garenoxacin Drugs 0.000 description 1
- NJDRXTDGYFKORP-LLVKDONJSA-N garenoxacin Chemical compound N([C@@H](C1=CC=2)C)CC1=CC=2C(C=1OC(F)F)=CC=C(C(C(C(O)=O)=C2)=O)C=1N2C1CC1 NJDRXTDGYFKORP-LLVKDONJSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 229960003923 gatifloxacin Drugs 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229960003170 gemifloxacin Drugs 0.000 description 1
- ZRCVYEYHRGVLOC-HYARGMPZSA-N gemifloxacin Chemical compound C1C(CN)C(=N/OC)/CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1CC1 ZRCVYEYHRGVLOC-HYARGMPZSA-N 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 229940085435 giardia lamblia Drugs 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229960002849 glucosamine sulfate Drugs 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 235000013761 grape skin extract Nutrition 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 239000005431 greenhouse gas Substances 0.000 description 1
- 229960000642 grepafloxacin Drugs 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000019314 gum ghatti Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 229960002383 halcinonide Drugs 0.000 description 1
- 229960002475 halometasone Drugs 0.000 description 1
- GGXMRPUKBWXVHE-MIHLVHIWSA-N halometasone Chemical compound C1([C@@H](F)C2)=CC(=O)C(Cl)=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]2(C)C[C@@H]1O GGXMRPUKBWXVHE-MIHLVHIWSA-N 0.000 description 1
- 229950004611 halopredone acetate Drugs 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- 229910052864 hemimorphite Inorganic materials 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- BNSYGCKJOAPBCM-UHFFFAOYSA-N heptan-2-ol Chemical compound [CH2]C(O)CCCCC BNSYGCKJOAPBCM-UHFFFAOYSA-N 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- XAMHKORMKJIEFW-AYTKPMRMSA-N hexadecyl (z,12r)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC XAMHKORMKJIEFW-AYTKPMRMSA-N 0.000 description 1
- QAKXLTNAJLFSQC-UHFFFAOYSA-N hexadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC QAKXLTNAJLFSQC-UHFFFAOYSA-N 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940106579 hops extract Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000001906 humulus lupulus l. absolute Substances 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- FWFVLWGEFDIZMJ-FOMYWIRZSA-N hydrocortamate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)CN(CC)CC)(O)[C@@]1(C)C[C@@H]2O FWFVLWGEFDIZMJ-FOMYWIRZSA-N 0.000 description 1
- 229950000208 hydrocortamate Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- DLINORNFHVEIFE-UHFFFAOYSA-N hydrogen peroxide;zinc Chemical compound [Zn].OO DLINORNFHVEIFE-UHFFFAOYSA-N 0.000 description 1
- 239000008309 hydrophilic cream Substances 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 229920013818 hydroxypropyl guar gum Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 125000000879 imine group Chemical group 0.000 description 1
- 229960002182 imipenem Drugs 0.000 description 1
- ZSKVGTPCRGIANV-ZXFLCMHBSA-N imipenem Chemical compound C1C(SCC\N=C\N)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21 ZSKVGTPCRGIANV-ZXFLCMHBSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- KHLVKKOJDHCJMG-QDBORUFSSA-L indigo carmine Chemical compound [Na+].[Na+].N/1C2=CC=C(S([O-])(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)[O-])C=C2C1=O KHLVKKOJDHCJMG-QDBORUFSSA-L 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 108700003621 insect attacin antibacterial Proteins 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- DDFOUSQFMYRUQK-RCDICMHDSA-N isavuconazole Chemical compound C=1SC([C@H](C)[C@](O)(CN2N=CN=C2)C=2C(=CC=C(F)C=2)F)=NC=1C1=CC=C(C#N)C=C1 DDFOUSQFMYRUQK-RCDICMHDSA-N 0.000 description 1
- 229960000788 isavuconazole Drugs 0.000 description 1
- UDIIBEDMEYAVNG-ZKFPOVNWSA-N isepamicin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)O)[C@@H](N)C[C@H]1NC(=O)[C@@H](O)CN UDIIBEDMEYAVNG-ZKFPOVNWSA-N 0.000 description 1
- 229960000798 isepamicin Drugs 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-M isobutyrate Chemical compound CC(C)C([O-])=O KQNPFQTWMSNSAP-UHFFFAOYSA-M 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940095045 isopulegol Drugs 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229960004130 itraconazole Drugs 0.000 description 1
- 239000012182 japan wax Substances 0.000 description 1
- SVURIXNDRWRAFU-UHFFFAOYSA-N juniperanol Natural products C1C23C(C)CCC3C(C)(C)C1C(O)(C)CC2 SVURIXNDRWRAFU-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 description 1
- 239000003835 ketolide antibiotic agent Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 229960004752 ketorolac Drugs 0.000 description 1
- OZWKMVRBQXNZKK-UHFFFAOYSA-N ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 description 1
- 229940031154 kluyveromyces marxianus Drugs 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 229940001882 lactobacillus reuteri Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 229910052629 lepidolite Inorganic materials 0.000 description 1
- 229960003376 levofloxacin Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- SDQFDHOLCGWZPU-UHFFFAOYSA-N lilial Chemical compound O=CC(C)CC1=CC=C(C(C)(C)C)C=C1 SDQFDHOLCGWZPU-UHFFFAOYSA-N 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229960005287 lincomycin Drugs 0.000 description 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 1
- 229940041028 lincosamides Drugs 0.000 description 1
- 229960003907 linezolid Drugs 0.000 description 1
- TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- JXNPEDYJTDQORS-UHFFFAOYSA-N linoleyl alcohol Natural products CCCCCC=CCC=CCCCCCCCCO JXNPEDYJTDQORS-UHFFFAOYSA-N 0.000 description 1
- 230000004576 lipid-binding Effects 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000008308 lipophilic cream Substances 0.000 description 1
- 235000010187 litholrubine BK Nutrition 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229960002422 lomefloxacin Drugs 0.000 description 1
- ZEKZLJVOYLTDKK-UHFFFAOYSA-N lomefloxacin Chemical compound FC1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1 ZEKZLJVOYLTDKK-UHFFFAOYSA-N 0.000 description 1
- 229960001977 loracarbef Drugs 0.000 description 1
- JAPHQRWPEGVNBT-UTUOFQBUSA-N loracarbef Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CC[C@@H]32)C([O-])=O)=O)[NH3+])=CC=CC=C1 JAPHQRWPEGVNBT-UTUOFQBUSA-N 0.000 description 1
- 229960003744 loteprednol etabonate Drugs 0.000 description 1
- DMKSVUSAATWOCU-HROMYWEYSA-N loteprednol etabonate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)OCCl)(OC(=O)OCC)[C@@]1(C)C[C@@H]2O DMKSVUSAATWOCU-HROMYWEYSA-N 0.000 description 1
- 229950005519 lucimycin Drugs 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 239000001115 mace Substances 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229940041033 macrolides Drugs 0.000 description 1
- QWDJLDTYWNBUKE-UHFFFAOYSA-L magnesium bicarbonate Chemical compound [Mg+2].OC([O-])=O.OC([O-])=O QWDJLDTYWNBUKE-UHFFFAOYSA-L 0.000 description 1
- 239000002370 magnesium bicarbonate Substances 0.000 description 1
- 229910000022 magnesium bicarbonate Inorganic materials 0.000 description 1
- 235000014824 magnesium bicarbonate Nutrition 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229940105112 magnesium myristate Drugs 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 235000012243 magnesium silicates Nutrition 0.000 description 1
- 229940057948 magnesium stearate Drugs 0.000 description 1
- DMRBHZWQMKSQGR-UHFFFAOYSA-L magnesium;tetradecanoate Chemical compound [Mg+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O DMRBHZWQMKSQGR-UHFFFAOYSA-L 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052630 margarite Inorganic materials 0.000 description 1
- 229950002555 mazipredone Drugs 0.000 description 1
- CZBOZZDZNVIXFC-VRRJBYJJSA-N mazipredone Chemical compound C1CN(C)CCN1CC(=O)[C@]1(O)[C@@]2(C)C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2CC1 CZBOZZDZNVIXFC-VRRJBYJJSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229960000826 meclocycline Drugs 0.000 description 1
- 229960001011 medrysone Drugs 0.000 description 1
- 229960003464 mefenamic acid Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 1
- 229960004665 menthyl salicylate Drugs 0.000 description 1
- 229960001810 meprednisone Drugs 0.000 description 1
- PIDANAQULIKBQS-RNUIGHNZSA-N meprednisone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)CC2=O PIDANAQULIKBQS-RNUIGHNZSA-N 0.000 description 1
- 229960002260 meropenem Drugs 0.000 description 1
- DMJNNHOOLUXYBV-PQTSNVLCSA-N meropenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](C(=O)N(C)C)C1 DMJNNHOOLUXYBV-PQTSNVLCSA-N 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229940042016 methacycline Drugs 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- KVWWIYGFBYDJQC-MNOVXSKESA-N methyl 2-[(1r,2s)-3-oxo-2-pentylcyclopentyl]acetate Chemical compound CCCCC[C@H]1[C@@H](CC(=O)OC)CCC1=O KVWWIYGFBYDJQC-MNOVXSKESA-N 0.000 description 1
- YKWKFUUHPFWRNV-UHFFFAOYSA-N methyl 3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC=C(C(C)C)C=C1C(C)C YKWKFUUHPFWRNV-UHFFFAOYSA-N 0.000 description 1
- PABHEXWDYRTPBQ-UHFFFAOYSA-N methyl 3-[2,5-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC(C(C)C)=CC=C1C(C)C PABHEXWDYRTPBQ-UHFFFAOYSA-N 0.000 description 1
- HRGPYCVTDOECMG-RHBQXOTJSA-N methyl cedryl ether Chemical compound C1[C@@]23[C@H](C)CC[C@H]2C(C)(C)[C@]1([H])[C@@](OC)(C)CC3 HRGPYCVTDOECMG-RHBQXOTJSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- CWKLZLBVOJRSOM-UHFFFAOYSA-N methyl pyruvate Chemical compound COC(=O)C(C)=O CWKLZLBVOJRSOM-UHFFFAOYSA-N 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 229960004584 methylprednisolone Drugs 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- 108091005601 modified peptides Proteins 0.000 description 1
- 229960001664 mometasone Drugs 0.000 description 1
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 229960000990 monobenzone Drugs 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229960003702 moxifloxacin Drugs 0.000 description 1
- FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- ALHUZKCOMYUFRB-UHFFFAOYSA-N muskone Natural products CC1CCCCCCCCCCCCC(=O)C1 ALHUZKCOMYUFRB-UHFFFAOYSA-N 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- ZESIAEVDVPWEKB-ORCFLVBFSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O ZESIAEVDVPWEKB-ORCFLVBFSA-N 0.000 description 1
- JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229960004270 nabumetone Drugs 0.000 description 1
- 229960000515 nafcillin Drugs 0.000 description 1
- GPXLMGHLHQJAGZ-JTDSTZFVSA-N nafcillin Chemical compound C1=CC=CC2=C(C(=O)N[C@@H]3C(N4[C@H](C(C)(C)S[C@@H]43)C(O)=O)=O)C(OCC)=CC=C21 GPXLMGHLHQJAGZ-JTDSTZFVSA-N 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 description 1
- 229960000210 nalidixic acid Drugs 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-M naproxen(1-) Chemical compound C1=C([C@H](C)C([O-])=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-M 0.000 description 1
- 229960003255 natamycin Drugs 0.000 description 1
- 235000010298 natamycin Nutrition 0.000 description 1
- 239000004311 natamycin Substances 0.000 description 1
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 1
- ZYTMANIQRDEHIO-UHFFFAOYSA-N neo-Isopulegol Natural products CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 229960000808 netilmicin Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 229960000965 nimesulide Drugs 0.000 description 1
- HYWYRSMBCFDLJT-UHFFFAOYSA-N nimesulide Chemical compound CS(=O)(=O)NC1=CC=C([N+]([O-])=O)C=C1OC1=CC=CC=C1 HYWYRSMBCFDLJT-UHFFFAOYSA-N 0.000 description 1
- 239000004309 nisin Substances 0.000 description 1
- 235000010297 nisin Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 229960001699 ofloxacin Drugs 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- QQBDLJCYGRGAKP-FOCLMDBBSA-N olsalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=C(C(O)=CC=2)C(O)=O)=C1 QQBDLJCYGRGAKP-FOCLMDBBSA-N 0.000 description 1
- 229960004110 olsalazine Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000012168 ouricury wax Substances 0.000 description 1
- 229960001019 oxacillin Drugs 0.000 description 1
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 description 1
- OFPXSFXSNFPTHF-UHFFFAOYSA-N oxaprozin Chemical compound O1C(CCC(=O)O)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 OFPXSFXSNFPTHF-UHFFFAOYSA-N 0.000 description 1
- 229960002739 oxaprozin Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- 229960000321 oxolinic acid Drugs 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- LMXFTMYMHGYJEI-UHFFFAOYSA-N p-menthane-3,8-diol Chemical compound CC1CCC(C(C)(C)O)C(O)C1 LMXFTMYMHGYJEI-UHFFFAOYSA-N 0.000 description 1
- 229930006948 p-menthane-3,8-diol Natural products 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 244000138993 panchioli Species 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000001688 paprika extract Substances 0.000 description 1
- DYUUPIKEWLHQGQ-SDXBLLFJSA-N paprika oleoresin Chemical compound C(\[C@]12[C@@](O1)(C)C[C@@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=C[C@H]1C(C)=C[C@H](O)CC1(C)C DYUUPIKEWLHQGQ-SDXBLLFJSA-N 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229960002625 pazufloxacin Drugs 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 229960004236 pefloxacin Drugs 0.000 description 1
- FHFYDNQZQSQIAI-UHFFFAOYSA-N pefloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCN(C)CC1 FHFYDNQZQSQIAI-UHFFFAOYSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 229940056367 penicillin v Drugs 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- LVECZGHBXXYWBO-UHFFFAOYSA-N pentadecanolide Natural products CC1CCCCCCCCCCCCC(=O)O1 LVECZGHBXXYWBO-UHFFFAOYSA-N 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- BPLBGHOLXOTWMN-MBNYWOFBSA-N phenoxymethylpenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)COC1=CC=CC=C1 BPLBGHOLXOTWMN-MBNYWOFBSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- GVKCHTBDSMQENH-UHFFFAOYSA-L phloxine B Chemical compound [Na+].[Na+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 GVKCHTBDSMQENH-UHFFFAOYSA-L 0.000 description 1
- ZYIBVBKZZZDFOY-UHFFFAOYSA-N phloxine O Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 ZYIBVBKZZZDFOY-UHFFFAOYSA-N 0.000 description 1
- 150000008298 phosphoramidates Chemical class 0.000 description 1
- 229960001106 phthalylsulfathiazole Drugs 0.000 description 1
- PBMSWVPMRUJMPE-UHFFFAOYSA-N phthalylsulfathiazole Chemical compound OC(=O)C1=CC=CC=C1C(=O)NC1=CC=C(S(=O)(=O)\N=C\2SC=CN/2)C=C1 PBMSWVPMRUJMPE-UHFFFAOYSA-N 0.000 description 1
- CGIHFIDULQUVJG-UHFFFAOYSA-N phytantriol Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)(O)C(O)CO CGIHFIDULQUVJG-UHFFFAOYSA-N 0.000 description 1
- CGIHFIDULQUVJG-VNTMZGSJSA-N phytantriol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(O)[C@H](O)CO CGIHFIDULQUVJG-VNTMZGSJSA-N 0.000 description 1
- 229960002292 piperacillin Drugs 0.000 description 1
- WCMIIGXFCMNQDS-IDYPWDAWSA-M piperacillin sodium Chemical compound [Na+].O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C([O-])=O)C(C)(C)S[C@@H]21 WCMIIGXFCMNQDS-IDYPWDAWSA-M 0.000 description 1
- OIQJEQLSYJSNDS-UHFFFAOYSA-N piroctone Chemical compound CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O OIQJEQLSYJSNDS-UHFFFAOYSA-N 0.000 description 1
- 229940081510 piroctone olamine Drugs 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 235000021018 plums Nutrition 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920003217 poly(methylsilsesquioxane) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 150000004291 polyenes Chemical class 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 description 1
- KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 229960001589 posaconazole Drugs 0.000 description 1
- RAGOYPUPXAKGKH-XAKZXMRKSA-N posaconazole Chemical compound O=C1N([C@H]([C@H](C)O)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@H]3C[C@@](CN4N=CN=C4)(OC3)C=3C(=CC(F)=CC=3)F)=CC=2)C=C1 RAGOYPUPXAKGKH-XAKZXMRKSA-N 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 229930191090 pradimicin Natural products 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 229960002794 prednicarbate Drugs 0.000 description 1
- FNPXMHRZILFCKX-KAJVQRHHSA-N prednicarbate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)CC)(OC(=O)OCC)[C@@]1(C)C[C@@H]2O FNPXMHRZILFCKX-KAJVQRHHSA-N 0.000 description 1
- 229960002943 prednisolone sodium phosphate Drugs 0.000 description 1
- VJZLQIPZNBPASX-OJJGEMKLSA-L prednisolone sodium phosphate Chemical compound [Na+].[Na+].O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)COP([O-])([O-])=O)[C@@H]4[C@@H]3CCC2=C1 VJZLQIPZNBPASX-OJJGEMKLSA-L 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- BOFKYYWJAOZDPB-FZNHGJLXSA-N prednival Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O BOFKYYWJAOZDPB-FZNHGJLXSA-N 0.000 description 1
- 229950000696 prednival Drugs 0.000 description 1
- WSVOMANDJDYYEY-CWNVBEKCSA-N prednylidene Chemical group O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](C(=C)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 WSVOMANDJDYYEY-CWNVBEKCSA-N 0.000 description 1
- 229960001917 prednylidene Drugs 0.000 description 1
- WYGBHCSVNDTUKK-UHFFFAOYSA-N prop-1-ene Chemical group CC=C.CC=C.CC=C WYGBHCSVNDTUKK-UHFFFAOYSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- WUBJISGMPZWFKY-UHFFFAOYSA-N propan-2-yl 2-oxopropanoate Chemical compound CC(C)OC(=O)C(C)=O WUBJISGMPZWFKY-UHFFFAOYSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- WZXKPNYMUZGZIA-RMKNXTFCSA-N propyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCOC(=O)\C=C\C1=CC=C(OC)C=C1 WZXKPNYMUZGZIA-RMKNXTFCSA-N 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000012846 protein folding Effects 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 150000003217 pyrazoles Chemical class 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- MIXMJCQRHVAJIO-TZHJZOAOSA-N qk4dys664x Chemical compound O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O MIXMJCQRHVAJIO-TZHJZOAOSA-N 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- TVRGPOFMYCMNRB-UHFFFAOYSA-N quinizarine green ss Chemical compound C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1 TVRGPOFMYCMNRB-UHFFFAOYSA-N 0.000 description 1
- 229940051201 quinoline yellow Drugs 0.000 description 1
- 235000012752 quinoline yellow Nutrition 0.000 description 1
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 description 1
- FZUOVNMHEAPVBW-UHFFFAOYSA-L quinoline yellow ws Chemical compound [Na+].[Na+].O=C1C2=CC=CC=C2C(=O)C1C1=NC2=C(S([O-])(=O)=O)C=C(S(=O)(=O)[O-])C=C2C=C1 FZUOVNMHEAPVBW-UHFFFAOYSA-L 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 229960005442 quinupristin Drugs 0.000 description 1
- WTHRRGMBUAHGNI-LCYNINFDSA-N quinupristin Chemical compound N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N2C[C@@H](CS[C@H]3C4CCN(CC4)C3)C(=O)C[C@H]2C(=O)N[C@H](C(=O)O[C@@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O WTHRRGMBUAHGNI-LCYNINFDSA-N 0.000 description 1
- 108700028429 quinupristin Proteins 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 229950004154 ravuconazole Drugs 0.000 description 1
- OPAHEYNNJWPQPX-RCDICMHDSA-N ravuconazole Chemical compound C=1SC([C@H](C)[C@](O)(CN2N=CN=C2)C=2C(=CC(F)=CC=2)F)=NC=1C1=CC=C(C#N)C=C1 OPAHEYNNJWPQPX-RCDICMHDSA-N 0.000 description 1
- 108010058314 rennet Proteins 0.000 description 1
- 229940108461 rennet Drugs 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- FCBUKWWQSZQDDI-UHFFFAOYSA-N rhamnolipid Chemical compound CCCCCCCC(CC(O)=O)OC(=O)CC(CCCCCCC)OC1OC(C)C(O)C(O)C1OC1C(O)C(O)C(O)C(C)O1 FCBUKWWQSZQDDI-UHFFFAOYSA-N 0.000 description 1
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 229960000885 rifabutin Drugs 0.000 description 1
- BTVYFIMKUHNOBZ-QXMMDKDBSA-N rifamycin s Chemical class O=C1C(C(O)=C2C)=C3C(=O)C=C1NC(=O)\C(C)=C/C=C\C(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)\C=C/OC1(C)OC2=C3C1=O BTVYFIMKUHNOBZ-QXMMDKDBSA-N 0.000 description 1
- 229940081192 rifamycins Drugs 0.000 description 1
- WDZCUPBHRAEYDL-GZAUEHORSA-N rifapentine Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N(CC1)CCN1C1CCCC1 WDZCUPBHRAEYDL-GZAUEHORSA-N 0.000 description 1
- 229960002599 rifapentine Drugs 0.000 description 1
- 229960003040 rifaximin Drugs 0.000 description 1
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 description 1
- 229960001487 rimexolone Drugs 0.000 description 1
- QTTRZHGPGKRAFB-OOKHYKNYSA-N rimexolone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CC)(C)[C@@]1(C)C[C@@H]2O QTTRZHGPGKRAFB-OOKHYKNYSA-N 0.000 description 1
- 229960000371 rofecoxib Drugs 0.000 description 1
- 229930007790 rose oxide Natural products 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000003079 shale oil Substances 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229960005456 sisomicin Drugs 0.000 description 1
- URWAJWIAIPFPJE-YFMIWBNJSA-N sisomycin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC=C(CN)O2)N)[C@@H](N)C[C@H]1N URWAJWIAIPFPJE-YFMIWBNJSA-N 0.000 description 1
- 229960003177 sitafloxacin Drugs 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 229940023574 sodium palmate Drugs 0.000 description 1
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 description 1
- 229960003339 sodium phosphate Drugs 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- XNRNJIIJLOFJEK-UHFFFAOYSA-N sodium;1-oxidopyridine-2-thione Chemical compound [Na+].[O-]N1C=CC=CC1=S XNRNJIIJLOFJEK-UHFFFAOYSA-N 0.000 description 1
- VRDAELYOGRCZQD-NFLRKZIHSA-M sodium;4-[(2z)-2-[(5e)-5-[(2,4-dimethylphenyl)hydrazinylidene]-4,6-dioxocyclohex-2-en-1-ylidene]hydrazinyl]benzenesulfonate Chemical compound [Na+].CC1=CC(C)=CC=C1N\N=C(/C(=O)C=C\1)C(=O)C/1=N\NC1=CC=C(S([O-])(=O)=O)C=C1 VRDAELYOGRCZQD-NFLRKZIHSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- LJFWQNJLLOFIJK-UHFFFAOYSA-N solvent violet 13 Chemical compound C1=CC(C)=CC=C1NC1=CC=C(O)C2=C1C(=O)C1=CC=CC=C1C2=O LJFWQNJLLOFIJK-UHFFFAOYSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 229960004954 sparfloxacin Drugs 0.000 description 1
- DZZWHBIBMUVIIW-DTORHVGOSA-N sparfloxacin Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=C(F)C(N)=C2C(=O)C(C(O)=O)=CN(C3CC3)C2=C1F DZZWHBIBMUVIIW-DTORHVGOSA-N 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229940041030 streptogramins Drugs 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 108010082567 subtilin Proteins 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000001957 sucroglyceride Substances 0.000 description 1
- 235000010964 sucroglyceride Nutrition 0.000 description 1
- 229940099373 sudan iii Drugs 0.000 description 1
- 229960002607 sulconazole Drugs 0.000 description 1
- 229960004306 sulfadiazine Drugs 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229960000654 sulfafurazole Drugs 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical class NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 1
- 229960001940 sulfasalazine Drugs 0.000 description 1
- NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229960000894 sulindac Drugs 0.000 description 1
- MLKXDPUZXIRXEP-MFOYZWKCSA-N sulindac Chemical compound CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(S(C)=O)C=C1 MLKXDPUZXIRXEP-MFOYZWKCSA-N 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 235000008603 tangeritin Nutrition 0.000 description 1
- 229960000943 tartrazine Drugs 0.000 description 1
- 235000012756 tartrazine Nutrition 0.000 description 1
- 239000004149 tartrazine Substances 0.000 description 1
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 description 1
- 229960000565 tazarotene Drugs 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- 229960001608 teicoplanin Drugs 0.000 description 1
- LJVAJPDWBABPEJ-PNUFFHFMSA-N telithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@@H]([C@]2(OC(=O)N(CCCCN3C=C(N=C3)C=3C=NC=CC=3)[C@@H]2[C@@H](C)C(=O)[C@H](C)C[C@@]1(C)OC)C)CC)[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O LJVAJPDWBABPEJ-PNUFFHFMSA-N 0.000 description 1
- 229960003250 telithromycin Drugs 0.000 description 1
- 229960004576 temafloxacin Drugs 0.000 description 1
- BVCKFLJARNKCSS-DWPRYXJFSA-N temocillin Chemical compound N([C@]1(OC)C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C(C(O)=O)C=1C=CSC=1 BVCKFLJARNKCSS-DWPRYXJFSA-N 0.000 description 1
- 229960001114 temocillin Drugs 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- 229940116411 terpineol Drugs 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- RLNWRDKVJSXXPP-UHFFFAOYSA-N tert-butyl 2-[(2-bromoanilino)methyl]piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCCC1CNC1=CC=CC=C1Br RLNWRDKVJSXXPP-UHFFFAOYSA-N 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical class CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- LFSYLMRHJKGLDV-UHFFFAOYSA-N tetradecanolide Natural products O=C1CCCCCCCCCCCCCO1 LFSYLMRHJKGLDV-UHFFFAOYSA-N 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 150000003527 tetrahydropyrans Chemical class 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 229960004659 ticarcillin Drugs 0.000 description 1
- OHKOGUYZJXTSFX-KZFFXBSXSA-N ticarcillin Chemical compound C=1([C@@H](C(O)=O)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)C=CSC=1 OHKOGUYZJXTSFX-KZFFXBSXSA-N 0.000 description 1
- 229960004214 tioconazole Drugs 0.000 description 1
- 229960004631 tixocortol Drugs 0.000 description 1
- YWDBSCORAARPPF-VWUMJDOOSA-N tixocortol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CS)[C@@H]4[C@@H]3CCC2=C1 YWDBSCORAARPPF-VWUMJDOOSA-N 0.000 description 1
- 229960000707 tobramycin Drugs 0.000 description 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 229940068778 tocotrienols Drugs 0.000 description 1
- 229960001017 tolmetin Drugs 0.000 description 1
- UPSPUYADGBWSHF-UHFFFAOYSA-N tolmetin Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=C(CC(O)=O)N1C UPSPUYADGBWSHF-UHFFFAOYSA-N 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 229960005294 triamcinolone Drugs 0.000 description 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 1
- 229960002117 triamcinolone acetonide Drugs 0.000 description 1
- GUYPYYARYIIWJZ-CYEPYHPTSA-N triamcinolone benetonide Chemical compound O=C([C@]12[C@H](OC(C)(C)O1)C[C@@H]1[C@@]2(C[C@H](O)[C@]2(F)[C@@]3(C)C=CC(=O)C=C3CC[C@H]21)C)COC(=O)C(C)CNC(=O)C1=CC=CC=C1 GUYPYYARYIIWJZ-CYEPYHPTSA-N 0.000 description 1
- 229950006782 triamcinolone benetonide Drugs 0.000 description 1
- 229960004221 triamcinolone hexacetonide Drugs 0.000 description 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 229960001082 trimethoprim Drugs 0.000 description 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
- AAAQKTZKLRYKHR-UHFFFAOYSA-N triphenylmethane Chemical compound C1=CC=CC=C1C(C=1C=CC=CC=1)C1=CC=CC=C1 AAAQKTZKLRYKHR-UHFFFAOYSA-N 0.000 description 1
- FQCQGOZEWWPOKI-UHFFFAOYSA-K trisalicylate-choline Chemical compound [Mg+2].C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O FQCQGOZEWWPOKI-UHFFFAOYSA-K 0.000 description 1
- 229960000497 trovafloxacin Drugs 0.000 description 1
- WVPSKSLAZQPAKQ-CDMJZVDBSA-N trovafloxacin Chemical compound C([C@H]1[C@@H]([C@H]1C1)N)N1C(C(=CC=1C(=O)C(C(O)=O)=C2)F)=NC=1N2C1=CC=C(F)C=C1F WVPSKSLAZQPAKQ-CDMJZVDBSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 150000003667 tyrosine derivatives Chemical class 0.000 description 1
- 229950008396 ulobetasol propionate Drugs 0.000 description 1
- BDSYKGHYMJNPAB-LICBFIPMSA-N ulobetasol propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]2(C)C[C@@H]1O BDSYKGHYMJNPAB-LICBFIPMSA-N 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000012712 vegetable carbon Nutrition 0.000 description 1
- 239000004108 vegetable carbon Substances 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 150000002266 vitamin A derivatives Chemical class 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229960004740 voriconazole Drugs 0.000 description 1
- BCEHBSKCWLPMDN-MGPLVRAMSA-N voriconazole Chemical compound C1([C@H](C)[C@](O)(CN2N=CN=C2)C=2C(=CC(F)=CC=2)F)=NC=NC=C1F BCEHBSKCWLPMDN-MGPLVRAMSA-N 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003911 water pollution Methods 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 239000001018 xanthene dye Substances 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 229940098697 zinc laurate Drugs 0.000 description 1
- 229940105296 zinc peroxide Drugs 0.000 description 1
- 229940057977 zinc stearate Drugs 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- 229930007850 β-damascenone Natural products 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4717—Plasma globulins, lactoglobulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
Definitions
- the present invention relates generally to cosmetic or personal care compositions that comprise recombinant milk proteins.
- the present invention further provides methods for producing such cosmetic or personal care compositions.
- compositions comprise proteins derived from mammalian milk. These milk proteins impart or contribute to critical attributes and/or functionalities of such compositions.
- a cosmetic or personal care composition comprising a milk protein component, wherein the milk protein component comprises or consists essentially of a recombinant milk protein.
- the recombinant milk protein comprised in the milk protein component of the cosmetic or personal care composition of paragraph [0007] may be a single recombinant milk protein.
- the single recombinant milk protein may be: a recombinant p-lactoglobulin, a recombinant a-lactalbumin, a recombinant GMP, a recombinant lactotransferrin, a recombinant bovine serum albumin, a recombinant lactoperoxidase, a recombinant K-casein, a recombinant -casein, a recombinant a-Sl -casein; or a recombinant a-S2-casein.
- the recombinant milk protein comprised in the milk protein component of the cosmetic or personal care composition of paragraph [0007] may be a mixture of two or more recombinant milk proteins.
- the mixture of two or more recombinant milk proteins may comprise: a recombinant P-lactoglobulin, a recombinant a-lactalbumin, a recombinant GMP, a recombinant lactotransferrin, a recombinant bovine serum albumin, a recombinant lactoperoxidase, a recombinant K-casein, a recombinant [3-casein, a recombinant a-Sl -casein; and/or a recombinant a-S2-casein.
- the recombinant milk protein comprised in the milk protein component of the cosmetic or personal care composition of paragraph [0007] may be hydrolyzed.
- the recombinant milk protein comprised in the milk protein component of the cosmetic or personal care composition of paragraph [0007] may be a multimer or polymer of recombinant milk protein monomers.
- the recombinant milk protein may be obtained via production by a recombinant host cell.
- the recombinant host cell may be a recombinant fungal host cell (e.g., recombinant yeast host cell, recombinant filamentous fungal host cell).
- the recombinant fungal host cell may be derived from Saccharomyces, Kluyveromyces, Pichia, Tetrahymena, Yarrowia, Hansenula, Blastobotrys, Zygosaccharomyces, Debaryomyces, Aspergillus, Candida, Trichoderma, Fusarium, Chrysosporium, Physcomitrella, or Neurospora.
- the method may further comprise polymerizing the recombinant milk protein.
- SUBSTITUTE SHEET ( RULE 26) [0013]
- the method comprises applying to a body surface a cosmetic or personal care composition of any of paragraphs [0007] through [0011], DETAILED DESCRIPTION OF THE INVENTION
- x, y, and/or z may refer to “x” alone, “y” alone, “z” alone, “x, y, and z", “(x and y) or z", “(x and z) or y”, “(y and z) or x", "x and y” alone, “x and z” alone, “y and z” alone, or "x or y or z”.
- At least one and “one or more” as used herein refer to one, two, three, four, five, six, seven, eight, nine, ten, at least one, at least two, at least three, at least four, at least five, at least six, at least seven, at least eight, at least nine, at least ten, or more, or all of the elements subsequently listed.
- body surface refers to the exposed area of a human body.
- body surfaces include skin, hair, nail, tooth, and tissues of the oral cavity (e.g., gums).
- casein refers to a polypeptide that comprises a sequence of at least 20 (e.g., at least 20, at least 30, at least 40, at least 50, at least 60, at least 70, at least
- SUBSTITUTE SHEET (RULE 26) 80, at least 90, at least 100, at least 150) amino acids that is at least 40% (e.g., at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, 100%) identical to a sequence of ammo acids in a casein natively found in a mammal-produced milk (i.e., a casein that is native to a mammal-produced milk; e.g., a native casein).
- a casein natively found in a mammal-produced milk i.e., a casein that is native to a mammal-produced milk; e.g., a native casein.
- caseins include P-casein, /-casein, K-casein, a-Sl-casein, and a-S2-casein.
- P- casein”, “/-casein”, “K-casein”, “a-Sl -casein”, and “a-S2-casein” as used herein refer to a polypeptide that comprises a sequence of at least 20 (e.g., at least 20, at least 30, at least 40, at least 50, at least 60, at least 70, at least 80, at least 90, at least 100, at least 150) amino acids that is at least 40% (e.g., at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, 100%) identical to a sequence of amino acids in a P-casein, /-casein, K-casein, a- S
- corresponding cosmetic or personal care composition refers to a cosmetic or personal care composition that is identical in composition to the cosmetic or personal care composition that is compared to the “corresponding cosmetic or personal care composition” except that the “corresponding cosmetic or personal care composition” comprises a corresponding native milk protein in place of the recombinant milk protein that is comprised in the cosmetic or personal care composition that is compared to the “corresponding cosmetic or personal care composition”.
- corresponding native milk protein refers to a native milk protein that is identical in amino acid sequence to the recombinant milk protein that is compared to the “corresponding native milk protein” but that is obtained from a mammal- produced milk.
- cosmetic or personal care composition refers to a composition that upon application to a body surface confers a perceived or actual beautifying
- Non-limiting examples of cosmetic or personal care compositions include anti-wrinkling treatments (i.e., compositions used for tensioning [e.g., smoothing out of skin, reducing wrinkles in skin, removing fine lines in skm]), anti-aging treatments (i.e., compositions used for removing signs of aging [e.g., wrinkles, fine lines, manifestations of photodamage (e.g., sun spots)]), sun protection (i.e., compositions used to protect against UV exposure), anti-bum treatments (i.e., compositions used for soothing bums [e.g., sunbums]), anti-acne treatments (i.e., compositions that are effective in the treatment of acne and/or the symptoms associated therewith), skin cleansers (i.e., compositions used for cleaning skin and/or skin pores [e.g., nose strips for pore cleaning]), anti-dandruff treatments (i.
- anti-wrinkling treatments i.e., compositions used for tensioning [
- SUBSTITUTE SHEET (RULE 26) gums, mouthwashes, toothpastes, gum-cleaning agents, denture adhesives, denture fixatives, breath strips, floss mechanisms, teeth whitening strips).
- the term "essentially free of' as used herein refers to the indicated component being either not detectable in the indicated composition by common analytical methods, or to the indicated component being present in such trace amount as to not be functional.
- the term "functional” as used in this context refers to not materially contributing to properties of the composition comprising the trace amount of the indicated component, or to not having material activity (e.g., chemical activity, enzymatic activity) in the indicated composition comprising the trace amount of the indicated component, or to not having health-adverse effects upon use or consumption of the composition comprising the trace amount of the indicated component.
- materially contributing refers to the indicated component contributing to an attribute of a composition to such extent that in the absence of the component (e.g., in a reference composition that is identical to the composition except that it lacks the indicated component) the attribute is at least 10%, at least 20%, at least 30%, at least 40%, or at least 50% less present/active/measurable.
- filamentous fungus refers to an organism from the filamentous form of the subdivision Eumycota and Oomycota (as defined by Hawksworth et al., In, Ainsworth and Bisby's Dictionary of The Fungi, 8th edition, 1995, CAB International, University Press, Cambridge, UK).
- a filamentous fungus is distinguished from a yeast by its hyphal elongation during vegetative growth.
- fungus refers to organisms of the phyla Ascomycotas, Basidiomycota, Zygomycota, and Chythridiomycota, Oomycota, and Glomeromycota. It is understood, however, that fungal taxonomy is continually evolving, and therefore this specific definition of the fungal kingdom may be adjusted in the future.
- host cell refers not only to the particular subject cell but also to the progeny of such cell. Because certain modifications may occur in succeeding generations due to either mutation or environmental influences, such progeny may not, in fact, be identical to the subject cell, but are still included within the scope of the term “host cell” as used herein.
- identity refers to the nucleotide or amino acid residues that are the same when the two or more polynucleotide or polypeptide sequences, respectively, are aligned for maximum correspondence.
- the "identity” may exist over a region of the sequences being compared (e.g., over the length of a functional domain) or over
- SUBSTITUTE SHEET (RULE 26) the full length of the sequences.
- a “region” is considered to be a continuous stretch of at least 6, 9, 14, 19, 24, 29, 34, 39, or more nucleotides, or of at least 2, 6, 10, 14, 18, 22, 26, 30, or more amino acids.
- typically one sequence acts as a reference sequence to which one or more test sequences are compared.
- test and reference sequences are input into a computer, subsequence coordinates are designated, if necessary', and sequence algorithm program parameters are designated. The sequence comparison algorithm then calculates the percent sequence identity for the test sequence(s) relative to the reference sequence, based on the designated program parameters.
- Optimal alignment of sequences for comparison may be conducted, e.g., by the local homology algorithm of Smith & Waterman, Adv. Appl. Math. 2:482 (1981), by the homology alignment algorithm of Needleman & Wunsch, J. Mol. Biol. 48:443 (1970), by the search for similarity method of Pearson & Lipman, Proc. Natl. Acad. Sci. USA 85:2444 (1988), by computerized implementations of these algorithms (GAP, BESTFIT, FASTA, and TFASTA in the Sequence Analysis Software Package of the Genetics Computer Group (GCG), University of Wisconsin Biotechnology Center, which may be used with default parameters), or by visual inspection (see generally Ausubel et al., infra).
- BLAST Altschul et al. 1990 J. Mol. Biol. 215:403-410; Gish & States. 1993 Nature Genet. 3:266-272; Madden et al. 1996 Meth. Enzymol. 266:131-141; Altschul et al. 1997 Nucleic Acids Res. 25:3389-3402; Zhang 7 Madden. 1997 Genome Res. 7:649-656).
- Software for performing BLAST analyses is publicly available through the National Center for Biotechnology Information.
- the percent sequence identity or degree of homology may be adjusted upwards to correct for the conservative nature of the substitution. Means for making this adjustment are well know n to those of skill in the art. See, e.g., Pearson, 1994, Methods Mol. Biol. 24:307-31 and 25:365-89.
- mammal-produced milk refers to a milk produced by a mammal.
- mammals include cow, human, sheep, mouflon, goat, buffalo, camel, horse, donkey, alpaca, yak, llama, lemur, panda, guinea pig, squirrel, bear, macaque, gorilla, chimpanzee, mountain goat, monkey, ape, cat, dog, wallaby, rat, mouse,
- SUBSTITUTE SHEET (RULE 26) elephant, opossum, rabbit, whale, baboons, gibbons, orangutan, mandrill, pig, wolf, fox, lion, tiger, echidna, and woolly mammoth.
- microbe or "microbial cell” as used herein is an abbreviation for microorganism, and includes all bacteria, archaea, unicellular protista, unicellular animals, unicellular plants, fungi (e.g., unicellular fungi, filamentous fungi, yeast), unicellular algae, protozoa, and chromista.
- fungi e.g., unicellular fungi, filamentous fungi, yeast
- microbial is used herein as the corresponding adjective.
- milk protein as used herein refers to a whey protein or a casein.
- milk protein component refers to a component that consists of a subset of whey proteins comprised in a mammal-produced milk, or of a subset of caseins comprised in a mammal-produced milk, or a mixture of a subset of whey proteins and a subset of caseins comprised in a mammal-produced milk, (i.e., consists of some but not all proteins present in, for example, whey protein concentrate, whey protein isolate, whey protein hydrolysate, casein isolate, casein concentrate, casein hydrolysate, milk, milk protein isolate, milk protein concentrate, milk protein hydrolysate, micellar casein concentrate, sodium caseinate, or acid caseinate).
- the term implies that the milk proteins of which the milk protein component consists are the only milk proteins comprised in a composition provided herein (i.e., the composition comprises no other milk proteins other than the milk proteins of which the milk protein component consists).
- non-native refers to what is found in nature in its unmodified state (e.g., a cell that is not genetically modified by a human, and that is maintained under conditions [e.g., level of oxygenation, pH, salt concentration, temperature, and nutrient (e.g., carbon, nitrogen, sulfur) availability] that are not defined by a human).
- conditions e.g., level of oxygenation, pH, salt concentration, temperature, and nutrient (e.g., carbon, nitrogen, sulfur) availability
- polynucleotide refers to a polymeric form of at least 2 (e.g., at least 5, at least 10, at least 20, at least 30, at least 40, at least 50, at least 100, at least 500, at least 1,000) nucleotides.
- the term includes both sense and antisense strands of DNA molecules (e.g., cDNA, genomic DNA, synthetic DNA) and RNA molecules (e.g., mRNA, synthetic RNA), as well as analogs of DNA or RNA containing non-natural nucleotide analogs, non-native intemucleoside bonds, and/or chemical modifications.
- a polynucleotide may be modified chemically or biochemically, or it may contain non-natural or derivatized nucleotide
- SUBSTITUTE SHEET (RULE 26) bases.
- modifications include, for example, labels; methylation; substitution of one or more of the naturally occurring nucleotides with an analog; intemucleotide modifications such as uncharged linkages (e.g., methyl phosphonates, phosphotriesters, phosphoramidates, carbamates), charged linkages (e.g., phosphorothioates, phosphorodithioates), pendent moieties (e.g., polypeptides), intercalators (e.g., acridine, psoralen), chelators, alkylators, and modified linkages (e.g., alpha anomeric nucleic acids).
- uncharged linkages e.g., methyl phosphonates, phosphotriesters, phosphoramidates, carbamates
- charged linkages e.g., phosphorothioates, phosphorodithioates
- pendent moieties e.
- modified nucleotides are described in the art (see, for example, Malyshev et al. 2014. Nature 509:385; Li et al. 2014. J. Am. Chem. Soc. 136:826). Also included are synthetic molecules that mimic polynucleotides in their ability to bind to a designated sequence via hydrogen bonding or other chemical interactions. Such molecules are known in the art and include, for example, molecules in which peptide linkages substitute for phosphate linkages in the backbone of the molecule. Other modifications can include, for example, analogs in which the ribose ring contains a bridging moiety or other structure, such as the modifications found in “locked” polynucleotides.
- a polynucleotide can be in any topological conformation.
- a polynucleotide can be single-stranded, double-stranded, triple-stranded, quadruplexed, partially double-stranded, branched, hairpinned, circular, or in a padlocked conformation.
- polynucleotide sequence refers to a sequence of nucleotides that are comprised in a polynucleotide or of which a polynucleotide consists.
- polypeptide and “protein” as used herein can be interchanged and refer to both a naturally occurring and a non-naturally occurring polymeric form of at least 2 (e.g., at least 5, at least 10, at least 20, at least 30, at least 40, at least 50, at least 100) amino acids, having an active structure or lacking a functional structure.
- protein refers to a polypeptide of any length, which can include polypeptides comprising coded and non-coded amino acids, polypeptides compnsing amino acids that occur in nature, and those that do not occur in nature, polypeptides comprising chemically or biochemically modified or derivatized amino acids, and polypeptides comprising modified peptide backbones.
- a protein can be monomeric, meaning it has a single chain, or polymeric, meaning it is composed of two or more chains, which can be covalently or non-covalently associated.
- recombinant P-lactoglobulin refers to a recombinantly produced polypeptide that comprises a sequence of at least 20 (e.g., at least 20, at least 30, at least 40, at least 50, at least 60, at least 70, at least 80, at least 90, at least 100, at least 150) amino acids that is at least 50% (e.g., at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, 100%) identical to a sequence of amino acids in a native P-lactoglobulin (e.g., a native Bos
- SUBSTITUTE SHEET (RULE 26) taurus P-lactoglobulin [e.g., amino acids 17 to 178 of UniProt sequence P02754], a native Ovis aries P-lactoglobulin [e.g., amino acids 19 to 180 of UniProt sequence P67976], a native Capra hircus P-lactoglobulin [e.g., amino acids 19 to 180 of UniProt sequence P02756], a native Equus caballus P-lactoglobulin [amino acids 19-180 of UniProt sequence P02758], a native Equus asinus P-lactoglobulin [UniProt sequence P13613], a native Equus caballus P- lactoglobulin [amino acids 19 to 181 of UniProt sequence P07380], a native Equus asinus
- P-lactoglobulin e.g., amino acids 17 to
- recombinant host cell refers to a host cell that comprises a recombinant polynucleotide.
- a recombinant host cell may produce a polynucleotide or polypeptide not found in the native (non-recombinant) form of the host cell, or a recombinant host cell may produce a polynucleotide or polypeptide at a level that is different from that in the native (non-recombinant) form of the host cell. It should be understood that such term is intended to refer not only to the particular subject cell but also to the progeny of such a cell.
- a recombinant host cell may be an isolated cell or cell line grown in culture or a cell that resides in a living tissue or organism.
- recombinant milk protein refers to a milk protein, whey protein, casein, or non-milk protein, respectively, that is produced recombinantly (i.e., that is produced by a recombinant host cell).
- the term "similar” as used herein refers to being within about +/— 15% with regard to a specified attribute.
- the term includes being within about +/- 15%, about +/- 14%, about +/— 13%, about +/— 12%, about +/— 11%, about +/— 10%, about +/— 9%, about +/-8%, about +/-7%, about +/-6%, about +/— 5%, about +/-4%, about +/-3%, about +/-2%, or about +/-!% with regard to the specified attribute.
- two or more refers to two, three, four, five, six, seven, eight, nine, ten, or more, or all of the elements subsequently listed.
- hey protein refers to a polypeptide that comprises a sequence of at least 20 (e.g., at least 20, at least 30, at least 40, at least 50, at least 60, at least 70, at least 80, at least 90, at least 100, at least 150) amino acids that is at least 40% (e.g., at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, 100%) identical
- SUBSTITUTE SHEET (RULE 26) to a sequence of amino acids in a whey protein natively found in a mammal-produced milk (i.e., a whey protein that is native to a mammal-produced milk; e.g., a native whey protein).
- whey proteins include a-lactalbumin, [3-lactoglobulin, lactotransferrin, lactoferricin, serum albumin protein, lactoperoxidase protein, and glycomacropeptide.
- a-lactalbumin refers to a polypeptide that comprises a sequence of at least 20 (e.g., at least 20, at least 30, at least 40, at least 50, at least 60, at least 70, at least 80, at least 90, at least 100, at least 150) amino acids that is at least 40% (e.g., at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, 100%) identical to a sequence of amino acids in an a-lactalbumin, P-lactoglobulin, lactotransferrin, lactoferricin, serum albumin, lactoperoxidase, and glyco
- yeast refers to an organism of the order Saccharomycetales. Vegetative growth of yeast is by budding/blebbing of a unicellular thallus, and carbon catabolism may be fermentative.
- % by mass refers to a percentage value for a mass as determined in a hydrated composition, such that the composition includes the mass of powder as well as the mass of the hydrating agent, with 100% fixed as the percentage value for the entire hydrated composition.
- the term refers to a percentage value for a mass as determined relative to the eventual entire hydrated composition (with 100% fixed as the percentage value for that entire eventual hydrated composition).
- a cosmetic or personal care composition that comprises a milk protein component, wherein the milk protein component comprises or consists essentially of a recombinant milk protein.
- the cosmetic or personal care composition may comprise between 0.1% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.9%, 0.8%, 0.7%, 0.6%, 0.5%, 0.4%, 0.3%, or 0.2%; between 0.2% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.9%, 0.8%, 0.7%, 0.6%, 0.5%, 0.4%, or 0.3%; between 0.3% and 100%, 95%, 90%, 85%, 80%, 75%, 70%
- SUBSTITUTE SHEET (RULE 26) 0.9%; between 0.9% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, or 1%; between 1% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, or 2%; between 2% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%,
- SUBSTITUTE SHEET 50%; between 50% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, or 55%; between 55% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, or 60%; between 60% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, or 65%; between 65% and 100%, 95%, 90%, 85%, 80%, 75%, or 70%; between 70% and 100%, 95%, 90%, 85%, 80%, or 75%; between 75% and 100%, 95%, 90%, 85%, or 80%; between 80% and 100%, 95%, 90%, or 85%; or between 85% and 100%, 95%, 90%; between 90% and 100% or 95%, or between 95% and 100% by mass of the milk protein component.
- the cosmetic or personal care composition according to any of the above may be in any form normally used for topical application, including a liquid (e.g., an aqueous dispersion, an oily dispersion, a dispersion in a solvent, an aqueous suspension, an aqueous-alcoholic solution, an oily solution, a milky liquid, a foaming liquid), an emulsion (e.g., water-in-oil emulsion, oil- in-water emulsion, water-in-oil-in-water emulsion, oil-in-water-in-oil emulsion, Pickering emulsion, microemulsion), a gel (e.g., a hydrogel, a lipogel, an organogel), a powder (e.g., an anhydrous powder or substantially anhydrous powder [e.g., pressed powder], a liquid
- a liquid e.g., an aqueous dispersion, an oily dispersion,
- the cosmetic or personal care composition according to any of the above when in powder form may comprise a moisture content of less than 20%, less than 15%, less than 10%, less than 7%, less than 5%, less than 3%, or less than 1%; or between 0.1% and 20%, 15%, 10%, 5%, or 1%; between 1% and 20%, 15%, 10%, or 5%; between 5% and 20%, 15%, or 10%; between 10% and 20%, or 15%; or between 15% and 20%.
- the powder may be used in powder form, or may be reconstituted with a hydrating agent (e.g., water) prior to use, or may be mixed with other dry components before a hydrating agent is added to the mixture.
- a hydrating agent e.g., water
- the cosmetic or personal care composition according to any of the above when in emulsion form may comprise between 5% and 80%, 70%, 60%, 50%, 40%, 30%, 20%, or 10%; between 10% and 80%, 70%, 60%, 50%, 40%, 30%, or 20%; between 20% and 80%, 70%, 60%, 50%, 40%, or 30%; between 30% and 80%, 70%, 60%, 50%, or 40%; between 40% and 80%, 70%, 60%, or 50%; between 50% and 80%, 70%, or 60%; between 60% and 80%, or 70%; or between 70% and 80% by mass of lipid.
- the cosmetic or personal care composition according to any of the above may further comprise an other ingredient (e.g., any of the other ingredients disclosed herein).
- the cosmetic or personal care composition may comprise between 0.001% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, 20%, 15%, 10%, 9%,
- SUBSTITUTE SHEET (RULE 26) 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, or 0.01%; between 0.01% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, 20%, 15%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.5%, or 0.1%; between 0.1% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, 20%, 15%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, or 0.5%; between 0.5% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, 20%, 15%, 10%, 9%,
- the cosmetic or personal care composition according to any of the above may be essentially free of a component found in a mammal-produced milk, or may comprise a lower
- SUBSTITUTE SHEET (RULE 26) concentration of at least one component found in a mammal-produced milk.
- components found in mammal-produced milk include lactose, saturated fat, cholesterol, native milk proteins, and native milk lipids.
- the cosmetic or personal care composition according to any of the above may be essentially free of a component obtained from an animal (i.e., a component that is native to an animal, including animal products [i.e., parts of an animal that are consumables or typically prepared for consumption by humans; e.g., animal meat, animal fat, animal blood], animal byproducts [i.e., products that are typically not consumable by themselves but are the byproducts of slaughtering animals for consumption; e g., animal bones, animal carcasses, and constituents isolated therefrom], products produced by an animal [e.g., mammal-produced milk, chicken eggs, bee honey], and consumables produced therefrom [e.g., gelatin, rennet, whey proteins extracted from mammal-produced milk, casein extracted from mammal- produced milk, milk lipid extracted from mammal-produced milk, animal lipids, animal proteins]), or comprise 2% or less by mass of such component.
- an animal i.e., a component that is native to an
- the cosmetic or personal care composition according to any of the above may be essentially free of antibiotics.
- the cosmetic or personal care composition according to any of the above may be essentially free of animal hormones.
- the cosmetic or personal care composition according to any of the above may be hypoallergenic.
- the milk protein component comprised in a cosmetic or personal care composition according to any of the above comprises or consists essentially of a recombinant milk protein.
- the recombinant milk protein may be a single recombinant milk protein, or may be a mixture of two or more recombinant milk proteins.
- the milk protein component may, for example, comprise or consist essentially of: a recombinant P-lactoglobulin; a recombinant P- lactoglobulin and a recombinant a-lactalbumin; a recombinant P-lactoglobulin and a recombinant GMP; a recombinant P-lactoglobulin and a recombinant lactotransferrin; a recombinant P-lactoglobulin and a recombinant bovine serum albumin; a recombinant [L lactoglobulin and a recombinant lactoperoxidase; a recombinant [Tlactoglobulin and a recombinant K-casein; a recombinant P-lactoglobulin and a recombinant [3-casein; a recombinant P-lactoglobulin and a recombinant [3-case
- SUBSTITUTE SHEET (RULE 26) and a recombinant GMP; a recombinant P-lactoglobulin, a recombinant a-lactalbumin. and a recombinant lactotransferrin; a recombinant P-lactoglobulin, a recombinant a-lactalbumin, and a recombinant bovine serum albumin; a recombinant P-lactoglobulin, a recombinant a- lactalbumm, and a recombinant lactoperoxidase; a recombinant P-lactoglobulin, a recombinant a-lactalbumin, and a recombinant K-casein; a recombinant P-lactoglobulin, a recombinant a- lactalbumin, and a recombinant P-casein; a recombinant P-lac
- SUBSTITUTE SHEET (RULE 26) lactoglobulin, a recombinant 0-casein, and a recombinant a-S2-casein; a recombinant 0- lactoglobulin, a recombinant a-Sl -casein, and a recombinant a-S2-casein; a recombinant a- lactalbumm; a recombinant a-lactalbumin and a recombinant GMP; a recombinant a- lactalbumm and a recombinant lactotransferrin; a recombinant a-lactalbumin and a recombinant bovine serum albumin; a recombinant a-lactalbumin and a recombinant lactoperoxidase; a recombinant a-lactalbumin and a recombinant K-casein; a recombin
- SUBSTITUTE SHEET (RULE 26) recombinant a-lactalbumin, a recombinant P-casein, and a recombinant a-S2-casein; a recombinant a-lactalbumin, a recombinant a-Sl -casein, and a recombinant a-S2-casein; a recombinant GMP; a recombinant GMP and a recombinant lactotransferrin; a recombinant GMP and a recombinant bovine serum albumin; a recombinant GMP and a recombinant lactoperoxidase; a recombinant GMP and a recombinant K-casein; a recombinant GMP and a recombinant P-casein; a recombinant GMP and a recombinant a-Sl -casein;
- SUBSTITUTE SHEET (RULE 26) lactotransferrin, a recombinant bovine serum albumin, and a recombinant a-Sl -casein; a recombinant lactotransferrin, a recombinant bovine serum albumin, and a recombinant a-S2- casein; a recombinant lactotransferrin, a recombinant lactoperoxidase, and a recombinant K- casein; a recombinant lactotransferrin, a recombinant lactoperoxidase, and a recombinant P- casein; a recombinant lactotransferrin, a recombinant lactoperoxidase, and a recombinant a- S1 -casein; a recombinant lactotransferrin, a recombinant lactoperoxidase, and
- SUBSTITUTE SHEET (RULE 26) recombinant lactoperoxidase, a recombinant 0-casein, and a recombinant a-S2-casein; a recombinant lactoperoxidase, a recombinant a-Sl-casein, and a recombinant a-S2-casein; a recombinant K-casein; a recombinant K-casem and a recombinant -casein; a recombinant K- casein and a recombinant a-Sl -casein; a recombinant K-casein and a recombinant a-S2-casein; a recombinant K-casein, a recombinant
- Recombinant milk proteins, and methods for producing recombinant milk proteins are disclosed, for example, in U.S. Patent 9,924,728, issued March 27, 2018; U.S. publication US20190216106, published July 18, 2019; and PCT publication WO2020219596, published October 29, 2020.
- the milk protein component comprised in a cosmetic or personal care composition may comprise or consist of a multimer (e g., dimer, trimer, tetramer) or polymer of recombinant milk protein monomers (i.e., molecules composed of repeated recombinant milk protein monomers that are covalently linked, either directly with each other or via intermediary molecules).
- the polymer of recombinant milk protein monomers may have the capacity to form a flexible film upon application of the cosmetic or personal care composition to a body surface.
- the milk protein component comprised in a cosmetic or personal care composition may consist of whey protein and casein at a mass ratio of between about 10 to 0 and about 0 to 10 (e.g., about 10 to 0, about 10 to 1, about 9 to 1, about 8 to 1, about 7 to 1, about 6 to 1, about 5 to 1, about 4 to 1, about 3 to 1, about 2 to 1, about 1 to 1, about 1 to 2, about 1 to 3, about 1 to 4, about 1 to 5, about 1 to 6, about 1 to 7, about 1 to 8, about 1 to 9, about 1 to 10, about 0 to 10).
- about 10 to 0 and about 0 to 10 e.g., about 10 to 0, about 10 to 1, about 9 to 1, about 8 to 1, about 7 to 1, about 6 to 1, about 5 to 1, about 4 to 1, about 3 to 1, about 2 to 1, about 1 to 1, about 1 to 2, about 1 to 3, about 1 to 4, about 1 to 5, about 1 to 6, about 1 to 7, about 1 to 8, about 1 to 9, about 1 to 10, about 0 to 10).
- the milk protein component comprised in a cosmetic or personal care composition may comprise or consist of recombinant [3-lactoglobuhn and recombinant a-lactalbumin at a mass ratio of between about 10 to 0 and about 0 to 10 (e.g., about 10 to 0, about 10 to 1, about 9 to 1, about 8 to 1, about 7 to 1, about 6 to 1, about 5 to 1, about 4 to 1, about 3 to 1, about 2 to 1, about 1 to 1, about 1 to 2, about 1 to 3, about 1 to 4, about 1 to 5, about 1 to 6, about 1 to 7, about 1 to 8, about 1 to 9, about 1 to 10, about 0 to 10).
- recombinant [3-lactoglobuhn and recombinant a-lactalbumin at a mass ratio of between about 10 to 0 and about 0 to 10 (e.g., about 10 to 0, about 10 to 1, about 9 to 1, about 8 to 1, about 7 to 1, about 6 to 1, about 5 to 1, about 4 to 1, about 3 to 1, about 2 to 1, about 1 to 1, about
- the milk protein component comprised in a cosmetic or personal care composition according to any of the above may be comprised in a cosmetically or physiologically acceptable medium.
- the milk protein component comprised in a cosmetic or personal care composition according to any of the above may be comprised in a coating layer around a core of the cosmetic or personal care composition.
- Such core may comprise an active agent (e.g., any of the other ingredients disclosed herein).
- the recombinant milk protein comprised in the milk protein component comprised in a cosmetic or personal care product according to any of the above may be undenatured (i.e., not heat-insolubilized as shown by electrophoretic measurements).
- the recombinant milk protein comprised in the milk protein component comprised in a cosmetic or personal care product according to any of the above may be hydrolyzed (e.g., via action of an endopeptidase [e.g., trypsin, chymotrypsin]).
- an endopeptidase e.g., trypsin, chymotrypsin
- Such hydrolyzed recombinant milk protein may consist essentially of peptides having a molecular weight of between 200 to 5,000.
- the recombinant milk protein comprised in the milk protein component comprised in a cosmetic or personal care product according to any of the above may be covalently or non- covalently associated with a lipid to form an amphiphilic complex.
- suitable lipids for covalent association include fatty acids or acyls having carbon atom numbers of between 4 and 30, selected from fatty acids, fatty alcohols, and fatty amines, and derivatives thereof, and having chains that are unsaturated, linear, branched or cyclic.
- Non-limiting examples include heptanoic acid, octanoic acid, decanoic acid, lauric acid, myristic acid, palmitic acid, stearic acid, ncinoleic acid, oleic acid, linoleic acid, linolenic acid, caprylic acid, capric acid; the corresponding fatty alcohols and fatty amines; the derivatives of said fatty acids, fatty alcohols, and fatty amines; and mixtures thereof.
- the recombinant milk protein may comprise such lipid at a mass ratio of between about 1,000 to 1 and about 1 to 10.
- the lipid may be covalently linked to the recombinant milk protein via a monofunctional agent (which may be the fatty containing component [fatty monoacid, monoalcohol, or monoamine]) or a multifunctional grafting agent (which may be the fatty containing component [fatty polyacid, polyalcohol, or poly amine]).
- a monofunctional agent which may be the fatty containing component [fatty monoacid, monoalcohol, or monoamine]
- a multifunctional grafting agent which may be the fatty containing component [fatty polyacid, polyalcohol, or poly amine]
- the recombinant milk protein comprised in the milk protein component comprised in a cosmetic or personal care product according to any of the above may be covalently or non- covalently associated with a coloring agent (e.g., any of the coloring agents disclosed herein).
- a coloring agent e.g., any of the coloring agents disclosed herein.
- the recombinant milk protein comprised in the milk protein component comprised in a cosmetic or personal care product according to any of the above may be covalently or non- covalently associated with a UVA and/or UVB light filtering or UVA and/or UVB light scattering agent.
- Non-limiting examples of UVA and/or UVB light filtering or UVA and/or UVB light scattering agents include BP-3 (2-hydroxy-4-methoxybenzophenone); cinnamoyl radical (optionally substituted by one or more alkoxy groups); p-dialkylaminobenzoyl radical; salicyloyl radical; sulphonyl radical originating from an isophthalylidene-camphor radical; acyl radical onginating from a carboxylic or sulphonic acid derived from benzylidenecamphor, 2-aiylbenzimidazoles, 2-arylbenzofurans, 2-arylbenzoxazoles, 2-arylbenzotriazoles, 2-aryhndoles, or hydroxybenzophenones; sulphonyl radical originating from a terephthalylidene-camphor radical; acyl radical derived from an absorber of carboxylic coumarin, monophenylcyanoacrylic, diphenylcyanoacryl
- the recombinant milk protein comprised in the milk protein component comprised in a cosmetic or personal care product according to any of the above may be comprised in a coacervate with a polysaccharide.
- the polysaccharide may be an anionic polysaccharide (i.e., a polysaccharide that has a negative total charge or linear charge density at a pH near the IEP of the recombinant milk protein comprised in the milk protein component of the cosmetic or personal care composition), or a cationic polysaccharide (i.e., a polysacchande that has a positive total charge or linear charge density at the pH near the IEP of the recombinant milk protein comprised in the milk protein component of the cosmetic or personal care composition).
- Non-limiting examples of suitable anionic polysaccharides include polysaccharides having pendant carboxylic acid or sulfate groups, pectins (e.g., pectin from aloe, pectins from tobacco, pectins from apple pomace, pectins from citrus peel, pectins from plums, pectins from gooseberries sources, pectins from sugar beet), water soluble cellulose (e.g., sodium carboxymethyl cellulose, sulfated cellulose), seaweed hydrocolloid extracts (e.g., sodium alginate, propyleneglycol alginate, ammonium alginate, alginic acid, carageenans (e.g., iota carageenan, kappa carageenan, lambda carageenan)), microbial and agaroid gums and gum components (e.g., gellan gum, xanthan gum, gum Arabic, gum tragacanth
- SUBSTITUTE SHEET (RULE 26) di ethylaminoethyl dextran, guar gum derivatives (e.g., guar hydroxypropyltrimonium chloride), quaternary nitrogen-containing cellulose ethers, copolymers of etherified cellulose, guar and starch, cationic cellulose, modified cationic cellulose polymers (e.g., polyquatemium 4, polyquatemium 10, polyquatemium 24, polyquatemium 28), laurdimonium hydroxypropyl oxyethyl cellulose, steardimonium hydroxyethyl cellulose, polysaccharides that comprise an amino group or an imine group, and derivatives thereof.
- guar gum derivatives e.g., guar hydroxypropyltrimonium chloride
- quaternary nitrogen-containing cellulose ethers e.g., guar hydroxypropyltrimonium chloride
- the recombinant milk protein may be comprised in the milk protein component comprised in a cosmetic or personal care product according to any of the above as a gel (e.g., a hydrogel).
- a gel e.g., a hydrogel
- the other ingredient that may be comprised in a cosmetic or personal care composition according to any of the above may be any known ingredient normally used in cosmetic or personal care compositions.
- the other ingredient should be of pharmaceutical or cosmetic grade, non-irritating on body surfaces, and non-toxic as used.
- Non-limiting examples of other ingredients include: an aqueous solvent; a lipid; a wax; an emulsifying agent; a pH and/or ionic strength adjusting agent (i.e., a compound that can raise or lower the pH and/or the ionic strength of a solution; e.g., to balance the pH of the cosmetic or personal care composition to a pH of between 5 and 7); a buffering agent; a binding agent; a thickening agent; a filler agent (i.e., a colorless or white particle of any shape that is insoluble in the medium of the composition); a plasticizing agent; an anti-foam agent (e.g., to decrease foaming during compounding and handling of the composition); a foam stabilizer; a surfactant (e.g., a cationic, anionic, non-ionic, amphoteric, or zwitterionic surfactant); a gelling agent; a coloring agent (i.e., a molecule that
- SUBSTITUTE SHEET (RULE 26) and/or scalp, for example by soothing the feelings of itching); a cooling agent (i.e. , a compound that provides a sensation of cooling); a fragrance; an anti-aging agent (i.e., a compound that inhibits or reduces signs of aging, such as wrinkles, fine lines, and manifestations of photodamage [e.g., sun spots]); an UVA and/or UVB light absorbing agent; an UVA and/or UVB light scattering agent; an antibacterial agent (i.e., a compound that has either a killing or growth inhibiting effect upon bacteria); an anti-fungal agent (i.e., a compound that has either a killing or growth inhibiting effect upon fungi); an anti-inflammatoiy agent (i.e., a compound effective in treating inflammation); a salt; a humectant; a hair growth agent; a hair anti-static agent; an anti-viral agent (i.e., a compound capable of
- Non-limiting examples of aqueous solvents include water, floral water, mineral water, Cl to C6 alcohols (e.g., ethyl alcohol, propanol, isopropyl alcohol, butanol, pentanol, hexanol, glycerol), glycols (e.g., ethylene glycol, butylene glycol, isoprene glycol, propylene glycol, polyethylene glycol), glycol ethers (e.g., methyl ether, ethyl ether, butyl ether, 2- butoxyethanol, ethylene glycol monoethyl ether, propylene glycol, diethylene glycol monoethyl ether, di ethylene glycol monomethyl ether), and mixtures thereof.
- alcohols e.g., ethyl alcohol, propanol, isopropyl alcohol, butanol, pentanol, hexanol, glycerol
- glycols e.
- Non-limiting examples of lipids include fatty alcohols (e.g., linoleyl alcohol, linolenyl alcohol, oleyl alcohol), polyalcohols (e.g., glycol, polyethylene glycol, polypropylene glycol, glycerol), fatty acid esters (e.g., alkyl myristates [e.g., isopropyl myristate, butyl myristate, cetyl myristate], alkyl stearates [e.g., butyl stearate, hexadecyl stearate], alkyl palmitates [e.g., ethyl palmitate, isopropyl palmitate], alkyl lanolates [e.g., isopropyl lanolate, isocetyl lanolate], alkyl oleates [e.g., decyl oleate], alkyl oct
- Non-limiting examples of waxes include ozokerite wax, montan wax; ouricury wax,
- Japan wax, cork fibre wax, sugar cane wax, lanolins e.g., lanolin, lanolin alcohol,
- SUBSTITUTE SHEET (RULE 26) hydrogenated lanolin, acetylated lanolin, lanolin wax, lanolin fatty acids), beeswax, candellila wax, microcrystalline wax, carnauba wax, cetyl alcohol, stearyl alcohol, cocoa butter; paraffins, ozokerites, petrolatum, vaselines, petroleum jelly, hydrogenated oils that are solid at 25C, mono-/di-/tri-glycerides that are solid at 25C, fatty esters that are solid at 25C, silicone waxes (e.g., methyloctadecane-oxypolysiloxane, poly(dimethyl-siloxy) stearoxysiloxane), fluoro waxes, stearic acid monoethanolamide, colophony and its derivatives (e g., glycol abietate, glycerol abietate), hydrogenated oils that are solid at 25C, jojoba oil, sucroglycerides
- Non-limiting examples of emulsifying agents include polyglycerin esters, sorbitan esters, partially esterified glycerides, and derivatives and mixtures thereof.
- Non-limiting examples of pH adjusting agents include organic acids, mono- or triethanolamine, ammonia, sodium phosphate, sodium carbonate, phosphoric acid, hydrochloric acid, lactic acid, tartaric acid, acetic acid, citric acid, and mixtures thereof.
- Non-limiting examples of buffering agents include ethylenediaminetetracetic acid (EDTA), sodium salt of EDTA, sodium chloride, sodium phosphate, diazolidinyl urea, iodopropynyl butylcarbamate, and mixtures thereof.
- EDTA ethylenediaminetetracetic acid
- sodium salt of EDTA sodium chloride
- sodium phosphate sodium phosphate
- diazolidinyl urea iodopropynyl butylcarbamate
- Non-limiting examples of binding agents include silicone resins (e.g., silanes, siloxanes [e.g., polydimethylsiloxane (PDMS)], siloxysilicates [e.g., tnmethylsiloxysilicate], silsesqui oxanes [e.g., polymethylsilsesqui oxane]), dimethicone silylate/isododecane, polyglyceryyl-2 triisostearate, dry binders (e.g., zinc, lithium, magnesium stearate), and derivatives and mixtures thereof.
- silicone resins e.g., silanes, siloxanes [e.g., polydimethylsiloxane (PDMS)], siloxysilicates [e.g., tnmethylsiloxysilicate], silsesqui oxanes [e.g., polymethylsilsesqui oxane]
- Non-limiting examples of thickeners include salts, PEG-55, propylene glycol oleate, PEG- 120 methyl lucose ioleate, cellulose derivatives [e.g., carboxymethyl cellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose], and derivatives and mixtures thereof.
- Non-limiting examples of fdlers include silica microspheres (e.g., hollow silica microspheres, acrylic polymer microspheres [e.g., microspheres made of crosslinked acrylate copolymer, microspheres made of polymethyl methacrylate]); polyurethane powders (e.g., powder of a copolymer of hexamethylene diisocyante and of trimethylol hexyl lactone); elastomeric crosslinked organopolysiloxane spherical powders; carnauba or paraffin wax microbeads; metal soaps in powder form (e.g., metal soaps of fatty acids containing from 12 to 22 carbons, where the metal may be zinc or magnesium, and the fatty acid may be lauric acid, myristic acid, stearic acid, and palamitic acid [e.g., zinc laurate, magnesium stearate, magnesium myristate, zinc stearate]), tal
- SUBSTITUTE SHEET (RULE 26) aluminosilicates (e.g., micas of natural origin [e.g., muscovite, margarite, roscoelite, lepidolite, biotite] or of synthetic origin); clays (e.g., sericites); kaolin or hydrated aluminum silicate; boron nitrides; powders of tetrafluoroethylene polymers; precipitated calcium carbonate, magnesium carbonate, or magnesium hydrogen carbonate; hydroxyapatite; powders of nonexpanded synthetic polymers (e.g., polyethylene, polyesters [e.g., polyethylene isophthalate or terephthalate], polyamides [e.g., Nylon]); powders of spheronized, crosslinked or noncrosslinked synthetic polymers (e.g., polyamide powders [e.g., poly-P-alanine powder, Nylon powder, polyacrylic acid powder, polymethacrylic acid powder, powder
- Non-limiting examples of plasticizing agents include glycerin, sorbitol, a non-toxic glycol or polyglycol (e.g., propylene dipropylene or other C2-C4 glycol), and derivatives and mixtures thereof.
- Non-limiting examples of surfactants include alkyl sulfates, alkyl ether sulfates, alkyl sulfonates, alkyl aryl sulfonates, alkyl succinates, alkyl sulfosuccinates, N-alkoyl sarcosinates, acyl taurates, acyl isothionates, alkyl phosphates, alkyl ether phosphates, alkyl ether carboxylates, alpha-olefin sulfonates (e.g., alkaline and earth alkaline metal salts [e.g., sodium, potassium, magnesium, calcium, ammonium, and triethanolamine salts]), alkyl betaines, alkyl amido propyle betaines, alkyl sulfobetaines, alkyl glycinates, alkyl carboxy glycinates, alkyl amphoacetates, alky prop
- Non-limiting examples of coloring agents include dyes, lacquers, mineral pigments, organic pigments, nacres (i.e., colored particles of any form, which may or may not be iridescent, especially produced by certain molluses in their shell, or alternatively synthesized, and which have a color effect via optical interference), reflective particles (i.e., particles that impart sparkle), FD&C Blue No. 1 (Brilliant Blue), FD&C Blue No. 2 (Indigotine), FD&C Green No. 3 (Fast Green), FD&C Red No. 3 (Erythrosine), FD&C Red No. 40 (Allura Red), FD&C Yellow No. 5 (Tartrazine), FD&C Yellow No.
- SUBSTITUTE SHEET (RULE 26) extract, copper-chlorophyll, copper-chlorophyllin, curcumin, curcumin/Cu-chlorophyllin, elderberry, grape, grape skin extract, hibiscus, lutein, mixed carotenoids, paprika, paprika extract, paprika oleoresin, riboflavin, saffron, spinach, stinging nettle, titanium dioxide, turmeric, titanium dioxide, zirconium oxide, cerium oxide, zinc oxide, iron (black, yellow or red) oxide, chromium oxide, sericites, micas, talcs, kaolin, manganese violet, ultramarine blue, chromium hydrate and ferric blue, metal powders (e.g., aluminum powder, copper powder), cochineal carmine, carotenoids, curcumin, porphyrin pigment, vegetable carbon black, organic pigments of azo dyes, anthraquinone dyes, indigoid
- titanium mica coated with an iron oxide titanium mica coated with bismuth oxychloride, titanium mica coated with chromium oxide, pigments based on bismuth oxychloride, and particles comprising a borosilicate substrate coated with titanium oxide, and derivatives and mixtures thereof.
- Non-limiting examples of agents that impart pearlescence include bismuth oxychloride, titanium mica, and guanine crystals.
- Non-limiting examples of oil-dispersing agents include rhamnolipid biosurfactants, sophorolipid biosurfactants, polylipid protein sulfates, and derivatives and mixtures thereof.
- conditioning agents include silicone compounds (e.g., polyalkyl siloxanes, polyaryl siloxanes, polyarylalkyl siloxanes, polyether siloxanes, silicone resins).
- Non-limiting examples of anti-oxidants include alpha hydroxy acids (e.g., glycolic acid, citric acid, lactic acid, malic acid, mandelic acid, ascorbic acid, alpha-hydroxybutyric acid, alpha-hydroxyisobutyric acid, alpha-hydroxyisocaproic acid, atrrolactic acid, alphahydroxyisovaleric acid, ethyl pyruvate, galacturonic acid, glucopehtonic acid, glucopheptono 1,4-lactone, gluconic acid, gluconolactone, glucuronic acid, glucurronolactone, glycolic acid, isopropyl pyruvate, methyl pyruvate, mucic acid, pyruvia acid, saccharic acid, saccanc acid 1,4-lactone, tartaric acid, tartronic acid), chelating agents (e.g., metal chelators) such as ethylenediaminetetraacetic acid (EDTA), cit
- SUBSTITUTE SHEET bis(o-aminophenoxy)ethane-N,N,N' ,N' -tetraacetic acid (BAPTA), diethylene triamine pentaacetic acid (DTP A), 2, 3-dimercapto-l -propanesulfonic acid (DMPS), dimercaptosuccinic acid (DMSA), a-lipoic acid, salicylaldehyde isonicotinoyl hydrazone (SIH), hexyl thioethylamine hydrochloride (HTA), desferrioxamine, ascorbic acid (vitamin C), cysteine, glutathione, dihydrolipoic acid, 2-mercaptoethane sulfonic acid, 2-mercaptobenzimidazole sulfonic acid, 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, sodium metabisulfite, vitamin E isomers (e.
- BAPTA
- Non-limiting examples of suitable anti-dandruff agents, anti-seborrheic dermatitis agents, and anti-psoriasis agents include zinc pyrithione, selenium sulfide, sulfur, sulfonated shale oil, salicylic acid, coal tar, povidone-iodine, imidazoles (e.g., ketoconazole, dichlorophenyl imidazolodioxalan, clotrimazole, itraconazoie, miconazole, climbazole, tioconazole, sulconazole, butoconazole, fluconazole, miconazolenitrite, anthralin), piroctone olamine (Octopirox), selenium sulfide, ciclopirox olamine, anti-psoriasis agents, vitamin A analogs, corticosteroids, and derivatives and mixtures thereof.
- imidazoles e.g.,
- Non-limiting examples of anti-acne agents include to keratolytics (e.g., salicylic acid, derivatives of salicylic acid, resorcinol); retinoids (e.g., retinoic acid, tretinoin, adapalene, tazarotene); sulfur-containing D- and L-amino acids and their derivatives and salts; lipoic acid; antibiotics and antimicrobials (e.g., lantibiotics [e.g., nisin, subtilin, epidermin, gallidermin], defensins, attacins [e.g., sarcotoxin], cecropins [e.g, cecropin A, bactericidin, lepidopteran], magainins, melittins, histatins, brevinins, novispirins, benzoyl peroxide, triclosan, chlorhexidine gluconate, octopi
- Non-limiting examples of skin whitening agents include hydrogen peroxide, zinc peroxide, sodium peroxide, hydroquinone, 4-isopropylcatechol, hydroquinone monobenzyl ether, kojic acid, lactic acid, ascorbyl acid and derivatives (e.g., magnesium ascorbyl
- SUBSTITUTE SHEET (RULE 26) phosphate), arbutin, licorice root, sugar amines (e.g., glucosamine, N-acetyl glucosamine, glucosamine sulfate, mannosamine, N-acetyl mannosamine, galactosamine, N-acetyl galactosamine), N-acyl amino acids (e.g., N-acyl phenylalanine, N-acyl tyrosine, N- undecylenoyl-L-phenylalanine), soy isoflavones, retinoids (e.g., retinol), kojic dipalmitate, arbutin, transexamic acid, vitamins (e.g., niacin, vitamin C), azelaic acid, linolenic acid, linoleic acid, placertia, natural extracts (e.g., chamomile, green tea
- Non-limiting examples of skin self-tanning agents include dihydroxy acetone (DHA), glyceryl aldehyde, tyrosine and tyrosine derivatives (e.g., malyltyrosine, tyrosine glucosinate, ethyl tyrosine), phospho-DOPA, indoles, and derivatives and combinations thereof.
- DHA dihydroxy acetone
- tyrosine and tyrosine derivatives e.g., malyltyrosine, tyrosine glucosinate, ethyl tyrosine
- phospho-DOPA indoles
- Non-limiting examples of soothing agents include aloe, avocado oil, green tea extract, hops extract, chamomile extract, colloidal oatmeal, calamine, cucumber extract, sodium palmate, sodium palm kemelate, butyrospermum parkii (i.e., shea butter), menthe piperita (i.e., peppermint) leaf oil, sericin, pyridoxine (a form of vitamin B6), retinyl palmitate and/or other forms of vitamin A, tocopheryl acetate and/or other forms of vitamin E, lauryl laurate, hyaluronic acid, aloe barbadensis leaf juice powder, euterpe oleracea (i.e., acai berry) fruit extract, riboflavin (i.e., vitamin B2), thiamin HC1 and/or other forms of vitamin Bl, and variations and mixtures thereof.
- menthe piperita i.e., peppermint
- Non-limiting examples of cooling agents include WS-3, WS-23, menthol, 3- substituted-P-menthanes, N-substituted-P-menthane-3-carboxamides, isopulegol, 1,2- alkanediols (e.g., 3-(l-menthoxy)propane-l,2-diol, 3-(l-menthoxy)-2-methylpropane-l,2- diol, p-menthane-2,3-diol, p-menthane-3,8-diol), 6-isopropyl-9-methyl-l,4- dioxaspiro[4,5]decane-2-methanol, menthyl succinate and its alkaline earth metal salts, trimethylcyclohexanol, N-ethyl-2-isopropyl-5-methylcyclohexanecarboxamide, Japanese mint oil, peppermint oil, menthone, menthone glycerol
- Non-limiting examples of fragrances include bisabolol; 2,4-dimethyl-3- cyclohexene-l-carbaldehyde; isocyclocitral; menthone; isomenthone; ROMASCONE® (methyl 2, 2-dimethyl-6-methylene-l -cyclohexanecarboxylate); nerone; terpineol; dihydroterpineol; terpenyl acetate; dihydroterpenyl acetate; dipentene; eucalyptol; hexylate;
- SUBSTITUTE SHEET (RULE 26) rose oxide; PERYCOROLLE® ((S)-l,8-p-menthadiene-7-ol); l-p-menthene-4-ol; (lRS,3RS,4SR)-3-p-mentanyl acetate; (lR,2S,4R)-4,6,6-trimethyl-bicyclo[3,l,l]heptan-2-ol; DOREMOX® (tetrahydro-4-methyl-2-phenyl-2H-pyran); cyclohexyl acetate; cyclanol acetate; Fructalate (1,4-cyclohexane di ethyldicarboxylate); KOUMALACTONE® ((3ARS,6SR,7ASR)-perhydro-3,6-dimethyl-benzo[B]furan-2-one); Natactone ((6R)- perhydro-3,6-dimethyl-benzo[B]furan-2-one
- SUBSTITUTE SHEET (RULE 26) 3-(l,l-dimethyl-5-indanyl)propanal); Rhubofix® (3' ,4-dimethyl- tricyclo[6.2.1.0(2,7)]undec-4-ene-9-spiro-2 z -oxirane); 9/10-ethyldiene-3- oxatricyclo[6.2.1 ,0(2,7)]undecane; POLYWOOD® (perhydro-5,5,8A-tnmethyl-2- naphthalenyl acetate); octalynol; CETALOX® (dodecahydro-3a,6,6,9a-tetramethyl- naphtho[2, l-b]furan); tricyclo[5.2.1 ,0(2,6)]dec-3-en-8-yl acetate and tricyclo[5.2.1 ,0(2,6)]dec-
- Non-limiting examples of anti-aging agents include vitamins (e.g., vitamin E, vitamin A, vitamin C (ascorbic acid), vitamin B, vitamin E acetate, vitamin C palmitate), hydroxy acids (e.g., alpha-hydroxy acids [e.g., glycolic acid, lactic acid, 2-hydroxy butanoic acid, malic acid, citric acid tartaric acid, alpha-hydroxyethanoic acid, hydroxycaprylic acid], beta hydroxy acids [e.g., beta-hydroxybutyric acid, beta-phenyl-lactic acid, beta-phenylpyruvic acid, salicylic acid], polyhydroxy acids [e.g., gluconolactone (G4)]), gamma-linolenic acid, flavonoids (e.g., quercetin, hesperidin, quercitrin, rutin, tangeritin, epicatechin), CoQlO, retinoids, other proteins (e.g., collagen, soybean protein) and protein
- UVA and/or UVB light absorbing agents include UV absorbers of benzoic acid system (e.g., para-aminobenzoic acid (PABA); PABA monoglycerin ester; N,N-dipropoxy PABA ethyl ester; N,N-diethoxy PABA ethyl ester; N,N-dimethyl PABA ethyl ester; N,N-dimethyl PABA butyl ester; N,N-dimethyl PABA methyl ester); UV absorbers of benzoic acid system (e.g., para-aminobenzoic acid (PABA); PABA monoglycerin ester; N,N-dipropoxy PABA ethyl ester; N,N-diethoxy PABA ethyl ester; N,N-dimethyl PABA ethyl ester; N,N-dimethyl PABA butyl ester; N,N-dimethyl PABA methyl ester); UV absorbers of
- SUBSTITUTE SHEET (RULE 26) absorbers of anthranilic acid system (e.g., homomenthyl-N-acetyl anthranilate); UV absorbers of salicylic acid system (e.g., amyl salicylate; menthyl salicylate; homomenthyl salicylate; octyl salicylate; phenyl salicylate; benzyl salicylate; p-isopropanol phenyl salicylate); UV absorbers of cinnamic acid system (e.g., octyl cinnamate; ethyl-4-isopropyl cinnamate; methyl- 2,5-diisopropyl cinnamate; ethyl-2,4-diisopropyl cinnamate; methyl-2,4-diisopropyl cinnamate; propyl-p-methoxy cinnamate; isoprop
- UVA and/or UVB light scattering agents include titanium oxide, particulate titanium oxide, zinc oxide, particulate zinc oxide, ferric oxide, particulate ferric oxide, ceric oxide, and derivatives and combinations thereof.
- Non-limiting examples of antibacterial agents include macrolides or ketolides (e.g., erythromycin, azithromycin, clarithromycin, telithromycin); beta-lactams (e.g., penicillin, cephalosporin, carbapenems [e.g., carbapenem, imipenem, meropenem]); monolactams (e.g., penicillin G, penicillin V, methicillin, oxacillin, cioxacillin, dicloxacillin, nafcillin, ampicillin, amoxicillin, carbenicillin, ticarcillin, meziocillin, piperacillin, azlocillin, temocillin, cepalothin, cephapirin, cephradine, cephaloridine, cefazolin, cefamandole, cefuroxime, cephalexin, cefprozil, cefaclor, loracarbef,
- SUBSTITUTE SHEET (RULE 26) sulphanilamides (e.g., para-aminobenzoic acid, sulfadiazine, sulfisoxazole, sulfamethoxazole, sulfathalidine); aminoglycosides (e.g., streptomycin, neomycin, kanamycin, paromycin, gentamicin, tobramycin, amikacin, netilmicin, spectinomycin, sisomicin, dibekalin, isepamicin); tetracyclines (e.g., tetracycline, chlortetracycline, demeclocy cline, minocycline, oxy tetracycline, methacycline, doxycycline); rifamycins (e.g., rifampicin [i.e., rifampin], rifapentine, rifabutin, bez
- Non-limiting examples of antifungal agents include azoles (e.g., Fluconazole, Isavuconazole, Itraconazole, Ketoconazole (or a pyrithione salt thereof [e.g., zinc pyrithione, sodium pyrithione, potassium pyrithione, lithium pyrithione, ammonium pyrithione, copper pyrithione, calcium pyrithione, magnesium pyrithione, strontium pyrithione, silver pyrithione, gold pyrithione, manganese pyrithione, ethanolamine salt, chitosan salt, disulfide salt of pyrithione]), Miconazole, Clortrimazole, Voriconazole, Posaconazole, Ravuconazole, Ciclopirox, etc.), polyenes (e.g., natamycin, lucensomycin, nystatin, amphotericin B,
- Non-limiting examples of anti-inflammatory agents include steroidal antiinflammatory (e.g., 21-acetoxypregnenolone, alclometasone, algestone, amcinonide, beclomethasone, betamethasone, budesonide, chloroprednisone, clobetasol, clobetansone, clocortolone, cloprednol, corticosterone, cortisone, cortivazol, deflazacort, desonide, desoximetasone, dexamethasone, diflorasone, diflucortolone, difluprednate, enoxolone, fluazacort, flucloronide, flumethasone flunisolide, fluocinolone acetonide, fluocinonide, fluocortin butyl, fluocortolone, fluoromethoIone, fluperolone acetate, fluprednidene a
- SUBSTITUTE SHEET (RULE 26) or COX nonspecific inhibitors; e.g., salicylic acid derivatives (e.g., aspirin, sodium salicylate, choline magnesium trisalicylate, salicylate, diflunisal, sulfasalazine, olsalazine), paraaminophenol derivatives (e.g., acetaminophen); indole and indene acetic acids (e.g., indomethacin, sulindac); heteroaryl acetic acids (e.g, tolmetin, diclofenac, ketorolac); arylpropionic acids (e.g., ibuprofen, naproxen, flurbiprofen, ketoprofen, fenoprofen, oxaprozin); anthranilic acids (fenamates; e.g., mefenamic acid, meloxicam); enolic acids (
- a cosmetic or personal care composition according to any of the above may have an attribute (e.g., any one of the attributes disclosed herein, or combination of two or more of the attributes disclosed herein) that is between 50% and 150%, 140%, 130%, 120%, 110%, 100%, 90%, 80%, 70%, or 60%; between 60% and 150%, 140%, 130%, 120%, 110%, 100%, 90%, 80%, or 70%; between 70% and 150%, 140%, 130%, 120%, 110%, 100%, 90%, or 80%; between 80% and 150%, 140%, 130%, 120%, 110%, 100%, or 90%; between 90% and 150%, 140%, 130%, 120%, 110%, or 100%; between 100% and 150%, 140%, 130%, 120%, or 110%; between 110% and 150%, 140%, 130%, 120%, or 110%; between 110% and 150%, 140%, 130%, or 120%; between 120% and 150%, 140%, or 130%; between 130% and 150%, or 14
- Non-limiting examples of attributes include film forming (e.g., for even spreading on a body surface); film elasticity (e.g., elasticity of film formed on body surface); film flexibility (e.g., flexibility of film formed on body surface); adhesion to body surface (e.g., binding to sebum secreted from skin or keratin in hair to influence duration of wear); foam forming (e.g., foaming of hair shampoo); gelling; moisturizing of body surface; emulsifying (e.g., to stabilize oil droplets comprised in the cosmetic or personal care composition and/or capture oil secreted by skin to prevent pooling of oil); binding (e.g., water binding, lipid binding, binding of bioactive agent); delivery (e.g., delivery of bioactive compound); oilcontrolling and/or oil removing (e.g., absorption or breaking up into droplets of excess oil
- SUBSTITUTE SHEET (RULE 26) produced and/or accumulated on body surface [e.g., to provide matte finish; to prevent acne, oily hair, or oily nail]); hypoallergenicity; softening of body surface; restructuring of body surface; glossing of body surface; de-glossing of body surface (e.g., to remove reflective shine); soothing of body surface (e.g., soothing of bum or sunbum); penetration of body surface (e.g., penetration into skin epidermis); revitalizing of body surface (e.g., modulate in situ production of collagen); activity on cutaneous necrosis; modulate (e.g., increase) rupture force of cicatrices; detangling of hair; strengthening, mending, and/or thickening of hair; humidity shielding (e.g., to enable long, sweat-free, and transfer-proof wear on body surface); encapsulating (e.g., to protect) active agent (e.g., any of the other ingredients disclosed herein); delivering active agent (e
- the recombinant milk protein comprised in the milk protein component comprised in a cosmetic or personal care composition according to any of the above may impart or materially contribute to such attribute of the cosmetic or personal care composition.
- the properties of milk proteins are in large part determined by the side chains of amino acids in the primary sequence of the milk proteins, the secondary and tertiary structures of the milk proteins, and on the interactions the secondary and tertiary structures permit the side chains to have with other molecules (e.g., other milk proteins, other non-milk proteins).
- the primary sequence of milk proteins can be maintained in their recombinant production, amino acid side chains as well as secondary and tertiary structures may be impacted by protein folding pathways and non-native post-translational modifications (PTMs) that may occur in recombinant host cells.
- PTMs post-translational modifications
- SUBSTITUTE SHEET (RULE 26) of any of the above may have a non-native PTM that impacts a functionality of the recombinant milk protein, such that the recombinant milk protein imparts or materially contributes to an attribute of the cosmetic or personal care composition according to any of the above that differs from that imparted by a corresponding native milk protein in a corresponding cosmetic or personal care composition.
- use of a native milk protein in production of a cosmetic or personal care composition often entails use of milk protein preparations that typically comprise at least small amounts of other components present in milk (e.g., other proteins, carbohydrates, minerals, lipids), which may impact an attribute of the cosmetic or personal care composition that is imparted or materially contributed to by the native milk protein.
- recombinant production of a milk protein provides for preparations that are substantially purer, and that may therefor impart or materially contribute to an attribute of a cosmetic or personal care composition according to any of the above in a measurably different manner.
- a cosmetic or personal care composition according to any of the above may comprise a lower amount of the recombinant milk protein than is necessary for the corresponding native protein in the corresponding cosmetic or personal care composition to obtain a similar attribute that is imparted or materially contributed to by the milk protein; and/or a cosmetic or personal care composition according to any of the above may comprise a different salt content than the corresponding cosmetic or personal care composition without effect on an attribute that is imparted or materially contributed to by the milk protein (e.g., without the recombinant milk protein becoming insoluble and leaving visible residue upon application of the cosmetic or personal care product on a body surface); and/or a cosmetic or personal care composition according to any of the above may have improved oil-controlling and/or oil removing capacity compared to the corresponding
- a method for producing a cosmetic or personal care composition according to any of the above, wherein the method comprises the step of obtaining a recombinant milk protein.
- the recombinant milk protein may be obtained using in vitro methods (e.g., using cell-free transcription and/or translation systems). Alternatively, the recombinant milk protein may be produced using a recombinant host cell.
- the recombinant host cell may be derived from any wildtype organism, including any bacterium, fungus (e.g., yeast, filamentous fungus), archaea, unicellular protista, animal, plant, algae, protozoan, and chromista, or from a genetic variant (e.g., mutant) thereof, as well as from any generally recognized as safe (GRAS) industrial host cell.
- Non-limiting examples of suitable bacteria include firmicutes, cyanobacteria (bluegreen algae), oscillatoriophcideae, bacillales, lactobacillales, oscillatoriales, bacillaceae, lactobacillaceae, and members of any of the following genera, and derivatives and crosses thereof: Acinetobacter, Acetobacter (e.g., Acetobacter suboxydans, Acetobacter xylinum), Actinoplane (e.g., Actinoplane missouriensis), Arthrospira (e.g., Arthrospira platensis, Arthrospira maxima), Bacillus (e g., Bacillus cereus, Bacillus coagulans, Bacillus licheniformis, Bacillus stearothermophilus, Bacillus subtilis), Escherichia (e.g., Escherichia coli), Lactobacillus (e.g., Lactobacillus acidophilus, Lac
- Streptococcus thermophilus Streptomyces (e.g., Streptomyces chattanoogensis, Streptomyces gnseus, Streptomyces natalensis, Streptomyces olivaceus, Streptomyces olivochromogenes, Streptomyces rubiginosus), Tetrahymena (e.g., Tetrahymena thermophile, Tetrahymena hegewischi, Tetrahymena hyperangularis, Tetrahymena malaccensis, Tetrahymena pigmentosa, Tetrahymena pyriformis, Tetrahymena vorax ), and Xanthomonas (e.g., Xanthomonas campestns).
- Streptomyces e.g., Streptomyces chattanoogensis, Streptomyces gnseus, Streptomyces natal
- Non-limiting examples of suitable yeast include members of any of the following genera, and derivatives and crosses thereof: Blastobotrys, Candida (e g., Candida albicans, Candida etchellsii, Candida guilliermondii, Candida humilis, Candida lipolytica, Candida orthopsilosis, Candida palmioleophila, Candida pseudotropicalis, Candida sp., Candida utilis,
- Candida e g., Candida albicans, Candida etchellsii, Candida guilliermondii, Candida humilis, Candida lipolytica, Candida orthopsilosis, Candida palmioleophila, Candida pseudotropicalis, Candida sp., Candida utilis,
- SUBSTITUTE SHEET (RULE 26) Candida versatilis), Cladosporium, Cryptococcus (e.g., Cryptococcus terricolus, Cryptococcus curvatus), Debaryomyces (e.g., Debaryomyces hansenii), Endomyces (e.g., Endomyces vemalis), Endomycopsis (e.g., Endomycopsis vemalis), Eremothecium (e.g., Eremothecium ashbyii), Hansenula (e.g., Hansenula sp., Hansenula polymorpha), Kluyveromyces (e.g., Kluyveromyces sp., Kluyveromyces lactis, Kluyveromyces marxianus var.
- Candida versatilis Cladosporium
- Cryptococcus e.g., Cryptococcus terricolus, Cryptococcus curvat
- Pichia e.g., Pichia sp., Pichia pastoris, Pichia finlandica, Pichia trehalophila, Pichia koclamae, Pichia membranaefaciens, Pichia minuta, Pichia lindnen), Pichia opuntiae, Pichia thermotolerans, Pichia salictaria, Pichia guercuum, Pichia pijperi, Pichia stiptis, Pichia methanolica), Rhodosporidium (e.g., Rhodosporidium toruloides), Rhodotorula (e.g., Rhodotorula s
- Trichosporon cacaoliposimilis sp. nov. Trichosporon gracile, Trichosporon dulcitum, Trichosporon jirovecii, Trichosporon insectorum), Xanthophyllomyces (e.g., Xanthophyllomyces dendrorhous), Yarrowia (e.g., Yarrowia lipolytica), and Zygosaccharomyces (e.g., Zygosaccharomyces rouxii).
- Xanthophyllomyces e.g., Xanthophyllomyces dendrorhous
- Yarrowia e.g., Yarrowia lipolytica
- Zygosaccharomyces e.g., Zygosaccharomyces rouxii).
- Non-limiting examples of suitable filamentous fungi include any holomorphic, teleomorphic, and anamorphic forms of fungi, including members of any of the following genera, and derivatives and crosses thereof: Acremonium (e.g., Acremonium alabamense), Aspergillus (e.g., Aspergillus aculeatus, Aspergillus awamori, Aspergillus clavatus, Aspergillus flavus, Aspergillus foetidus, Aspergillus fumigatus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, Aspergillus niger var.
- Acremonium e.g., Acremonium alabamense
- Aspergillus e.g., Aspergillus aculeatus, Aspergillus awamori, Aspergillus clavatus, Aspergillus
- Mucor e.g., Mucor miehei Cooney et Emerson (Rhizomucor miehei (Cooney & R. Emerson)
- S chipper Mucor pusillus Lindt, Mucor circinelloides Mucor mucedo
- Mycehophthora e.g., Myceliophthora thermophila
- Myrothecium Neocallimastix
- Neurospora e.g., Neurospora crassa
- Paecilomyces Penicillium (e.g., Penicillium chrysogenum, Pennicillium iilacinum, Penicillium roquefortii), Phenerochaete, Phlebia, Piromyces, Pythium, Rhizopus (e.g., Rhizopus niveus), Schizophyllum, Scytalidium, Sporotrichum (e.g., Sporotrichum cellulophilum), Stere
- Non-limiting examples of suitable plants include cycads, ginkgo biloba, conifers, cypress, junipers, thuja, cedarwood, pines, angelica, caraway, coriander, cumin, fennel, parsley, dill, dandelion, helichrysum, marigold, mugwort, safflower, camomile, lettuce,
- SUBSTITUTE SHEET (RULE 26) wormwood, calendula, citronella, sages, thyme, chia seed, mustard, olive, coffee, capsicum, eggplant, paprika, cranberry, kiwi, vegetables (e.g., carrot, celery), tagetes, tansy, tarragon, sunflower, wintergreen, basil, hyssop, lavender, lemon verbena, marjoram, melissa, patchouli, pennyroyal, peppermint, rosemary, sesame, spearmint, primroses, samara, pepper, pimento, potato, sweet potato, tomato, blueberry, nightshades, petunia, morning glory, lilac, jasmin, honeysuckle, snapdragon, psyllium, wormseed, buckwheat, amaranth, chard, quinoa, spinach, rhubarb, jojoba, cypselea, chlor
- the recombinant milk protein may be purified (i.e., be substantially separated from chemicals (e.g., carbohydrates, lipids, ash, metabolites, signaling molecules, other proteins), cellular components (e.g., cell walls, membrane lipids, chromosomes), and cells (e.g., other cells in an organism) of the source material from which the recombinant milk protein originated) comprised in a source material [e.g., a plant material, a fermentation broth]).
- chemicals e.g., carbohydrates, lipids, ash, metabolites, signaling molecules, other proteins
- cellular components e.g., cell walls, membrane lipids, chromosomes
- cells e.g., other cells in an organism
- the recombinant milk protein may be purified to a purity of greater than 30%, greater than 35%, greater than 40%, greater than 45%, greater than 50%, greater than 55%, greater
- SUBSTITUTE SHEET (RULE 26) than 60%, greater than 65%, greater than 70%, greater than 75%, greater than 80%, greater than 85%, greater than 90%, greater than 95%, greater than 97%, or greater than 99% relative to other components comprised in the source material, or to at least 2-fold, at least 3 -fold, at least 4-fold, at least 5-fold, at least 6-fold, at least 7-fold, at least 8-fold, at least 9-fold, or at least 10-fold greater abundancy relative to other components comprised in the source material, or to a purity of greater than 30%, greater than 35%, greater than 40%, greater than 45%, greater than 50%, greater than 55%, greater than 60%, greater than 65%, greater than 70%, greater than 75%, greater than 80%, greater than 85%, greater than 90%, greater than 95%, greater than 97%, or greater than 99% by weight.
- the method may further comprise the step of polymerizing the recombinant milk protein.
- Methods for polymerizing milk proteins are disclosed, for example, in U.S. patent publication US20060057131, published March 16, 2006; PCT publication WO2019213155, published November 7, 2019; and PCT publication WO2022031941, published February 10, 2022.
- the method may further comprise the step of producing a coacervate comprising the recombinant milk protein and a polysaccharide.
- a coacervate comprising the recombinant milk protein and a polysaccharide.
- a variety of recipes known in the art may be used to prepare cosmetic or personal care product.
- the recombinant milk may be used in such recipes in purified/isolated form or comprised in a fermentation broth to produce a cosmetic or personal care product according to any of the above.
- a method for beautifying or hygienizing comprising the step of applying to a body surface a cosmetic or personal care composition according to any of the above.
- Example 1 Skin lightening activity of recombinant B-lactoglobulin in melanoderm skin model
- the skin lightening activity of recombinantly produced B-lactoglobulin was evaluated using a MelanoDerm 24 tissue kit (MELB-300; MatTek, Ashland. MA).
- MELB-300 MelanoDerm 24 tissue kit
- EPI-100-NMM- 113 culture medium pre-warmed at 30-37C
- the MEL-300B tissue was removed from packaging using sterile forceps and transferred into the 12 well hanging top plates.
- the positive control exhibited the brightest skin (highest L* value).
- Lower concentrations of recombinant B-lactoglobulin (0.63mg/ml, 0.2mg/ml, and 0.06mg/ml) showed higher L*values, indicating lighter skin.
- concentrations (20mg/ml, 6.33mg/ml, and 2mg/ml)
- the recombinant B-lactoglobulin showed lower L*values, suggesting less effective skin lightening.
- Example 2 Anti-oxidant and anti-aging activity of recombinant B-lactoglobulin in epiderma skin model
Abstract
Provided are cosmetic or personal care compositions that comprise recombinant milk proteins, and methods for producing such cosmetic or personal care compositions.
Description
COSMETIC OR PERSONAL CARE COMPOSITION COMPRISING RECOMBINANT MILK PROTEIN
RELATED APPLICATIONS
[0001] This application claims priority to U.S. Provisional Patent Application Serial No. US63/391,511, filed on July 22, 2022, which is incorporated herein by reference, in its entirety.
FIELD OF THE INVENTION
[0002] The present invention relates generally to cosmetic or personal care compositions that comprise recombinant milk proteins. The present invention further provides methods for producing such cosmetic or personal care compositions.
BACKGROUND OF THE INVENTION
[0003] Many conventional cosmetic or personal care compositions comprise proteins derived from mammalian milk. These milk proteins impart or contribute to critical attributes and/or functionalities of such compositions.
[0004] There is, however, widespread concern over the impact of conventional milk production via animal husbandry on animal welfare and the environment. It is estimated that 30% of Earth's land surface is dedicated to animal farming, and that livestock account for 20% of the total terrestrial animal biomass. Due to its massive scale, animal farming produces more than 18% of net greenhouse gas emissions, constitutes the largest human source of water pollution, poses the world's largest threat to biodiversity, and in its industrialized implementation is cruel and exploitative.
[0005] Therefore, there exists a need for cosmetic or personal care products that, in their production and function, do not rely on the use of milk derived from animals, and for methods for producing such cosmetic or personal care products.
INCORPORATION BY REFERENCE
[0006] All publications, patents, patent applications, sequences, database entries, scientific publications, and other references mentioned herein are incorporated by reference in their entireties to the same extent as if each individual publication, patent, patent application, sequence, database entry, scientific publication, or other reference was specifically and individually indicated to be incorporated by reference. To the extent the material incorporated by reference contradicts or is inconsistent with the present disclosure, the present disclosure, including definitions, will supersede any such material.
1
SUBSTITUTE SHEET ( RULE 26)
BRIEF SUMMARY OF THE INVENTION
[0007] In various aspects provided herein is a cosmetic or personal care composition comprising a milk protein component, wherein the milk protein component comprises or consists essentially of a recombinant milk protein.
[0008] The recombinant milk protein comprised in the milk protein component of the cosmetic or personal care composition of paragraph [0007] may be a single recombinant milk protein. The single recombinant milk protein may be: a recombinant p-lactoglobulin, a recombinant a-lactalbumin, a recombinant GMP, a recombinant lactotransferrin, a recombinant bovine serum albumin, a recombinant lactoperoxidase, a recombinant K-casein, a recombinant -casein, a recombinant a-Sl -casein; or a recombinant a-S2-casein.
[0009] The recombinant milk protein comprised in the milk protein component of the cosmetic or personal care composition of paragraph [0007] may be a mixture of two or more recombinant milk proteins. The mixture of two or more recombinant milk proteins may comprise: a recombinant P-lactoglobulin, a recombinant a-lactalbumin, a recombinant GMP, a recombinant lactotransferrin, a recombinant bovine serum albumin, a recombinant lactoperoxidase, a recombinant K-casein, a recombinant [3-casein, a recombinant a-Sl -casein; and/or a recombinant a-S2-casein.
[0010] The recombinant milk protein comprised in the milk protein component of the cosmetic or personal care composition of paragraph [0007] may be hydrolyzed.
[0011] The recombinant milk protein comprised in the milk protein component of the cosmetic or personal care composition of paragraph [0007] may be a multimer or polymer of recombinant milk protein monomers.
[0012] In various further aspects provided herein is a method for producing a cosmetic or personal care composition of any of paragraphs [0007] through [0011], wherein the method comprises obtaining a recombinant milk protein. The recombinant milk protein may be obtained via production by a recombinant host cell. The recombinant host cell may be a recombinant fungal host cell (e.g., recombinant yeast host cell, recombinant filamentous fungal host cell). The recombinant fungal host cell may be derived from Saccharomyces, Kluyveromyces, Pichia, Tetrahymena, Yarrowia, Hansenula, Blastobotrys, Zygosaccharomyces, Debaryomyces, Aspergillus, Candida, Trichoderma, Fusarium, Chrysosporium, Physcomitrella, or Neurospora. The method may further comprise polymerizing the recombinant milk protein.
2
SUBSTITUTE SHEET ( RULE 26)
[0013] In various further aspects provided herein is a method for beautifying or hygienizing, wherein the method comprises applying to a body surface a cosmetic or personal care composition of any of paragraphs [0007] through [0011], DETAILED DESCRIPTION OF THE INVENTION
[0014] The terminology and description used herein are for the purpose of describing particular embodiments only, and are not intended to limit the scope of the invention. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as is commonly understood by one of ordinary skill in the art to which this disclosure pertains. Further, unless otherwise required by context, singular terms shall include the plural, and plural terms shall include the singular.
Definitions
[0015] The terms "a" and "an" and "the" and similar references as used herein refer to both the singular and the plural (e.g., meaning "at least one" or "one or more"), unless otherwise indicated herein or clearly contradicted by context. For example, the term "a compound" is synonymous with the terms "at least one compound" and “one or more compounds”, and may refer to a single compound or to a plurality of compounds, including mixtures thereof.
[0016] The term "about" as used herein in conjunction with a stated numerical value or range of numerical values is meant to encompass variations of the stated numerical value or range of numerical values (i.e., denoting somewhat more or somewhat less than the stated numerical value or range of numerical values, to within a range of ±10% of the stated value or range of numerical values).
[0017] The term "and/or" as used herein refers to multiple components in combination with or exclusive of one another. For example, "x, y, and/or z" may refer to "x" alone, "y" alone, "z" alone, "x, y, and z", "(x and y) or z", "(x and z) or y", "(y and z) or x", "x and y" alone, "x and z" alone, "y and z" alone, or "x or y or z".
[0018] The terms “at least one” and “one or more” as used herein refer to one, two, three, four, five, six, seven, eight, nine, ten, at least one, at least two, at least three, at least four, at least five, at least six, at least seven, at least eight, at least nine, at least ten, or more, or all of the elements subsequently listed.
[0019] The term “body surface” as used herein refers to the exposed area of a human body. Non-limiting examples of body surfaces include skin, hair, nail, tooth, and tissues of the oral cavity (e.g., gums).
[0020] The term "casein" as used herein refers to a polypeptide that comprises a sequence of at least 20 (e.g., at least 20, at least 30, at least 40, at least 50, at least 60, at least 70, at least
3
SUBSTITUTE SHEET ( RULE 26)
80, at least 90, at least 100, at least 150) amino acids that is at least 40% (e.g., at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, 100%) identical to a sequence of ammo acids in a casein natively found in a mammal-produced milk (i.e., a casein that is native to a mammal-produced milk; e.g., a native casein). Non-limiting examples of caseins include P-casein, /-casein, K-casein, a-Sl-casein, and a-S2-casein. Accordingly, the terms “P- casein”, “/-casein”, “K-casein”, “a-Sl -casein”, and “a-S2-casein” as used herein refer to a polypeptide that comprises a sequence of at least 20 (e.g., at least 20, at least 30, at least 40, at least 50, at least 60, at least 70, at least 80, at least 90, at least 100, at least 150) amino acids that is at least 40% (e.g., at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, 100%) identical to a sequence of amino acids in a P-casein, /-casein, K-casein, a- Sl-casein, and a-S2-casein, respectively, natively found in a mammal-produced milk (e.g., native P-casein (e.g., amino acids 16 to 224 of UniProt sequence P02666; amino acids 16 to 222 ofUniProt sequence Pl 1839 orP33048; amino acids 16 to 226 ofP05814), native /-casein, native K-casein (e.g., amino acids 22 to 190 of UniProt sequence P02668; amino acids 22 to 192 of UniProt sequence P02669 or P02670; amino acids 21 to 182 of UniProt sequence P07498), native a-Sl-casein (e.g., amino acids 16 to 214 ofUniProt sequence P02662, P04653, or P18626; amino acids 16 to 185 of UniProt sequence P47710), and native a-S2-casein (e.g., amino acids 16 to 222 ofUniProt sequence P02663; amino acids 16 to 223 ofUniProt sequence P04654 or P33049, respectively).
[0021] The term "corresponding cosmetic or personal care composition " as used herein refers to a cosmetic or personal care composition that is identical in composition to the cosmetic or personal care composition that is compared to the “corresponding cosmetic or personal care composition” except that the “corresponding cosmetic or personal care composition” comprises a corresponding native milk protein in place of the recombinant milk protein that is comprised in the cosmetic or personal care composition that is compared to the “corresponding cosmetic or personal care composition”.
[0022] The term “corresponding native milk protein” as used herein refers to a native milk protein that is identical in amino acid sequence to the recombinant milk protein that is compared to the “corresponding native milk protein” but that is obtained from a mammal- produced milk.
[0023] The term “cosmetic or personal care composition” as used herein refers to a composition that upon application to a body surface confers a perceived or actual beautifying
4
SUBSTITUTE SHEET ( RULE 26)
or hygienizing effect. Non-limiting examples of cosmetic or personal care compositions include anti-wrinkling treatments (i.e., compositions used for tensioning [e.g., smoothing out of skin, reducing wrinkles in skin, removing fine lines in skm]), anti-aging treatments (i.e., compositions used for removing signs of aging [e.g., wrinkles, fine lines, manifestations of photodamage (e.g., sun spots)]), sun protection (i.e., compositions used to protect against UV exposure), anti-bum treatments (i.e., compositions used for soothing bums [e.g., sunbums]), anti-acne treatments (i.e., compositions that are effective in the treatment of acne and/or the symptoms associated therewith), skin cleansers (i.e., compositions used for cleaning skin and/or skin pores [e.g., nose strips for pore cleaning]), anti-dandruff treatments (i.e., compositions used for reducing or eliminating dandruff), anti-body odor treatments (i.e., compositions used for reducing or eliminating body odor), self-tanning treatments (i.e., compositions used for darkening skm color), skin whitening treatments (i.e., compositions used for bleaching/depigmenting skin color), hair coloring treatments (i.e., compositions used for coloring hair), lotions (e.g., skin lotions, body care lotions, wash lotions, moisture retention lotions, pre-shave lotions, after-shave lotions), pastes (e.g., washing pastes), ointments, balms, salves, masks, creams (e.g., water in oil creams, oil in water creams, day creams, night creams, eye creams, skin creams, face creams, anti-wrinkle creams, sun protection creams, moisture retention creams, after-shave creams, skin bleaching creams, self-tanning creams, vitamin creams, moisturizing creams, massage creams), eye care products (e.g., eye moisturizing mists, eye lens solutions), milks (e.g., body milks, cleansing milks), gels (e.g., anhydrous gels, shower gels), Eau de Toilette, soaps (e.g., transparent soaps, luxurious soaps, deodorant soaps, cream soaps, baby soaps, skin protection soaps, abrasive soaps, syndets, pasty soaps, soft soaps, peeling soaps), skin peeling treatments, liquid washes, shower and bath preparations (e.g., wash lotions, shower baths, shower gels, foam baths, oil baths, scrub preparations), foams (e.g., shaving foams, foam baths), deodorants, hair care products (e.g., shampoos, conditioners, hair mousses, hair colorants, hair sprays, rinse-off lotions, hair gels, hair emulsions, hair laquers, hair tonics, hair oils), lip glosses, sprays (e.g., hair sprays, pump sprays, sprays containing blowing agents), treatments for skin defects (e.g., dermatitis, weals, chaps, blemishes, cracks, scars, freckles, moles, rashes, blisters, pustules), toners, cleaning tissues, sanitary towels, tampons, nappies, repellents, make-up products (e.g., studio pigments, mascara, eye shadows, eyeliners, eye liner pens, rouges, face powders, eyebrow pencils, lipsticks, foundations, tinted creams, concealer sticks, blemish sticks, blushes, nail polish), sticks (e.g., lipsticks, concealer sticks, blemish sticks), hair removing agents, hand cleaning products, intimate hygiene products, foot care products, baby care products, and oral hygiene products (e.g., chewing
5
SUBSTITUTE SHEET ( RULE 26)
gums, mouthwashes, toothpastes, gum-cleaning agents, denture adhesives, denture fixatives, breath strips, floss mechanisms, teeth whitening strips).
[0024] The term "essentially free of' as used herein refers to the indicated component being either not detectable in the indicated composition by common analytical methods, or to the indicated component being present in such trace amount as to not be functional. The term "functional" as used in this context refers to not materially contributing to properties of the composition comprising the trace amount of the indicated component, or to not having material activity (e.g., chemical activity, enzymatic activity) in the indicated composition comprising the trace amount of the indicated component, or to not having health-adverse effects upon use or consumption of the composition comprising the trace amount of the indicated component. The term “materially contributing” as used herein refers to the indicated component contributing to an attribute of a composition to such extent that in the absence of the component (e.g., in a reference composition that is identical to the composition except that it lacks the indicated component) the attribute is at least 10%, at least 20%, at least 30%, at least 40%, or at least 50% less present/active/measurable.
[0025] The term "filamentous fungus" as used herein refers to an organism from the filamentous form of the subdivision Eumycota and Oomycota (as defined by Hawksworth et al., In, Ainsworth and Bisby's Dictionary of The Fungi, 8th edition, 1995, CAB International, University Press, Cambridge, UK). A filamentous fungus is distinguished from a yeast by its hyphal elongation during vegetative growth.
[0026] The term "fungus" as used herein refers to organisms of the phyla Ascomycotas, Basidiomycota, Zygomycota, and Chythridiomycota, Oomycota, and Glomeromycota. It is understood, however, that fungal taxonomy is continually evolving, and therefore this specific definition of the fungal kingdom may be adjusted in the future.
[0027] The term "host cell" as used herein refers not only to the particular subject cell but also to the progeny of such cell. Because certain modifications may occur in succeeding generations due to either mutation or environmental influences, such progeny may not, in fact, be identical to the subject cell, but are still included within the scope of the term "host cell" as used herein.
[0028] The term “identity ” or “identical” in the context of two or more polynucleotide or polypeptide sequences as used herein refer to the nucleotide or amino acid residues that are the same when the two or more polynucleotide or polypeptide sequences, respectively, are aligned for maximum correspondence. Depending on the application, the "identity" may exist over a region of the sequences being compared (e.g., over the length of a functional domain) or over
6
SUBSTITUTE SHEET ( RULE 26)
the full length of the sequences. A “region” is considered to be a continuous stretch of at least 6, 9, 14, 19, 24, 29, 34, 39, or more nucleotides, or of at least 2, 6, 10, 14, 18, 22, 26, 30, or more amino acids. For comparison, typically one sequence acts as a reference sequence to which one or more test sequences are compared. When using a sequence comparison algorithm, test and reference sequences are input into a computer, subsequence coordinates are designated, if necessary', and sequence algorithm program parameters are designated. The sequence comparison algorithm then calculates the percent sequence identity for the test sequence(s) relative to the reference sequence, based on the designated program parameters. Optimal alignment of sequences for comparison may be conducted, e.g., by the local homology algorithm of Smith & Waterman, Adv. Appl. Math. 2:482 (1981), by the homology alignment algorithm of Needleman & Wunsch, J. Mol. Biol. 48:443 (1970), by the search for similarity method of Pearson & Lipman, Proc. Natl. Acad. Sci. USA 85:2444 (1988), by computerized implementations of these algorithms (GAP, BESTFIT, FASTA, and TFASTA in the Sequence Analysis Software Package of the Genetics Computer Group (GCG), University of Wisconsin Biotechnology Center, which may be used with default parameters), or by visual inspection (see generally Ausubel et al., infra). One example of an algorithm that is suitable for determining percent sequence identity and sequence similarity is the BLAST algorithm (see, for example, Altschul et al. 1990 J. Mol. Biol. 215:403-410; Gish & States. 1993 Nature Genet. 3:266-272; Madden et al. 1996 Meth. Enzymol. 266:131-141; Altschul et al. 1997 Nucleic Acids Res. 25:3389-3402; Zhang 7 Madden. 1997 Genome Res. 7:649-656). Software for performing BLAST analyses is publicly available through the National Center for Biotechnology Information. In cases where two or more polypeptide sequences differ from each other by conservative substitutions (i.e., substitutions of amino acids with chemically similar amino acids; conservative substitution tables providing functionally similar amino acids are well known in the art), the percent sequence identity or degree of homology may be adjusted upwards to correct for the conservative nature of the substitution. Means for making this adjustment are well know n to those of skill in the art. See, e.g., Pearson, 1994, Methods Mol. Biol. 24:307-31 and 25:365-89.
[0029] The terms “including,” “includes,” “having,” “has,” “with,” or variants thereof as used herein are intended to be inclusive in a manner similar to the term “comprising”.
[0030] The term “mammal-produced milk” as used herein refers to a milk produced by a mammal. Non-limiting examples of mammals include cow, human, sheep, mouflon, goat, buffalo, camel, horse, donkey, alpaca, yak, llama, lemur, panda, guinea pig, squirrel, bear, macaque, gorilla, chimpanzee, mountain goat, monkey, ape, cat, dog, wallaby, rat, mouse,
7
SUBSTITUTE SHEET ( RULE 26)
elephant, opossum, rabbit, whale, baboons, gibbons, orangutan, mandrill, pig, wolf, fox, lion, tiger, echidna, and woolly mammoth.
[0031] The term "microbe" or "microbial cell" as used herein is an abbreviation for microorganism, and includes all bacteria, archaea, unicellular protista, unicellular animals, unicellular plants, fungi (e.g., unicellular fungi, filamentous fungi, yeast), unicellular algae, protozoa, and chromista. The term "microbial" is used herein as the corresponding adjective. [0032] The term "milk protein" as used herein refers to a whey protein or a casein.
[0033] The term "milk protein component" as used herein refers to a component that consists of a subset of whey proteins comprised in a mammal-produced milk, or of a subset of caseins comprised in a mammal-produced milk, or a mixture of a subset of whey proteins and a subset of caseins comprised in a mammal-produced milk, (i.e., consists of some but not all proteins present in, for example, whey protein concentrate, whey protein isolate, whey protein hydrolysate, casein isolate, casein concentrate, casein hydrolysate, milk, milk protein isolate, milk protein concentrate, milk protein hydrolysate, micellar casein concentrate, sodium caseinate, or acid caseinate). The term implies that the milk proteins of which the milk protein component consists are the only milk proteins comprised in a composition provided herein (i.e., the composition comprises no other milk proteins other than the milk proteins of which the milk protein component consists).
[0034] The term "native" as used herein refers to what is found in nature in its unmodified state (e.g., a cell that is not genetically modified by a human, and that is maintained under conditions [e.g., level of oxygenation, pH, salt concentration, temperature, and nutrient (e.g., carbon, nitrogen, sulfur) availability] that are not defined by a human).
[0035] The terms "optional" or "optionally" as used herein refer to a feature or structure being present or not, or an event or circumstance occurring or not. The description includes instances in which a feature or structure is present, instances in which a feature or structure is absent, instances in which an event or circumstance occurs, and instances in which an event or circumstance does not occur.
[0036] The term “polynucleotide” as used herein refers to a polymeric form of at least 2 (e.g., at least 5, at least 10, at least 20, at least 30, at least 40, at least 50, at least 100, at least 500, at least 1,000) nucleotides. The term includes both sense and antisense strands of DNA molecules (e.g., cDNA, genomic DNA, synthetic DNA) and RNA molecules (e.g., mRNA, synthetic RNA), as well as analogs of DNA or RNA containing non-natural nucleotide analogs, non-native intemucleoside bonds, and/or chemical modifications. A polynucleotide may be modified chemically or biochemically, or it may contain non-natural or derivatized nucleotide
8
SUBSTITUTE SHEET ( RULE 26)
bases. Such modifications include, for example, labels; methylation; substitution of one or more of the naturally occurring nucleotides with an analog; intemucleotide modifications such as uncharged linkages (e.g., methyl phosphonates, phosphotriesters, phosphoramidates, carbamates), charged linkages (e.g., phosphorothioates, phosphorodithioates), pendent moieties (e.g., polypeptides), intercalators (e.g., acridine, psoralen), chelators, alkylators, and modified linkages (e.g., alpha anomeric nucleic acids). Examples of modified nucleotides are described in the art (see, for example, Malyshev et al. 2014. Nature 509:385; Li et al. 2014. J. Am. Chem. Soc. 136:826). Also included are synthetic molecules that mimic polynucleotides in their ability to bind to a designated sequence via hydrogen bonding or other chemical interactions. Such molecules are known in the art and include, for example, molecules in which peptide linkages substitute for phosphate linkages in the backbone of the molecule. Other modifications can include, for example, analogs in which the ribose ring contains a bridging moiety or other structure, such as the modifications found in “locked” polynucleotides. A polynucleotide can be in any topological conformation. For instance, a polynucleotide can be single-stranded, double-stranded, triple-stranded, quadruplexed, partially double-stranded, branched, hairpinned, circular, or in a padlocked conformation. The term “polynucleotide sequence” as used herein refers to a sequence of nucleotides that are comprised in a polynucleotide or of which a polynucleotide consists.
[0037] The terms “polypeptide” and “protein” as used herein can be interchanged and refer to both a naturally occurring and a non-naturally occurring polymeric form of at least 2 (e.g., at least 5, at least 10, at least 20, at least 30, at least 40, at least 50, at least 100) amino acids, having an active structure or lacking a functional structure. The term “protein” as used herein refers to a polypeptide of any length, which can include polypeptides comprising coded and non-coded amino acids, polypeptides compnsing amino acids that occur in nature, and those that do not occur in nature, polypeptides comprising chemically or biochemically modified or derivatized amino acids, and polypeptides comprising modified peptide backbones. A protein can be monomeric, meaning it has a single chain, or polymeric, meaning it is composed of two or more chains, which can be covalently or non-covalently associated.
[0038] The term "recombinant P-lactoglobulin" as used herein refers to a recombinantly produced polypeptide that comprises a sequence of at least 20 (e.g., at least 20, at least 30, at least 40, at least 50, at least 60, at least 70, at least 80, at least 90, at least 100, at least 150) amino acids that is at least 50% (e.g., at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, 100%) identical to a sequence of amino acids in a native P-lactoglobulin (e.g., a native Bos
9
SUBSTITUTE SHEET ( RULE 26)
taurus P-lactoglobulin [e.g., amino acids 17 to 178 of UniProt sequence P02754], a native Ovis aries P-lactoglobulin [e.g., amino acids 19 to 180 of UniProt sequence P67976], a native Capra hircus P-lactoglobulin [e.g., amino acids 19 to 180 of UniProt sequence P02756], a native Equus caballus P-lactoglobulin [amino acids 19-180 of UniProt sequence P02758], a native Equus asinus P-lactoglobulin [UniProt sequence P13613], a native Equus caballus P- lactoglobulin [amino acids 19 to 181 of UniProt sequence P07380], a native Equus asinus |3- lactoglobulin [UniProt sequence Pl 9647]).
[0039] The term "recombinant host cell" as used herein refers to a host cell that comprises a recombinant polynucleotide. Thus, for example, a recombinant host cell may produce a polynucleotide or polypeptide not found in the native (non-recombinant) form of the host cell, or a recombinant host cell may produce a polynucleotide or polypeptide at a level that is different from that in the native (non-recombinant) form of the host cell. It should be understood that such term is intended to refer not only to the particular subject cell but also to the progeny of such a cell. Because certain modifications may occur in succeeding generations due to either mutation or environmental influences, such progeny may not be identical to the subject cell, but are still included within the scope of the term "recombinant host cell" as used herein. A recombinant host cell may be an isolated cell or cell line grown in culture or a cell that resides in a living tissue or organism.
[0040] The term "recombinant milk protein", “recombinant whey protein”, “recombinant casein”, or “recombinant non-milk protein” as used herein refers to a milk protein, whey protein, casein, or non-milk protein, respectively, that is produced recombinantly (i.e., that is produced by a recombinant host cell).
[0041] The term "similar" as used herein refers to being within about +/— 15% with regard to a specified attribute. The term includes being within about +/- 15%, about +/- 14%, about +/— 13%, about +/— 12%, about +/— 11%, about +/— 10%, about +/— 9%, about +/-8%, about +/-7%, about +/-6%, about +/— 5%, about +/-4%, about +/-3%, about +/-2%, or about +/-!% with regard to the specified attribute.
[0042] The term "two or more” as used herein refers to two, three, four, five, six, seven, eight, nine, ten, or more, or all of the elements subsequently listed.
[0043] The term "whey protein" as used herein refers to a polypeptide that comprises a sequence of at least 20 (e.g., at least 20, at least 30, at least 40, at least 50, at least 60, at least 70, at least 80, at least 90, at least 100, at least 150) amino acids that is at least 40% (e.g., at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, 100%) identical
10
SUBSTITUTE SHEET ( RULE 26)
to a sequence of amino acids in a whey protein natively found in a mammal-produced milk (i.e., a whey protein that is native to a mammal-produced milk; e.g., a native whey protein). Non-limitmg examples of whey proteins include a-lactalbumin, [3-lactoglobulin, lactotransferrin, lactoferricin, serum albumin protein, lactoperoxidase protein, and glycomacropeptide. Accordingly, the terms “a-lactalbumin”, “P-lactoglobulin”, “lactotransferrin”, “lactoferricin”, “serum albumin”, “lactoperoxidase”, and “glycomacropeptide” as used herein refer to a polypeptide that comprises a sequence of at least 20 (e.g., at least 20, at least 30, at least 40, at least 50, at least 60, at least 70, at least 80, at least 90, at least 100, at least 150) amino acids that is at least 40% (e.g., at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, 100%) identical to a sequence of amino acids in an a-lactalbumin, P-lactoglobulin, lactotransferrin, lactoferricin, serum albumin, lactoperoxidase, and glycomacropeptide (GMP), respectively, natively found in a mammal- produced milk (e.g., native a-lactalbumin protein (e.g., amino acids 20-142 of UniProt sequence P00709, P00711, P00712, or P09462), native P-lactoglobulin protein (amino acids 17-178 of UniProt sequence P02754, amino acids 19-180 of UniProt sequence P67976 or P02756), native lactotransferrin protein (e.g., amino acids 20 to 708 of UniProt sequence P24627, D3G9G3, or Q29477; amino acids 20 to 710 of UniProt sequence P02788), native lactoferricin (amino acids 36 to 60 of UniProt sequence P24627), native serum albumin protein (e.g., amino acids 25 to 607 of UniProt sequence P02769 or P14639; amino acids 19 to 608 of UniProt sequence A0A452F7Y5; amino acids 25 to 609 of UniProt sequence P02768), native lactoperoxidase protein (amino acids 101 to 712 of UniProt sequence P80025), and native glycomacropeptide (GMP; e.g., amino acids 127 to 190 of UniProt sequence P02668)).
[0044] The term "yeast" as used herein refers to an organism of the order Saccharomycetales. Vegetative growth of yeast is by budding/blebbing of a unicellular thallus, and carbon catabolism may be fermentative.
[0045] The term “% by mass” as used herein refers to a percentage value for a mass as determined in a hydrated composition, such that the composition includes the mass of powder as well as the mass of the hydrating agent, with 100% fixed as the percentage value for the entire hydrated composition. In embodiments in which the composition provided herein is in powder form (to which the mass of the hydrating agent will be added at a later time), the term refers to a percentage value for a mass as determined relative to the eventual entire hydrated composition (with 100% fixed as the percentage value for that entire eventual hydrated composition).
11
SUBSTITUTE SHEET ( RULE 26)
[0046] Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value (fractional or integral) falling within the range inclusive of the recited minimum and maximum value, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. Also, it should be understood that any numerical range recited herein is intended to include all sub-ranges subsumed therein.
[0047] It further should be understood that in any method disclosed herein the order of steps or order for performing certain actions is immaterial so long as the invention remains operable. Moreover, two or more steps or actions may be conducted simultaneously.
Animal-Free Cosmetic Or Personal Care Composition
[0048] In various aspects, provided herein is a cosmetic or personal care composition that comprises a milk protein component, wherein the milk protein component comprises or consists essentially of a recombinant milk protein.
[0049] The cosmetic or personal care composition may comprise between 0.1% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.9%, 0.8%, 0.7%, 0.6%, 0.5%, 0.4%, 0.3%, or 0.2%; between 0.2% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.9%, 0.8%, 0.7%, 0.6%, 0.5%, 0.4%, or 0.3%; between 0.3% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.9%, 0.8%, 0.7%, 0.6%, 0.5%, or 0.4%; between 0.4% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.9%, 0.8%, 0.7%, 0.6%, or 0.5%; between 0.5% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.9%, 0.8%, 0.7%, or 0.6%; between 0.6% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.9%, 0.8%, or 0.7%; between 0.7% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.9%, or 0.8%; between 0.8% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, or
12
SUBSTITUTE SHEET ( RULE 26)
0.9%; between 0.9% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, or 1%; between 1% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, or 2%; between 2% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, or 3%; between 3% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, or 4%; between 4% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, or 5%; between 5% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, or 6%; between 6% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, or 7%; between 7% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, or 8%; between 8% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, or 9%; between 9% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, 11%, or 10%; between 10% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, 12%, or 11%; between 11% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, 13%, or 12%; between 12% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 14%, or 13%; between 13% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, or 14%; between 14% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, or 15%; between 15% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, or 20%; between 20% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, or 25%; between 25% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, or 30%; between 30% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, or 35%; between 35% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, or 40%; between 40% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, or 45%; between 45% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, or
13
SUBSTITUTE SHEET ( RULE 26)
50%; between 50% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, or 55%; between 55% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, or 60%; between 60% and 100%, 95%, 90%, 85%, 80%, 75%, 70%, or 65%; between 65% and 100%, 95%, 90%, 85%, 80%, 75%, or 70%; between 70% and 100%, 95%, 90%, 85%, 80%, or 75%; between 75% and 100%, 95%, 90%, 85%, or 80%; between 80% and 100%, 95%, 90%, or 85%; or between 85% and 100%, 95%, 90%; between 90% and 100% or 95%, or between 95% and 100% by mass of the milk protein component.
[0050] At standard ambient temperature and conditions (i.e., 20-30°C and 0.95-1.05 atm), the cosmetic or personal care composition according to any of the above may be in any form normally used for topical application, including a liquid (e.g., an aqueous dispersion, an oily dispersion, a dispersion in a solvent, an aqueous suspension, an aqueous-alcoholic solution, an oily solution, a milky liquid, a foaming liquid), an emulsion (e.g., water-in-oil emulsion, oil- in-water emulsion, water-in-oil-in-water emulsion, oil-in-water-in-oil emulsion, Pickering emulsion, microemulsion), a gel (e.g., a hydrogel, a lipogel, an organogel), a powder (e.g., an anhydrous powder or substantially anhydrous powder [e.g., pressed powder], a liquid-to- powder formulation, a cream-to-powder formulation), an aerosol, a semi-solid (e.g., a paste, a cream, an ointment, a lotion, a mousse), or a solid (e.g., a stick, a tube).
[0051] The cosmetic or personal care composition according to any of the above when in powder form may comprise a moisture content of less than 20%, less than 15%, less than 10%, less than 7%, less than 5%, less than 3%, or less than 1%; or between 0.1% and 20%, 15%, 10%, 5%, or 1%; between 1% and 20%, 15%, 10%, or 5%; between 5% and 20%, 15%, or 10%; between 10% and 20%, or 15%; or between 15% and 20%. The powder may be used in powder form, or may be reconstituted with a hydrating agent (e.g., water) prior to use, or may be mixed with other dry components before a hydrating agent is added to the mixture.
[0052] The cosmetic or personal care composition according to any of the above when in emulsion form may comprise between 5% and 80%, 70%, 60%, 50%, 40%, 30%, 20%, or 10%; between 10% and 80%, 70%, 60%, 50%, 40%, 30%, or 20%; between 20% and 80%, 70%, 60%, 50%, 40%, or 30%; between 30% and 80%, 70%, 60%, 50%, or 40%; between 40% and 80%, 70%, 60%, or 50%; between 50% and 80%, 70%, or 60%; between 60% and 80%, or 70%; or between 70% and 80% by mass of lipid.
[0053] The cosmetic or personal care composition according to any of the above may further comprise an other ingredient (e.g., any of the other ingredients disclosed herein). For example, the cosmetic or personal care composition may comprise between 0.001% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, 20%, 15%, 10%, 9%,
14
SUBSTITUTE SHEET ( RULE 26)
8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, or 0.01%; between 0.01% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, 20%, 15%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.5%, or 0.1%; between 0.1% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, 20%, 15%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, or 0.5%; between 0.5% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, 20%, 15%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, or 1%; between 1% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, 20%, 15%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, or 2%; between 2% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, 20%, 15%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, or 3%; between 3% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, 20%, 15%, 10%, 9%, 8%, 7%, 6%, 5%, or 4%; between 4% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, 20%, 15%, 10%, 9%, 8%, 7%, 6%, or 5%; between 5% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, 20%, 15%, 10%, 9%, 8%, 7%, or 6%; between 6% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, 20%, 15%, 10%, 9%, 8%, or 7%; between 7% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, 20%, 15%, 10%, 9%, or 8%; between 8% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, 20%, 15%, 10%, or 9%; between 9% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, 20%, 15%, or 10%; between 10% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, 20%, or 15%; between 15% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50%, 25%, or 20%; between 20% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, 50% or 25%; between 25% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, 60%, or 50%; between 50% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, 70%, or 60%; between 60% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, 80%, or 70%; between 70% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, 90%, or 80%; between 80% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, 95%, or 90%; between 90% and 99.9%, 99.5%, 99%, 98%, 97%, 96%, or 95%; or between 95% and 99.9%, 99.5%, 99%, 98%, 97%, or 96%; between 96% or 99.9%, 99.5%, 99%, 98%, or 97%; between 97% and 99.9%, 99.5%, 99%, or 98%; between 98% and 99.9%, 99.5%, or 99%; between 99% and 99.9%, or 99.5%; or between 99.5% and 99.9% by mass of any one such other ingredient, any combination of two or more such other ingredients, or all such other ingredients.
[0054] The cosmetic or personal care composition according to any of the above may be essentially free of a component found in a mammal-produced milk, or may comprise a lower
15
SUBSTITUTE SHEET ( RULE 26)
concentration of at least one component found in a mammal-produced milk. Non-limiting examples of components found in mammal-produced milk include lactose, saturated fat, cholesterol, native milk proteins, and native milk lipids.
[0055] The cosmetic or personal care composition according to any of the above may be essentially free of a component obtained from an animal (i.e., a component that is native to an animal, including animal products [i.e., parts of an animal that are consumables or typically prepared for consumption by humans; e.g., animal meat, animal fat, animal blood], animal byproducts [i.e., products that are typically not consumable by themselves but are the byproducts of slaughtering animals for consumption; e g., animal bones, animal carcasses, and constituents isolated therefrom], products produced by an animal [e.g., mammal-produced milk, chicken eggs, bee honey], and consumables produced therefrom [e.g., gelatin, rennet, whey proteins extracted from mammal-produced milk, casein extracted from mammal- produced milk, milk lipid extracted from mammal-produced milk, animal lipids, animal proteins]), or comprise 2% or less by mass of such component.
[0056] The cosmetic or personal care composition according to any of the above may be essentially free of antibiotics.
[0057] The cosmetic or personal care composition according to any of the above may be essentially free of animal hormones.
[0058] The cosmetic or personal care composition according to any of the above may be hypoallergenic.
Milk Protein Component
[0059] The milk protein component comprised in a cosmetic or personal care composition according to any of the above comprises or consists essentially of a recombinant milk protein. The recombinant milk protein may be a single recombinant milk protein, or may be a mixture of two or more recombinant milk proteins. The milk protein component may, for example, comprise or consist essentially of: a recombinant P-lactoglobulin; a recombinant P- lactoglobulin and a recombinant a-lactalbumin; a recombinant P-lactoglobulin and a recombinant GMP; a recombinant P-lactoglobulin and a recombinant lactotransferrin; a recombinant P-lactoglobulin and a recombinant bovine serum albumin; a recombinant [L lactoglobulin and a recombinant lactoperoxidase; a recombinant [Tlactoglobulin and a recombinant K-casein; a recombinant P-lactoglobulin and a recombinant [3-casein; a recombinant P-lactoglobulin and a recombinant a-Sl -casein; a recombinant P-lactoglobulin and a recombinant a-S2-casem; a recombinant P-lactoglobulin, a recombinant a-lactalbumin,
16
SUBSTITUTE SHEET ( RULE 26)
and a recombinant GMP; a recombinant P-lactoglobulin, a recombinant a-lactalbumin. and a recombinant lactotransferrin; a recombinant P-lactoglobulin, a recombinant a-lactalbumin, and a recombinant bovine serum albumin; a recombinant P-lactoglobulin, a recombinant a- lactalbumm, and a recombinant lactoperoxidase; a recombinant P-lactoglobulin, a recombinant a-lactalbumin, and a recombinant K-casein; a recombinant P-lactoglobulin, a recombinant a- lactalbumin, and a recombinant P-casein; a recombinant P-lactoglobulin, a recombinant a- lactal bumin, and a recombinant a-Sl -casein; a recombinant p-lactoglobulin, a recombinant a- lactalbumin, and a recombinant a-S2-casein; a recombinant P-lactoglobulin, a recombinant GMP, and a recombinant lactotransferrin; a recombinant P-lactoglobulin, a recombinant GMP, and a recombinant bovine serum albumin; a recombinant P-lactoglobulin, a recombinant GMP, and a recombinant lactoperoxidase; a recombinant P-lactoglobulin, a recombinant GMP, and a recombinant K-casem; a recombinant P-lactoglobulin, a recombinant GMP, and a recombinant P-casein; a recombinant P-lactoglobulin, a recombinant GMP, and a recombinant a-Sl -casein; a recombinant P-lactoglobulin, a recombinant GMP, and a recombinant a-S2-casein; a recombinant P-lactoglobulin, a recombinant lactotransferrin, and a recombinant bovine serum albumin; a recombinant P-lactoglobulin, a recombinant lactotransferrin, and a recombinant lactoperoxidase; a recombinant P-lactoglobulin, a recombinant lactotransferrin, and a recombinant K-casein; a recombinant p-lactoglobulin, a recombinant lactotransferrin, and a recombinant P-casein; a recombinant P-lactoglobulin, a recombinant lactotransferrin, and a recombinant a-Sl -casein; a recombinant P-lactoglobulin, a recombinant lactotransferrin, and a recombinant a-S2-casein; a recombinant P-lactoglobulin, a bovine serum albumin, and a recombinant lactoperoxidase; a recombinant P-lactoglobulin, a recombinant bovine serum albumin, and a recombinant K-casein; a recombinant P-lactoglobulin, a recombinant bovine serum albumin, and a recombinant P-casein; a recombinant P-lactoglobulin, a recombinant bovine serum albumin, and a recombinant a-Sl-casein; a recombinant P-lactoglobulin, a recombinant bovine serum albumin, and a recombinant a-S2-casein; a recombinant P- lactoglobulin, a recombinant lactoperoxidase, and a recombinant K-casein; a recombinant P- lactoglobulin, a recombinant lactoperoxidase, and a recombinant P-casein; a recombinant P- lactoglobulin, a recombinant lactoperoxidase, and a recombinant a-Sl -casein; a recombinant P-lactoglobulin, a recombinant lactoperoxidase, and a recombinant a-S2-casein; a recombinant P-lactoglobulin, a recombinant K-casein, and a recombinant P-casein; a recombinant P- lactoglobulin, a recombinant K-casein, and a recombinant a-Sl -casein; a recombinant P- lactoglobulin, a recombinant K-casein, and a recombinant a-S2-casein; a recombinant P- lactoglobulin, a recombinant P-casein, and a recombinant a-Sl -casein; a recombinant P-
17
SUBSTITUTE SHEET ( RULE 26)
lactoglobulin, a recombinant 0-casein, and a recombinant a-S2-casein; a recombinant 0- lactoglobulin, a recombinant a-Sl -casein, and a recombinant a-S2-casein; a recombinant a- lactalbumm; a recombinant a-lactalbumin and a recombinant GMP; a recombinant a- lactalbumm and a recombinant lactotransferrin; a recombinant a-lactalbumin and a recombinant bovine serum albumin; a recombinant a-lactalbumin and a recombinant lactoperoxidase; a recombinant a-lactalbumin and a recombinant K-casein; a recombinant a- lactal bumin and a recombinant 0-casein; a recombinant a-lactalbumin and a recombinant a-S 1- casein; a recombinant a-lactalbumin and a recombinant a-S2-casein; a recombinant a- lactalbumm, a recombinant GMP, and a recombinant lactotransferrin; a recombinant a- lactalbumin, a recombinant GMP, and a recombinant bovine serum albumin; a recombinant a- lactalbumm, a recombinant GMP, and a recombinant lactoperoxidase; a recombinant a- lactalbumm, a recombinant GMP, and a recombinant K-casein; a recombinant a-lactalbumin, a recombinant GMP, and a recombinant 0-casein; a recombinant a-lactalbumin, a recombinant GMP, and a recombinant a-S 1 -casein; a recombinant a-lactalbumin, a recombinant GMP, and a recombinant a-S2-casein; a recombinant a-lactalbumin, a recombinant lactotransferrin, and a recombinant bovine serum albumin; a recombinant a-lactalbumin, a recombinant lactotransferrin, and a recombinant lactoperoxidase; a recombinant a-lactalbumin, a recombinant lactotransferrin, and a recombinant K-casein; a recombinant a-lactalbumin, a recombinant lactotransferrin, and a recombinant 0-casein; a recombinant a-lactalbumin, a recombinant lactotransferrin, and a recombinant a-S 1 -casein; a recombinant a-lactalbumin, a recombinant lactotransferrin, and a recombinant a-S2-casein; a recombinant a-lactalbumin, a recombinant bovine serum albumin, and a recombinant lactoperoxidase; a recombinant a- lactalbumm, a recombinant bovine serum albumin, and a recombinant K-casein; a recombinant a-lactalbumin, a recombinant bovine serum albumin, and a recombinant 0-casein; a recombinant a-lactalbumm, a recombinant bovine serum albumin, and a recombinant a-Sl- casein; a recombinant a-lactalbumin, a recombinant bovine serum albumin, and a recombinant a-S2-casein; a recombinant a-lactalbumin, a recombinant lactoperoxidase, and a recombinant K-casein; a recombinant a-lactalbumin, a recombinant lactoperoxidase, and a recombinant 0- casein; a recombinant a-lactalbumin, a recombinant lactoperoxidase, and a recombinant a-Sl- casein; a recombinant a-lactalbumin, a recombinant lactoperoxidase, and a recombinant a-S2- casein; a recombinant a-lactalbumm, a recombinant K-casein, and a recombinant 0-casein; a recombinant a-lactalbumin, a recombinant K-casein, and a recombinant a-S 1 -casein; a recombinant a-lactalbumin, a recombinant K-casein, and a recombinant a-S2-casein; a recombinant a-lactalbumin, a recombinant 0-casein, and a recombinant a-S 1 -casein; a
18
SUBSTITUTE SHEET ( RULE 26)
recombinant a-lactalbumin, a recombinant P-casein, and a recombinant a-S2-casein; a recombinant a-lactalbumin, a recombinant a-Sl -casein, and a recombinant a-S2-casein; a recombinant GMP; a recombinant GMP and a recombinant lactotransferrin; a recombinant GMP and a recombinant bovine serum albumin; a recombinant GMP and a recombinant lactoperoxidase; a recombinant GMP and a recombinant K-casein; a recombinant GMP and a recombinant P-casein; a recombinant GMP and a recombinant a-Sl -casein; a recombinant GMP and a recombinant a-S2-casein; a recombinant GMP, a recombinant lactotransferrin, and a recombinant bovine serum albumin; a recombinant GMP, a recombinant lactotransferrin, and a recombinant lactoperoxidase; a recombinant GMP, a recombinant lactotransferrin, and a recombinant K-casein; a recombinant GMP, a recombinant lactotransferrin, and a recombinant P-casein; a recombinant GMP, a recombinant lactotransferrin, and a recombinant a-Sl -casein; a recombinant GMP, a recombinant lactotransferrin, and a recombinant a-S2-casein; a recombinant GMP, a recombinant bovine serum albumin, and a recombinant lactoperoxidase; a recombinant GMP, a recombinant bovine serum albumin, and a recombinant K-casein; a recombinant GMP, a recombinant bovine serum albumin, and a recombinant P-casein; a recombinant GMP, a recombinant bovine serum albumin, and a recombinant a-Sl -casein; a recombinant GMP, a recombinant bovine serum albumin, and a recombinant a-S2-casein; a recombinant GMP, a recombinant lactoperoxidase, and a recombinant K-casein; a recombinant GMP, a recombinant lactoperoxidase, and a recombinant P-casein; a recombinant GMP, a recombinant lactoperoxidase, and a recombinant a-Sl -casein; a recombinant GMP, a recombinant lactoperoxidase, and a recombinant a-S2-casein; a recombinant GMP, a recombinant K-casein, and a recombinant P-casein; a recombinant GMP, a recombinant K- casein, and a recombinant a-Sl -casein; a recombinant GMP, a recombinant K-casein, and a recombinant a-S2-casein; a recombinant GMP, a recombinant P-casein, and a recombinant a- S1 -casein; a recombinant GMP, a recombinant P-casein, and a recombinant a-S2-casein; a recombinant GMP, a recombinant a-Sl -casein, and recombinant a-S2-casein; a recombinant lactotransferrin; a recombinant lactotransferrin and a recombinant bovine serum albumin; a recombinant lactotransferrin and a recombinant lactoperoxidase; a recombinant lactotransferrin and a recombinant K-casein; a recombinant lactotransferrin and a recombinant P-casein; a recombinant lactotransferrin and a recombinant a-Sl -casein; a recombinant lactotransferrin and a recombinant a-S2-casein; a recombinant lactotransferrin, a recombinant bovine serum albumin, and a recombinant lactoperoxidase; a recombinant lactotransferrin, a recombinant bovine serum albumin, and a recombinant K-casein; a recombinant lactotransferrin, a recombinant bovine serum albumin, and a recombinant P-casein; a recombinant
19
SUBSTITUTE SHEET ( RULE 26)
lactotransferrin, a recombinant bovine serum albumin, and a recombinant a-Sl -casein; a recombinant lactotransferrin, a recombinant bovine serum albumin, and a recombinant a-S2- casein; a recombinant lactotransferrin, a recombinant lactoperoxidase, and a recombinant K- casein; a recombinant lactotransferrin, a recombinant lactoperoxidase, and a recombinant P- casein; a recombinant lactotransferrin, a recombinant lactoperoxidase, and a recombinant a- S1 -casein; a recombinant lactotransferrin, a recombinant lactoperoxidase, and a recombinant a-S2-casein; a recombinant lactotransferrin, a recombinant K-casein, and a recombinant p- casein; a recombinant lactotransferrin, a recombinant K-casein, and a recombinant a-S 1 -casein; a recombinant lactotransferrin, a recombinant K-casein, and a recombinant a-S2-casein; a recombinant lactotransferrin, a recombinant P-casein, and a recombinant a-Sl-casein; a recombinant lactotransferrin, a recombinant P-casein, and a recombinant a-S2-casein; a recombinant lactotransferrin, a recombinant a-S 1 -casein, and a recombinant a-S2-casein; a recombinant bovine serum albumin; a recombinant bovine serum albumin and a recombinant lactoperoxidase; a recombinant bovine serum albumin and a recombinant K-casein; a recombinant bovine serum albumin and a recombinant P-casem; a recombinant bovine serum albumin and a recombinant a-S 1 -casein; a recombinant bovine serum albumin and a recombinant a-S2-casein; a recombinant bovine serum albumin, a recombinant lactoperoxidase, and a recombinant K-casein; a recombinant bovine serum albumin, a recombinant lactoperoxidase, and a recombinant P-casein; a recombinant bovine serum albumin, a recombinant lactoperoxidase, and a recombinant a-S 1 -casein; a recombinant bovine serum albumin, a recombinant lactoperoxidase, and a recombinant a-S2-casein; a recombinant bovine serum albumin, a recombinant K-casein, and a recombinant P-casein; a recombinant bovine serum albumin, a recombinant K-casein, and a recombinant a-S 1 -casein; a recombinant bovine serum albumin, a recombinant K-casein, and a recombinant a-S2-casein; a recombinant bovine serum albumin, a recombinant P-casein, and a recombinant a-S 1 -casein; a recombinant bovine serum albumin, a recombinant P-casein, and a recombinant a-S2-casein; a recombinant bovine serum albumin, a recombinant a-S 1 -casein, and a recombinant a-S2-casein; a recombinant lactoperoxidase; a recombinant lactoperoxidase and a recombinant K-casein; a recombinant lactoperoxidase and a recombinant P-casein; a recombinant lactoperoxidase and a recombinant a-Sl-casein; a recombinant lactoperoxidase and a recombinant a-S2-casein; a recombinant lactoperoxidase, a recombinant K-casein, and a recombinant P-casein; a recombinant lactoperoxidase, a recombinant K-casein, and a recombinant a-Sl-casein; a recombinant lactoperoxidase, a recombinant K-casein, and a recombinant a-S2-casein; a recombinant lactoperoxidase, a recombinant P-casein, and a recombinant a-Sl-casein; a
20
SUBSTITUTE SHEET ( RULE 26)
recombinant lactoperoxidase, a recombinant 0-casein, and a recombinant a-S2-casein; a recombinant lactoperoxidase, a recombinant a-Sl-casein, and a recombinant a-S2-casein; a recombinant K-casein; a recombinant K-casem and a recombinant -casein; a recombinant K- casein and a recombinant a-Sl -casein; a recombinant K-casein and a recombinant a-S2-casein; a recombinant K-casein, a recombinant |3-casein, and a recombinant a-Sl -casein; a recombinant K-casein, a recombinant P-casein, and a recombinant a-S2-casein; recombinant K-casein, a recombinant a-Sl -casein, and recombinant a-S2-casein; a recombinant p-casein; a recombinant P-casein and a recombinant a-Sl -casein; a recombinant P-casein and a recombinant a-S2- casein; a recombinant P-casein, a recombinant a-Sl -casein, and recombinant a-S2-casein; a recombinant a-Sl -casein; or a recombinant a-Sl -casein and a recombinant a-S2-casein.
[0060] Recombinant milk proteins, and methods for producing recombinant milk proteins (e.g., in a recombinant microbial host cell [e.g., in a recombinant filamentous fungal host cell]) are disclosed, for example, in U.S. Patent 9,924,728, issued March 27, 2018; U.S. publication US20190216106, published July 18, 2019; and PCT publication WO2020219596, published October 29, 2020.
[0061] The milk protein component comprised in a cosmetic or personal care composition according to any of the above may comprise or consist of a multimer (e g., dimer, trimer, tetramer) or polymer of recombinant milk protein monomers (i.e., molecules composed of repeated recombinant milk protein monomers that are covalently linked, either directly with each other or via intermediary molecules). The polymer of recombinant milk protein monomers may have the capacity to form a flexible film upon application of the cosmetic or personal care composition to a body surface.
[0062] The milk protein component comprised in a cosmetic or personal care composition according to any of the above may consist of whey protein and casein at a mass ratio of between about 10 to 0 and about 0 to 10 (e.g., about 10 to 0, about 10 to 1, about 9 to 1, about 8 to 1, about 7 to 1, about 6 to 1, about 5 to 1, about 4 to 1, about 3 to 1, about 2 to 1, about 1 to 1, about 1 to 2, about 1 to 3, about 1 to 4, about 1 to 5, about 1 to 6, about 1 to 7, about 1 to 8, about 1 to 9, about 1 to 10, about 0 to 10).
[0063] The milk protein component comprised in a cosmetic or personal care composition according to any of the above may comprise or consist of recombinant [3-lactoglobuhn and recombinant a-lactalbumin at a mass ratio of between about 10 to 0 and about 0 to 10 (e.g., about 10 to 0, about 10 to 1, about 9 to 1, about 8 to 1, about 7 to 1, about 6 to 1, about 5 to 1, about 4 to 1, about 3 to 1, about 2 to 1, about 1 to 1, about 1 to 2, about 1 to 3, about 1 to 4, about 1 to 5, about 1 to 6, about 1 to 7, about 1 to 8, about 1 to 9, about 1 to 10, about 0 to 10).
21
SUBSTITUTE SHEET ( RULE 26)
[0064] The milk protein component comprised in a cosmetic or personal care composition according to any of the above may be comprised in a cosmetically or physiologically acceptable medium.
[0065] The milk protein component comprised in a cosmetic or personal care composition according to any of the above may be comprised in a coating layer around a core of the cosmetic or personal care composition. Such core may comprise an active agent (e.g., any of the other ingredients disclosed herein).
[0066] The recombinant milk protein comprised in the milk protein component comprised in a cosmetic or personal care product according to any of the above may be undenatured (i.e., not heat-insolubilized as shown by electrophoretic measurements).
[0067] The recombinant milk protein comprised in the milk protein component comprised in a cosmetic or personal care product according to any of the above may be hydrolyzed (e.g., via action of an endopeptidase [e.g., trypsin, chymotrypsin]). Such hydrolyzed recombinant milk protein may consist essentially of peptides having a molecular weight of between 200 to 5,000.
[0068] The recombinant milk protein comprised in the milk protein component comprised in a cosmetic or personal care product according to any of the above may be covalently or non- covalently associated with a lipid to form an amphiphilic complex. Non-limiting examples of suitable lipids for covalent association include fatty acids or acyls having carbon atom numbers of between 4 and 30, selected from fatty acids, fatty alcohols, and fatty amines, and derivatives thereof, and having chains that are unsaturated, linear, branched or cyclic. Non-limiting examples include heptanoic acid, octanoic acid, decanoic acid, lauric acid, myristic acid, palmitic acid, stearic acid, ncinoleic acid, oleic acid, linoleic acid, linolenic acid, caprylic acid, capric acid; the corresponding fatty alcohols and fatty amines; the derivatives of said fatty acids, fatty alcohols, and fatty amines; and mixtures thereof. The recombinant milk protein may comprise such lipid at a mass ratio of between about 1,000 to 1 and about 1 to 10. The lipid may be covalently linked to the recombinant milk protein via a monofunctional agent (which may be the fatty containing component [fatty monoacid, monoalcohol, or monoamine]) or a multifunctional grafting agent (which may be the fatty containing component [fatty polyacid, polyalcohol, or poly amine]).
[0069] The recombinant milk protein comprised in the milk protein component comprised in a cosmetic or personal care product according to any of the above may be covalently or non- covalently associated with a coloring agent (e.g., any of the coloring agents disclosed herein).
22
SUBSTITUTE SHEET ( RULE 26)
[0070] The recombinant milk protein comprised in the milk protein component comprised in a cosmetic or personal care product according to any of the above may be covalently or non- covalently associated with a UVA and/or UVB light filtering or UVA and/or UVB light scattering agent. Non-limiting examples of UVA and/or UVB light filtering or UVA and/or UVB light scattering agents include BP-3 (2-hydroxy-4-methoxybenzophenone); cinnamoyl radical (optionally substituted by one or more alkoxy groups); p-dialkylaminobenzoyl radical; salicyloyl radical; sulphonyl radical originating from an isophthalylidene-camphor radical; acyl radical onginating from a carboxylic or sulphonic acid derived from benzylidenecamphor, 2-aiylbenzimidazoles, 2-arylbenzofurans, 2-arylbenzoxazoles, 2-arylbenzotriazoles, 2-aryhndoles, or hydroxybenzophenones; sulphonyl radical originating from a terephthalylidene-camphor radical; acyl radical derived from an absorber of carboxylic coumarin, monophenylcyanoacrylic, diphenylcyanoacrylic, or dibenzoylmethane structure (optionally substituted), and derivatives thereof.
[0071] The recombinant milk protein comprised in the milk protein component comprised in a cosmetic or personal care product according to any of the above may be comprised in a coacervate with a polysaccharide. The polysaccharide may be an anionic polysaccharide (i.e., a polysaccharide that has a negative total charge or linear charge density at a pH near the IEP of the recombinant milk protein comprised in the milk protein component of the cosmetic or personal care composition), or a cationic polysaccharide (i.e., a polysacchande that has a positive total charge or linear charge density at the pH near the IEP of the recombinant milk protein comprised in the milk protein component of the cosmetic or personal care composition). Non-limiting examples of suitable anionic polysaccharides include polysaccharides having pendant carboxylic acid or sulfate groups, pectins (e.g., pectin from aloe, pectins from tobacco, pectins from apple pomace, pectins from citrus peel, pectins from plums, pectins from gooseberries sources, pectins from sugar beet), water soluble cellulose (e.g., sodium carboxymethyl cellulose, sulfated cellulose), seaweed hydrocolloid extracts (e.g., sodium alginate, propyleneglycol alginate, ammonium alginate, alginic acid, carageenans (e.g., iota carageenan, kappa carageenan, lambda carageenan)), microbial and agaroid gums and gum components (e.g., gellan gum, xanthan gum, gum Arabic, gum tragacanth, xanthan gum, ghatti gum, karaya gum, tragacanth gum, pullulan gum, scleroglucan, welan gum, rhamsan gum, okra gum, cellulose gum, carboxymethyl guar gum, carboxymethyl(hydroxypropyl) guar gum), starches containing carboxy groups (e.g., carboxymethyl starch), pullulanosic material containing carboxy groups, dextran materials containing carboxy groups, and derivatives thereof. Non-limiting examples of suitable cationic polysaccharides include chitosan,
23
SUBSTITUTE SHEET ( RULE 26)
di ethylaminoethyl dextran, guar gum derivatives (e.g., guar hydroxypropyltrimonium chloride), quaternary nitrogen-containing cellulose ethers, copolymers of etherified cellulose, guar and starch, cationic cellulose, modified cationic cellulose polymers (e.g., polyquatemium 4, polyquatemium 10, polyquatemium 24, polyquatemium 28), laurdimonium hydroxypropyl oxyethyl cellulose, steardimonium hydroxyethyl cellulose, polysaccharides that comprise an amino group or an imine group, and derivatives thereof.
[0072] The recombinant milk protein may be comprised in the milk protein component comprised in a cosmetic or personal care product according to any of the above as a gel (e.g., a hydrogel).
Other Ingredients
[0073] The other ingredient that may be comprised in a cosmetic or personal care composition according to any of the above may be any known ingredient normally used in cosmetic or personal care compositions. The other ingredient should be of pharmaceutical or cosmetic grade, non-irritating on body surfaces, and non-toxic as used.
[0074] Non-limiting examples of other ingredients include: an aqueous solvent; a lipid; a wax; an emulsifying agent; a pH and/or ionic strength adjusting agent (i.e., a compound that can raise or lower the pH and/or the ionic strength of a solution; e.g., to balance the pH of the cosmetic or personal care composition to a pH of between 5 and 7); a buffering agent; a binding agent; a thickening agent; a filler agent (i.e., a colorless or white particle of any shape that is insoluble in the medium of the composition); a plasticizing agent; an anti-foam agent (e.g., to decrease foaming during compounding and handling of the composition); a foam stabilizer; a surfactant (e.g., a cationic, anionic, non-ionic, amphoteric, or zwitterionic surfactant); a gelling agent; a coloring agent (i.e., a molecule that comprises a chromophoric or chromogenic group; e.g., to color the composition and/or to color a body surface); an agent that imparts pearlescence; an oil-dispersing agent (i.e., a compound that can break up sebum on a body surface and spread it over the surface to minimize oily appearance and feel); a conditioning agent; an anti-oxidant (i.e., a molecule capable of slowing, reducing, inhibiting, or preventing the oxidation of other molecules); an anti-dandruff agent (i.e., a compound that is effective in reducing or eliminating dandruff); an anti-seborrheic dermatitis agent; an anti-psoriasis agent; an anti-acne agent (i.e., compound that is effective in the treatment of acne and/or symptoms associated therewith); a skin whitening agent (i.e., a compound that is effective in bleaching/ depigmenting skin color); a skin self-tanning agent (i.e., a compound that is effective in darkening skin color); a soothing agent (i.e., compound that reduces discomfort of skin
24
SUBSTITUTE SHEET ( RULE 26)
and/or scalp, for example by soothing the feelings of itching); a cooling agent (i.e. , a compound that provides a sensation of cooling); a fragrance; an anti-aging agent (i.e., a compound that inhibits or reduces signs of aging, such as wrinkles, fine lines, and manifestations of photodamage [e.g., sun spots]); an UVA and/or UVB light absorbing agent; an UVA and/or UVB light scattering agent; an antibacterial agent (i.e., a compound that has either a killing or growth inhibiting effect upon bacteria); an anti-fungal agent (i.e., a compound that has either a killing or growth inhibiting effect upon fungi); an anti-inflammatoiy agent (i.e., a compound effective in treating inflammation); a salt; a humectant; a hair growth agent; a hair anti-static agent; an anti-viral agent (i.e., a compound capable of inhibiting cell entry or replication of a virus); a moisturizing agent (e.g., phytantriol, panthenol, vitamin F); an electrolyte; an herbal active agent (e.g., bioactive herbs, herbal extracts, tinctures, essential oils); and mixtures thereof.
[0075] Non-limiting examples of aqueous solvents include water, floral water, mineral water, Cl to C6 alcohols (e.g., ethyl alcohol, propanol, isopropyl alcohol, butanol, pentanol, hexanol, glycerol), glycols (e.g., ethylene glycol, butylene glycol, isoprene glycol, propylene glycol, polyethylene glycol), glycol ethers (e.g., methyl ether, ethyl ether, butyl ether, 2- butoxyethanol, ethylene glycol monoethyl ether, propylene glycol, diethylene glycol monoethyl ether, di ethylene glycol monomethyl ether), and mixtures thereof.
[0076] Non-limiting examples of lipids include fatty alcohols (e.g., linoleyl alcohol, linolenyl alcohol, oleyl alcohol), polyalcohols (e.g., glycol, polyethylene glycol, polypropylene glycol, glycerol), fatty acid esters (e.g., alkyl myristates [e.g., isopropyl myristate, butyl myristate, cetyl myristate], alkyl stearates [e.g., butyl stearate, hexadecyl stearate], alkyl palmitates [e.g., ethyl palmitate, isopropyl palmitate], alkyl lanolates [e.g., isopropyl lanolate, isocetyl lanolate], alkyl oleates [e.g., decyl oleate], alkyl octanoates, alkyl decanoates, alkyl ricinoleates [e.g., cetyl ricinoleate], laurates [e.g., hexyl laurate], adipates [e.g., isopropyl adipate]), fatty acids, fatty acid tnglycerides (e.g., triglycerides of C6-C30 fatty acids), natural oils (e.g., plant oils [e.g., sweet-almond oil, avocado oil, calophyllum oil, castor oil, sesame oil, jojoba oil, Karite oil, wheatgerm oil, sunflower oil, coconut oil, olive oil, com oil, soybean oil, marrow oil, grapeseed oil, hazelnut oil, apricot oil, avocado oil]), mineral and synthetic oils (e.g., paraffin oil, purcellin oil, perhydrosqualene, vaseline oil, silicone oils [e.g., dimethylpolysiloxanes, methylphenyl polysiloxanes], aliphatic hydrocarbons having more than 8 carbon atoms), fish oils (e.g., hoplostethus oil), and mixtures and derivatives thereof.
[0077] Non-limiting examples of waxes include ozokerite wax, montan wax; ouricury wax,
Japan wax, cork fibre wax, sugar cane wax, lanolins (e.g., lanolin, lanolin alcohol,
25
SUBSTITUTE SHEET ( RULE 26)
hydrogenated lanolin, acetylated lanolin, lanolin wax, lanolin fatty acids), beeswax, candellila wax, microcrystalline wax, carnauba wax, cetyl alcohol, stearyl alcohol, cocoa butter; paraffins, ozokerites, petrolatum, vaselines, petroleum jelly, hydrogenated oils that are solid at 25C, mono-/di-/tri-glycerides that are solid at 25C, fatty esters that are solid at 25C, silicone waxes (e.g., methyloctadecane-oxypolysiloxane, poly(dimethyl-siloxy) stearoxysiloxane), fluoro waxes, stearic acid monoethanolamide, colophony and its derivatives (e g., glycol abietate, glycerol abietate), hydrogenated oils that are solid at 25C, jojoba oil, sucroglycerides, calcium oleates, magnesium oleates, zirconium oleates, aluminum oleates, myristates, lanolates, stearates, dihydroxystearates, and mixtures and derivatives thereof.
[0078] Non-limiting examples of emulsifying agents include polyglycerin esters, sorbitan esters, partially esterified glycerides, and derivatives and mixtures thereof.
[0079] Non-limiting examples of pH adjusting agents include organic acids, mono- or triethanolamine, ammonia, sodium phosphate, sodium carbonate, phosphoric acid, hydrochloric acid, lactic acid, tartaric acid, acetic acid, citric acid, and mixtures thereof.
[0080] Non-limiting examples of buffering agents include ethylenediaminetetracetic acid (EDTA), sodium salt of EDTA, sodium chloride, sodium phosphate, diazolidinyl urea, iodopropynyl butylcarbamate, and mixtures thereof.
[0081] Non-limiting examples of binding agents include silicone resins (e.g., silanes, siloxanes [e.g., polydimethylsiloxane (PDMS)], siloxysilicates [e.g., tnmethylsiloxysilicate], silsesqui oxanes [e.g., polymethylsilsesqui oxane]), dimethicone silylate/isododecane, polyglyceryyl-2 triisostearate, dry binders (e.g., zinc, lithium, magnesium stearate), and derivatives and mixtures thereof.
[0082] Non-limiting examples of thickeners include salts, PEG-55, propylene glycol oleate, PEG- 120 methyl lucose ioleate, cellulose derivatives [e.g., carboxymethyl cellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose], and derivatives and mixtures thereof. [0083] Non-limiting examples of fdlers include silica microspheres (e.g., hollow silica microspheres, acrylic polymer microspheres [e.g., microspheres made of crosslinked acrylate copolymer, microspheres made of polymethyl methacrylate]); polyurethane powders (e.g., powder of a copolymer of hexamethylene diisocyante and of trimethylol hexyl lactone); elastomeric crosslinked organopolysiloxane spherical powders; carnauba or paraffin wax microbeads; metal soaps in powder form (e.g., metal soaps of fatty acids containing from 12 to 22 carbons, where the metal may be zinc or magnesium, and the fatty acid may be lauric acid, myristic acid, stearic acid, and palamitic acid [e.g., zinc laurate, magnesium stearate, magnesium myristate, zinc stearate]), talcs or hydrated magnesium silicates; micas or
26
SUBSTITUTE SHEET ( RULE 26)
aluminosilicates (e.g., micas of natural origin [e.g., muscovite, margarite, roscoelite, lepidolite, biotite] or of synthetic origin); clays (e.g., sericites); kaolin or hydrated aluminum silicate; boron nitrides; powders of tetrafluoroethylene polymers; precipitated calcium carbonate, magnesium carbonate, or magnesium hydrogen carbonate; hydroxyapatite; powders of nonexpanded synthetic polymers (e.g., polyethylene, polyesters [e.g., polyethylene isophthalate or terephthalate], polyamides [e.g., Nylon]); powders of spheronized, crosslinked or noncrosslinked synthetic polymers (e.g., polyamide powders [e.g., poly-P-alanine powder, Nylon powder, polyacrylic acid powder, polymethacrylic acid powder, powders of polystyrene crosslinked with divinylbenzene, silicone resin powders); bismuth oxychloride powders; powders of organic materials of natural origin (e.g., starches [e.g., com starch, wheat starch, rice starch]); and mixtures thereof.
[0084] Non-limiting examples of plasticizing agents include glycerin, sorbitol, a non-toxic glycol or polyglycol (e.g., propylene dipropylene or other C2-C4 glycol), and derivatives and mixtures thereof.
[0085] Non-limiting examples of surfactants include alkyl sulfates, alkyl ether sulfates, alkyl sulfonates, alkyl aryl sulfonates, alkyl succinates, alkyl sulfosuccinates, N-alkoyl sarcosinates, acyl taurates, acyl isothionates, alkyl phosphates, alkyl ether phosphates, alkyl ether carboxylates, alpha-olefin sulfonates (e.g., alkaline and earth alkaline metal salts [e.g., sodium, potassium, magnesium, calcium, ammonium, and triethanolamine salts]), alkyl betaines, alkyl amido propyle betaines, alkyl sulfobetaines, alkyl glycinates, alkyl carboxy glycinates, alkyl amphoacetates, alky propionates, alkyl amphodiacetates, alkyl dipropionates, reaction products of aliphatic alcohols or alkyl phenols having 6 to 20 C atoms in the alkyl chain with ethylene oxide and/or propylene oxide, quaternary ammonium compounds (e.g., cetyl trimethyl ammonium chloride), and derivatives and mixtures thereof.
[0086] Non-limiting examples of coloring agents include dyes, lacquers, mineral pigments, organic pigments, nacres (i.e., colored particles of any form, which may or may not be iridescent, especially produced by certain molluses in their shell, or alternatively synthesized, and which have a color effect via optical interference), reflective particles (i.e., particles that impart sparkle), FD&C Blue No. 1 (Brilliant Blue), FD&C Blue No. 2 (Indigotine), FD&C Green No. 3 (Fast Green), FD&C Red No. 3 (Erythrosine), FD&C Red No. 40 (Allura Red), FD&C Yellow No. 5 (Tartrazine), FD&C Yellow No. 6 (Sunset Yellow), annatto extract, anthocyanis, aronia/redfruit, beet juice, beet powder, beta-carotene, beta-apo-8-carotenal, black currant, burnt sugar, canthaxanthin, caramel, carbo medicinalis, carmine, carmine/beta- carotene, carmine blue, carminic acid, carrot, carrot oil, chlorophyll, chlorophyllin, cochineal
27
SUBSTITUTE SHEET ( RULE 26)
extract, copper-chlorophyll, copper-chlorophyllin, curcumin, curcumin/Cu-chlorophyllin, elderberry, grape, grape skin extract, hibiscus, lutein, mixed carotenoids, paprika, paprika extract, paprika oleoresin, riboflavin, saffron, spinach, stinging nettle, titanium dioxide, turmeric, titanium dioxide, zirconium oxide, cerium oxide, zinc oxide, iron (black, yellow or red) oxide, chromium oxide, sericites, micas, talcs, kaolin, manganese violet, ultramarine blue, chromium hydrate and ferric blue, metal powders (e.g., aluminum powder, copper powder), cochineal carmine, carotenoids, curcumin, porphyrin pigment, vegetable carbon black, organic pigments of azo dyes, anthraquinone dyes, indigoid dyes, xanthene dyes, pyrene dyes, quinoline dyes, triphenylmethane dyes, fluorane dyes, D&C certified pigments (e.g., D&C Blue No. 4, D&C Brown No. 1, D&C Green No. 5, D&C Green No. 6, D&C Orange No. 4, D&C Orange No. 5, D&C Orange No. 10, D&C Orange No. 11, D&C Red No. 6, D&C Red No. 7, D&C Red No. 17, D&C Red No. 21, D&C Red No. 22, D&C Red No. 27, D&C Red No. 28, D&C Red No. 30, D&C Red No. 31, D&C Red No. 33, D&C Red No. 34, D&C Red No. 36, D&C Violet No. 2, D&C Yellow No. 7, D&C Yellow No. 8, D&C Yellow No. 10, D&C Yellow No. 11, FD&C Blue No. 1, FD&C Green No. 3, FD&C Red No. 40, FD&C Yellow No. 5, FD&C Yellow No. 6), titanium mica coated with an iron oxide, mica coated with bismuth oxychloride, titanium mica coated with chromium oxide, pigments based on bismuth oxychloride, and particles comprising a borosilicate substrate coated with titanium oxide, and derivatives and mixtures thereof.
[0087] Non-limiting examples of agents that impart pearlescence include bismuth oxychloride, titanium mica, and guanine crystals.
[0088] Non-limiting examples of oil-dispersing agents include rhamnolipid biosurfactants, sophorolipid biosurfactants, polylipid protein sulfates, and derivatives and mixtures thereof.
[0089] Non-limiting examples of conditioning agents include silicone compounds (e.g., polyalkyl siloxanes, polyaryl siloxanes, polyarylalkyl siloxanes, polyether siloxanes, silicone resins).
[0090] Non-limiting examples of anti-oxidants include alpha hydroxy acids (e.g., glycolic acid, citric acid, lactic acid, malic acid, mandelic acid, ascorbic acid, alpha-hydroxybutyric acid, alpha-hydroxyisobutyric acid, alpha-hydroxyisocaproic acid, atrrolactic acid, alphahydroxyisovaleric acid, ethyl pyruvate, galacturonic acid, glucopehtonic acid, glucopheptono 1,4-lactone, gluconic acid, gluconolactone, glucuronic acid, glucurronolactone, glycolic acid, isopropyl pyruvate, methyl pyruvate, mucic acid, pyruvia acid, saccharic acid, saccanc acid 1,4-lactone, tartaric acid, tartronic acid), chelating agents (e.g., metal chelators) such as ethylenediaminetetraacetic acid (EDTA), citrate, ethylene glycol tetraacetic acid (EGTA), 1,2-
28
SUBSTITUTE SHEET ( RULE 26)
bis(o-aminophenoxy)ethane-N,N,N' ,N' -tetraacetic acid (BAPTA), diethylene triamine pentaacetic acid (DTP A), 2, 3-dimercapto-l -propanesulfonic acid (DMPS), dimercaptosuccinic acid (DMSA), a-lipoic acid, salicylaldehyde isonicotinoyl hydrazone (SIH), hexyl thioethylamine hydrochloride (HTA), desferrioxamine, ascorbic acid (vitamin C), cysteine, glutathione, dihydrolipoic acid, 2-mercaptoethane sulfonic acid, 2-mercaptobenzimidazole sulfonic acid, 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, sodium metabisulfite, vitamin E isomers (e.g., a-, |3-, y-, and 8-tocopherols; a-, 0-, y-, and 5-tocotrienols), polyphenols (e.g., 2-tert-butyl-4-methyl phenol, 2-tert-butyl-5 -methyl phenol, 2-tert-butyl-6-methyl phenol), butylated hydroxyanisole (BHA) (e.g., 2-tert-butyl-4-hydroxyanisole, 3-tert-butyl-4- hydroxyanisole), butylhydroxytoluene (BHT), tert-butylhydroquinone (TBHQ), ascorbyl palmitate, n-propyl gallate, and derivatives, salts, and mixtures thereof.
[0091] Non-limiting examples of suitable anti-dandruff agents, anti-seborrheic dermatitis agents, and anti-psoriasis agents include zinc pyrithione, selenium sulfide, sulfur, sulfonated shale oil, salicylic acid, coal tar, povidone-iodine, imidazoles (e.g., ketoconazole, dichlorophenyl imidazolodioxalan, clotrimazole, itraconazoie, miconazole, climbazole, tioconazole, sulconazole, butoconazole, fluconazole, miconazolenitrite, anthralin), piroctone olamine (Octopirox), selenium sulfide, ciclopirox olamine, anti-psoriasis agents, vitamin A analogs, corticosteroids, and derivatives and mixtures thereof.
[0092] Non-limiting examples of anti-acne agents include to keratolytics (e.g., salicylic acid, derivatives of salicylic acid, resorcinol); retinoids (e.g., retinoic acid, tretinoin, adapalene, tazarotene); sulfur-containing D- and L-amino acids and their derivatives and salts; lipoic acid; antibiotics and antimicrobials (e.g., lantibiotics [e.g., nisin, subtilin, epidermin, gallidermin], defensins, attacins [e.g., sarcotoxin], cecropins [e.g, cecropin A, bactericidin, lepidopteran], magainins, melittins, histatins, brevinins, novispirins, benzoyl peroxide, triclosan, chlorhexidine gluconate, octopirox, tetracycline, 2,4,4' -trichloro-2' -hydroxy diphenyl ether, 3,4,4' -tnchlorobanilide, nicotinamide, tea tree oil, rofecoxib, azelaic acid, phenoxyethanol, phenoxypropanol, phenoxisopropanol, ethyl acetate, clindamycin, erythromycin, meclocycline); sebostats (e.g., flavonoids); bile salts (e.g., scymnol sulfate and its derivatives, deoxy cholate, cholate); and derivatives and combinations thereof.
[0093] Non-limiting examples of skin whitening agents include hydrogen peroxide, zinc peroxide, sodium peroxide, hydroquinone, 4-isopropylcatechol, hydroquinone monobenzyl ether, kojic acid, lactic acid, ascorbyl acid and derivatives (e.g., magnesium ascorbyl
29
SUBSTITUTE SHEET ( RULE 26)
phosphate), arbutin, licorice root, sugar amines (e.g., glucosamine, N-acetyl glucosamine, glucosamine sulfate, mannosamine, N-acetyl mannosamine, galactosamine, N-acetyl galactosamine), N-acyl amino acids (e.g., N-acyl phenylalanine, N-acyl tyrosine, N- undecylenoyl-L-phenylalanine), soy isoflavones, retinoids (e.g., retinol), kojic dipalmitate, arbutin, transexamic acid, vitamins (e.g., niacin, vitamin C), azelaic acid, linolenic acid, linoleic acid, placertia, natural extracts (e.g., chamomile, green tea, soy extract), and derivatives and combinations thereof.
[0094] Non-limiting examples of skin self-tanning agents include dihydroxy acetone (DHA), glyceryl aldehyde, tyrosine and tyrosine derivatives (e.g., malyltyrosine, tyrosine glucosinate, ethyl tyrosine), phospho-DOPA, indoles, and derivatives and combinations thereof.
[0095] Non-limiting examples of soothing agents include aloe, avocado oil, green tea extract, hops extract, chamomile extract, colloidal oatmeal, calamine, cucumber extract, sodium palmate, sodium palm kemelate, butyrospermum parkii (i.e., shea butter), menthe piperita (i.e., peppermint) leaf oil, sericin, pyridoxine (a form of vitamin B6), retinyl palmitate and/or other forms of vitamin A, tocopheryl acetate and/or other forms of vitamin E, lauryl laurate, hyaluronic acid, aloe barbadensis leaf juice powder, euterpe oleracea (i.e., acai berry) fruit extract, riboflavin (i.e., vitamin B2), thiamin HC1 and/or other forms of vitamin Bl, and variations and mixtures thereof.
[0096] Non-limiting examples of cooling agents include WS-3, WS-23, menthol, 3- substituted-P-menthanes, N-substituted-P-menthane-3-carboxamides, isopulegol, 1,2- alkanediols (e.g., 3-(l-menthoxy)propane-l,2-diol, 3-(l-menthoxy)-2-methylpropane-l,2- diol, p-menthane-2,3-diol, p-menthane-3,8-diol), 6-isopropyl-9-methyl-l,4- dioxaspiro[4,5]decane-2-methanol, menthyl succinate and its alkaline earth metal salts, trimethylcyclohexanol, N-ethyl-2-isopropyl-5-methylcyclohexanecarboxamide, Japanese mint oil, peppermint oil, menthone, menthone glycerol ketal, menthyl lactate, 3-(l-menthoxy)ethan- l-ol, 3-(l-menthoxy)propan-l-ol, 3-(l-menthoxy)butan-l-ol, 1 -menthylacetic acid N-ethyl amide, l-menthyl-4-hydroxypentanoate, l-menthyl-3-hydroxybutyrate, N,2,3-trimethyl-2-(l- methylethylj-butanamide, n-ethyl-t-2-c-6 nonadienamide, N,N-dimethyl menthyl succinamide, menthyl pyrrolidone carboxylate, and derivatives and mixtures thereof.
[0097] Non-limiting exemples of fragrances include bisabolol; 2,4-dimethyl-3- cyclohexene-l-carbaldehyde; isocyclocitral; menthone; isomenthone; ROMASCONE® (methyl 2, 2-dimethyl-6-methylene-l -cyclohexanecarboxylate); nerone; terpineol; dihydroterpineol; terpenyl acetate; dihydroterpenyl acetate; dipentene; eucalyptol; hexylate;
30
SUBSTITUTE SHEET ( RULE 26)
rose oxide; PERYCOROLLE® ((S)-l,8-p-menthadiene-7-ol); l-p-menthene-4-ol; (lRS,3RS,4SR)-3-p-mentanyl acetate; (lR,2S,4R)-4,6,6-trimethyl-bicyclo[3,l,l]heptan-2-ol; DOREMOX® (tetrahydro-4-methyl-2-phenyl-2H-pyran); cyclohexyl acetate; cyclanol acetate; Fructalate (1,4-cyclohexane di ethyldicarboxylate); KOUMALACTONE® ((3ARS,6SR,7ASR)-perhydro-3,6-dimethyl-benzo[B]furan-2-one); Natactone ((6R)- perhydro-3,6-dimethyl-benzo[B]furan-2-one); 2,4,6-trimethyl-4-phenyl-l,3-dioxane; 2,4,6- trimethyl-3-cyclohexene-l-carbaldehyde; (E)-3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-l- yl)-4-penten-2-ol; (T R,E)-2-ethyl-4-(2' ,2' ,3' -trimethyl-3' -cyclopenten-T -yl)-2- buten-l-ol; POLYSANTOL® ((T R,E)-3,3-dimethyl-5-(2' ,2' ,3' -trimethyl-3' - cyclopenten-1' -yl)-4-penten-2-ol); fleuramone; PARADISONE® (methyl-(lR)-cis-3-oxo-2- pentyl-l-cyclopentane acetate); Veloutone (2,2,5-Trimethyl-5-pentyl-l-cyclopentanone); NIRVANOL® (3,3-dimethyl-5-(2,2,3-trimethyl-3-cyclopenten-l-yl)-4-penten-2-ol); 3- methyl-5-(2,2,3-trimethyl-3-cyclopenten-l-yl)-2-pentanol; damascenes; NEOBUTENONE® (l-(5,5-dimethyl-l-cyclohexen-l-yl)-4-penten-l-one); nectalactone ((!' R)-2-[2-(4' - methyl-3' -cyclohexen-1' -yl)propyl]cyclopentanone); alpha-ionone; beta-ionone; damascenone; DYNASCONE® (mixture of l-(5,5-dimethyl-l-cyclohexen-l-yl)-4-penten-l- one and l-(3,3-dimethyl-l-cyclohexen-l-yl)-4-penten-l-one); DORINONE® beta (l-(2,6,6- trimethyl-l-cyclohexen-l-yl)-2-buten-l-one); ROMANDOLIDE® ((1S,1' R)-[l-(3' ,3' - Dimethyl-1' -cyclohexyl)ethoxycarbonyl]methyl propanoate); 2-tert-butyl-l -cyclohexyl acetate; LIMB ANOL® (l-(2,2,3,6-tetramethyl-cyclohexyl)-3-hexanol); trans- 1 -(2,2,6- trimethyl-l-cyclohexyl)-3-hexanol; (E)-3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-l-yl)-3- buten-2-one; terpenyl isobutyrate; LORYSIA® (4-(l,l-dimethylethyl)-l-cyclohexyl acetate); 8-methoxy-l-p-menthene; HELVETOLIDE® ((1S,T R)-2-[l-(3' ,3' -dimethyl-1' - cyclohexyl)ethoxy]-2-methylpropyl propanoate); para tert-butylcyclohexanone; menthenethiol; l-methyl-4-(4-methyl-3-pentenyl)-3-cyclohexene-l-carbaldehyde; allyl cyclohexylpropionate; cyclohexyl salicylate; Methyl cedryl ketone; Verdylate; vetyverol; vetyverone; l-(octahydro-2,3,8,8-tetramethyl-2-naphtalenyl)-l-ethanone; (5RS,9RS,10SR)-
2.6.9.10-tetramethyl-l-oxaspiro[4.5]deca-3,6-diene and the (5RS,9SR,10RS) isomer; 6-ethyl-
2.10.10-tnmethyl-I-oxaspiro[4.5]deca-3,6-diene; l,2,3,5,6,7-hexahydro-l,l,2,3,3- pentamethyl-4-indenone; HIVERNAL® (a mixture of 3-(3,3-dimethyl-5-indanyl)propanal and
31
SUBSTITUTE SHEET ( RULE 26)
3-(l,l-dimethyl-5-indanyl)propanal); Rhubofix® (3' ,4-dimethyl- tricyclo[6.2.1.0(2,7)]undec-4-ene-9-spiro-2z -oxirane); 9/10-ethyldiene-3- oxatricyclo[6.2.1 ,0(2,7)]undecane; POLYWOOD® (perhydro-5,5,8A-tnmethyl-2- naphthalenyl acetate); octalynol; CETALOX® (dodecahydro-3a,6,6,9a-tetramethyl- naphtho[2, l-b]furan); tricyclo[5.2.1 ,0(2,6)]dec-3-en-8-yl acetate and tricyclo[5.2.1 ,0(2,6)]dec-
4-en-8-yl acetate as well as tricyclo[5.2.1.0(2,6)]dec-3-en-8-yl propanoate and tricyclo[5.2.1.0(2,6)]dec-4-en-8-yl propanoate; camphor; borneol; isobomyl acetate; 8- isopropyl-6-methyl-bicyclo[2.2.2]oct-5-ene-2-carbaldehyde; camphopinene; cedramber (8- methoxy-2,6,6,8-tetramethyl-tricyclo[5.3.1.0(l,5)]undecane); cedrene; cedrenol; cedrol; FLOREX® (mixture of 9-ethylidene-3-oxatricyclo[6.2. 1.0(2, 7)]undecan-4-one and 10- ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one); 3-methoxy-7,7-dimethyl-10- methylene-bicyclo[4.3.1]decane; CEDROXYDE® (trimethyl-13-oxabicyclo-[10.1.0]-trideca- 4,8-diene); Ambrettolide LG ((E)-9-hexadecen- 16-olide); HABANOLIDE® (pentadecenolide); muscenone (3-methyl-(4/5)-cyclopentadecenone); muscone; EXALTOLIDE® (pentadecanolide); EXALTONE® (cyclopentadecanone); (1- ethoxyethoxy)cyclododecane; Astrotone; LILIAL®; rosinol; and derivatives and combinations thereof.
[0098] Non-limiting examples of anti-aging agents include vitamins (e.g., vitamin E, vitamin A, vitamin C (ascorbic acid), vitamin B, vitamin E acetate, vitamin C palmitate), hydroxy acids (e.g., alpha-hydroxy acids [e.g., glycolic acid, lactic acid, 2-hydroxy butanoic acid, malic acid, citric acid tartaric acid, alpha-hydroxyethanoic acid, hydroxycaprylic acid], beta hydroxy acids [e.g., beta-hydroxybutyric acid, beta-phenyl-lactic acid, beta-phenylpyruvic acid, salicylic acid], polyhydroxy acids [e.g., gluconolactone (G4)]), gamma-linolenic acid, flavonoids (e.g., quercetin, hesperidin, quercitrin, rutin, tangeritin, epicatechin), CoQlO, retinoids, other proteins (e.g., collagen, soybean protein) and protein hydrolysates, bioactive agents (e.g., epidermal growth factor), botanical extracts (e.g., green tea, soy, milk thistle, algae, aloe, angelica, bitter orange, coffee, goldthread, grapefruit, hoellen, honeysuckle, Job's tears, lithospermum, mulberry, peony, puerarua, rice, safflower), and derivatives and combinations thereof.
[0099] Non-limiting examples of UVA and/or UVB light absorbing agents include UV absorbers of benzoic acid system (e.g., para-aminobenzoic acid (PABA); PABA monoglycerin ester; N,N-dipropoxy PABA ethyl ester; N,N-diethoxy PABA ethyl ester; N,N-dimethyl PABA ethyl ester; N,N-dimethyl PABA butyl ester; N,N-dimethyl PABA methyl ester); UV
32
SUBSTITUTE SHEET ( RULE 26)
absorbers of anthranilic acid system (e.g., homomenthyl-N-acetyl anthranilate); UV absorbers of salicylic acid system (e.g., amyl salicylate; menthyl salicylate; homomenthyl salicylate; octyl salicylate; phenyl salicylate; benzyl salicylate; p-isopropanol phenyl salicylate); UV absorbers of cinnamic acid system (e.g., octyl cinnamate; ethyl-4-isopropyl cinnamate; methyl- 2,5-diisopropyl cinnamate; ethyl-2,4-diisopropyl cinnamate; methyl-2,4-diisopropyl cinnamate; propyl-p-methoxy cinnamate; isopropyl-p-methoxy cinnamate; isoamyl-p- methoxy cinnamate; octyl-p-methoxy cinnamate(2-ethylhexyl-p-methoxy cinnamate); 2- ethoxyethyl-p-methoxy cinnamate; cyclohexyl-p-methoxy cinnamate; ethyl-a-cyano-0-phenyl cinnamate; 2-ethylhexyl-a-cyano-(3-phenyl cinnamate; glyceryl mono-2-ethylhexanoyl-dipara- methoxy cinnamate; methyl-bis(trimethylsiloxane)silylisopentyl trimethoxy cinnamate); 3-(4 -methylbenzylidene)-d,l-camphor; 3 -benzylidene-d.l -camphor: urocanic acid; urocanic acid ethyl ester; 2-phenyl-5-methylbenzoxazole; 2,2' -hydroxy-5-methylphenylbenzotriazole; 2-(2
-hydroxy-5' -t-octylphenyl)benzotriazole; 2-(2' -hydroxy-5' - methylphenylbenzotriazole; dibenzaladine; dianisoylmethane; 4-methoxy-4' -t- butyldibenzoylmethane; 5-(3,3-dimethyl-2-norbomylidene)-3-pentane-2-one; dimorpholinopyridazinone; and derivatives and combinations thereof.
[0100] Non-limiting examples of UVA and/or UVB light scattering agents include titanium oxide, particulate titanium oxide, zinc oxide, particulate zinc oxide, ferric oxide, particulate ferric oxide, ceric oxide, and derivatives and combinations thereof.
[0101] Non-limiting examples of antibacterial agents include macrolides or ketolides (e.g., erythromycin, azithromycin, clarithromycin, telithromycin); beta-lactams (e.g., penicillin, cephalosporin, carbapenems [e.g., carbapenem, imipenem, meropenem]); monolactams (e.g., penicillin G, penicillin V, methicillin, oxacillin, cioxacillin, dicloxacillin, nafcillin, ampicillin, amoxicillin, carbenicillin, ticarcillin, meziocillin, piperacillin, azlocillin, temocillin, cepalothin, cephapirin, cephradine, cephaloridine, cefazolin, cefamandole, cefuroxime, cephalexin, cefprozil, cefaclor, loracarbef, cefoxitin, cefmetazole, cefotaxime, ceftizoxime, ceftriaxone, cefoperazone, ceftazidime, cefixime, cefpodoxime, ceftibuten, cefdinir, cefpirome, cefepime, and astreonam; quinolones such as nalidixic acid, oxolinic acid, norfloxacin, pefloxacin, enoxacin, ofloxacin, levofloxacin, ciprofloxacin, temafloxacin, lomefloxacin, fleroxacin, grepafloxacin, sparfloxacin, trovafloxacin, clinafloxacin, gatifloxacin, moxifloxacin, sitafloxacin, besifloxacin, besifloxaxin, chntafloxacin, ganefloxacin, Gemifloxacin, pazufloxacin); antibacterial sulfonamides and antibacterial
33
SUBSTITUTE SHEET ( RULE 26)
sulphanilamides (e.g., para-aminobenzoic acid, sulfadiazine, sulfisoxazole, sulfamethoxazole, sulfathalidine); aminoglycosides (e.g., streptomycin, neomycin, kanamycin, paromycin, gentamicin, tobramycin, amikacin, netilmicin, spectinomycin, sisomicin, dibekalin, isepamicin); tetracyclines (e.g., tetracycline, chlortetracycline, demeclocy cline, minocycline, oxy tetracycline, methacycline, doxycycline); rifamycins (e.g., rifampicin [i.e., rifampin], rifapentine, rifabutin, bezoxazinorifamycin, rifaximin); lincosamides (e.g., lincomycin, clindamycin); glycopeptides (e.g., vancomycin, teicoplanin); streptogramins (e.g., quinupristin, daflopristin); oxazolidinones (e.g., linezolid); polymyxin, colistin, colymycin; trimethoprim, bacitracin, and phosphonomycin.
[0102] Non-limiting examples of antifungal agents include azoles (e.g., Fluconazole, Isavuconazole, Itraconazole, Ketoconazole (or a pyrithione salt thereof [e.g., zinc pyrithione, sodium pyrithione, potassium pyrithione, lithium pyrithione, ammonium pyrithione, copper pyrithione, calcium pyrithione, magnesium pyrithione, strontium pyrithione, silver pyrithione, gold pyrithione, manganese pyrithione, ethanolamine salt, chitosan salt, disulfide salt of pyrithione]), Miconazole, Clortrimazole, Voriconazole, Posaconazole, Ravuconazole, Ciclopirox, etc.), polyenes (e.g., natamycin, lucensomycin, nystatin, amphotericin B, etc.), echinocandins (e.g., Canci das), pradimicins (e.g., beanomicins, nikkomycins, sordarins, allylamines, etc.), Triclosan, Piroctone, fenpropimorph, terbinafme, an antifungal agent effective against the fungus of genus Malassezia (e.g., Malassezia globose) or of genus Trichophyton (e.g., Trichophyton rubrum), and derivatives and analogs thereof.
[0103] Non-limiting examples of anti-inflammatory agents include steroidal antiinflammatory (e.g., 21-acetoxypregnenolone, alclometasone, algestone, amcinonide, beclomethasone, betamethasone, budesonide, chloroprednisone, clobetasol, clobetansone, clocortolone, cloprednol, corticosterone, cortisone, cortivazol, deflazacort, desonide, desoximetasone, dexamethasone, diflorasone, diflucortolone, difluprednate, enoxolone, fluazacort, flucloronide, flumethasone flunisolide, fluocinolone acetonide, fluocinonide, fluocortin butyl, fluocortolone, fluoromethoIone, fluperolone acetate, fluprednidene acetate, fluprednisolone, flurandrenolide, fluticasone propionate, formocortal, halcinonide, halobetasol propionate, halometasone, halopredone acetate, hydrocortamate, hydrocortisone, loteprednol etabonate, mazipredone, medrysone, meprednisone, methylprednisolone, mometasone furcate, paramethosone, prednicarbate, prednisolone, prednisolone 25 -di ethylamino-acetate, prednisolone sodium phosphate, prednisone, prednival, prednylidene, rimexolone, tixocortol, triamcinolone, triamcinolone acetonide, triamcinolone benetonide, triamcinolone hexacetonide), non-steroidal antiinflammatory drugs (NSAIDs) (e.g., COX inhibitors [COX-1
34
SUBSTITUTE SHEET ( RULE 26)
or COX nonspecific inhibitors; e.g., salicylic acid derivatives (e.g., aspirin, sodium salicylate, choline magnesium trisalicylate, salicylate, diflunisal, sulfasalazine, olsalazine), paraaminophenol derivatives (e.g., acetaminophen); indole and indene acetic acids (e.g., indomethacin, sulindac); heteroaryl acetic acids (e.g, tolmetin, diclofenac, ketorolac); arylpropionic acids (e.g., ibuprofen, naproxen, flurbiprofen, ketoprofen, fenoprofen, oxaprozin); anthranilic acids (fenamates; e.g., mefenamic acid, meloxicam); enolic acids (e.g., oxicams [e.g., piroxicam, meloxicam]); alkanones (e.g., nabumetone)], selective COX-2 inhibitors [e.g., diarylsubstituted furanones (e.g., refecoxib); diaryl-substituted pyrazoles (e.g., celecoxib); indole acetic acids (e.g., etodolac, sulfonanilides [e.g., nimesulide])]), and derivatives and combinations thereof.
Attribute
[0104] A cosmetic or personal care composition according to any of the above may have an attribute (e.g., any one of the attributes disclosed herein, or combination of two or more of the attributes disclosed herein) that is between 50% and 150%, 140%, 130%, 120%, 110%, 100%, 90%, 80%, 70%, or 60%; between 60% and 150%, 140%, 130%, 120%, 110%, 100%, 90%, 80%, or 70%; between 70% and 150%, 140%, 130%, 120%, 110%, 100%, 90%, or 80%; between 80% and 150%, 140%, 130%, 120%, 110%, 100%, or 90%; between 90% and 150%, 140%, 130%, 120%, 110%, or 100%; between 100% and 150%, 140%, 130%, 120%, or 110%; between 110% and 150%, 140%, 130%, or 120%; between 120% and 150%, 140%, or 130%; between 130% and 150%, or 140%; or between 140% and 150% of such attribute of a corresponding cosmetic or personal care composition, or that is at least 1.5-fold, at least 2-fold, at least 3-fold, at least 4-fold, at least 5-fold, at least 6-fold, at least 7-fold, at least 8-fold, at least 9-fold, at least 10-fold, at least 15-fold, or at least 20-fold of such attribute of a corresponding cosmetic or personal care composition.
[0105] Non-limiting examples of attributes include film forming (e.g., for even spreading on a body surface); film elasticity (e.g., elasticity of film formed on body surface); film flexibility (e.g., flexibility of film formed on body surface); adhesion to body surface (e.g., binding to sebum secreted from skin or keratin in hair to influence duration of wear); foam forming (e.g., foaming of hair shampoo); gelling; moisturizing of body surface; emulsifying (e.g., to stabilize oil droplets comprised in the cosmetic or personal care composition and/or capture oil secreted by skin to prevent pooling of oil); binding (e.g., water binding, lipid binding, binding of bioactive agent); delivery (e.g., delivery of bioactive compound); oilcontrolling and/or oil removing (e.g., absorption or breaking up into droplets of excess oil
35
SUBSTITUTE SHEET ( RULE 26)
produced and/or accumulated on body surface [e.g., to provide matte finish; to prevent acne, oily hair, or oily nail]); hypoallergenicity; softening of body surface; restructuring of body surface; glossing of body surface; de-glossing of body surface (e.g., to remove reflective shine); soothing of body surface (e.g., soothing of bum or sunbum); penetration of body surface (e.g., penetration into skin epidermis); revitalizing of body surface (e.g., modulate in situ production of collagen); activity on cutaneous necrosis; modulate (e.g., increase) rupture force of cicatrices; detangling of hair; strengthening, mending, and/or thickening of hair; humidity shielding (e.g., to enable long, sweat-free, and transfer-proof wear on body surface); encapsulating (e.g., to protect) active agent (e.g., any of the other ingredients disclosed herein); delivering active agent (e.g., any of the other ingredients disclosed herein); anti-microbial and/or anti-viral activity (e.g., by coating the surface of pathogenic organisms inhibiting adhesion and/or growth of microbes [e.g., Streptococci [e.g., Streptococcus mutans], Lactobacilli, Corynebacteria, Propionibacteria, Actinomycetes, Clostridia, Bacillus, Enterococcus, Staphylococci (e.g., Staphylococcus aureus), Enterobacteria, Escherichia, Salmonella, Shigella, Chlamydia, Candida albicans, Trichophyton species, Entamoeba histolytica, Giardia lamblia, and Cryptosporidium neoformatans] or viruses [e.g., Herpes viridae, Herpes simplex, Varicella-zoster, Epstein-barr, Poxviridae, (Orthopoxvirus and Avipoxvirus); Togaviridae, (Alphavirus, Flavivirus, Rubivirus and Pestivirus); Lyssavirus, California Encaphalitis Virus, Lassa Virus, Paramyxovirus, Pneumovirus and Morbillivirus]); anti-inflammatory activity ; activity on vascular permeability; and formulating (e.g., to increase content of an active agent [e.g., any of the other ingredients disclosed herein] that does not mix well in the medium of the composition).
[0106] The recombinant milk protein comprised in the milk protein component comprised in a cosmetic or personal care composition according to any of the above may impart or materially contribute to such attribute of the cosmetic or personal care composition. The properties of milk proteins are in large part determined by the side chains of amino acids in the primary sequence of the milk proteins, the secondary and tertiary structures of the milk proteins, and on the interactions the secondary and tertiary structures permit the side chains to have with other molecules (e.g., other milk proteins, other non-milk proteins). Although the primary sequence of milk proteins can be maintained in their recombinant production, amino acid side chains as well as secondary and tertiary structures may be impacted by protein folding pathways and non-native post-translational modifications (PTMs) that may occur in recombinant host cells. Without wishing to be bound by theory, the recombinant milk protein comprised in the milk protein component comprised in a cosmetic or personal care composition
36
SUBSTITUTE SHEET ( RULE 26)
of any of the above may have a non-native PTM that impacts a functionality of the recombinant milk protein, such that the recombinant milk protein imparts or materially contributes to an attribute of the cosmetic or personal care composition according to any of the above that differs from that imparted by a corresponding native milk protein in a corresponding cosmetic or personal care composition. Moreover, use of a native milk protein in production of a cosmetic or personal care composition often entails use of milk protein preparations that typically comprise at least small amounts of other components present in milk (e.g., other proteins, carbohydrates, minerals, lipids), which may impact an attribute of the cosmetic or personal care composition that is imparted or materially contributed to by the native milk protein. In contrast, recombinant production of a milk protein provides for preparations that are substantially purer, and that may therefor impart or materially contribute to an attribute of a cosmetic or personal care composition according to any of the above in a measurably different manner. For example, a cosmetic or personal care composition according to any of the above may comprise a lower amount of the recombinant milk protein than is necessary for the corresponding native protein in the corresponding cosmetic or personal care composition to obtain a similar attribute that is imparted or materially contributed to by the milk protein; and/or a cosmetic or personal care composition according to any of the above may comprise a different salt content than the corresponding cosmetic or personal care composition without effect on an attribute that is imparted or materially contributed to by the milk protein (e.g., without the recombinant milk protein becoming insoluble and leaving visible residue upon application of the cosmetic or personal care product on a body surface); and/or a cosmetic or personal care composition according to any of the above may have improved oil-controlling and/or oil removing capacity compared to the corresponding cosmetic or personal care composition; and/or a cosmetic or personal care composition according to any of the above may have improved adhesion to a body surface compared to the corresponding cosmetic or personal care composition; and/or a cosmetic or personal care composition according to any of the above may have a greater opacity (or other attribute) while having a lower lipid content compared to the corresponding cosmetic or personal care composition; and/or a cosmetic or personal care composition according to any of the above may deliver an active agent (e.g., any of the other ingredients disclosed herein) or be more effective or efficient at delivering such active agent compared to the corresponding cosmetic or personal care composition.
37
SUBSTITUTE SHEET ( RULE 26)
Method for Producing Cosmetic or Personal Care Composition
[0107] In various aspects, provided herein is a method for producing a cosmetic or personal care composition according to any of the above, wherein the method comprises the step of obtaining a recombinant milk protein.
[0108] The recombinant milk protein may be obtained using in vitro methods (e.g., using cell-free transcription and/or translation systems). Alternatively, the recombinant milk protein may be produced using a recombinant host cell. The recombinant host cell may be derived from any wildtype organism, including any bacterium, fungus (e.g., yeast, filamentous fungus), archaea, unicellular protista, animal, plant, algae, protozoan, and chromista, or from a genetic variant (e.g., mutant) thereof, as well as from any generally recognized as safe (GRAS) industrial host cell.
[0109] Non-limiting examples of suitable bacteria include firmicutes, cyanobacteria (bluegreen algae), oscillatoriophcideae, bacillales, lactobacillales, oscillatoriales, bacillaceae, lactobacillaceae, and members of any of the following genera, and derivatives and crosses thereof: Acinetobacter, Acetobacter (e.g., Acetobacter suboxydans, Acetobacter xylinum), Actinoplane (e.g., Actinoplane missouriensis), Arthrospira (e.g., Arthrospira platensis, Arthrospira maxima), Bacillus (e g., Bacillus cereus, Bacillus coagulans, Bacillus licheniformis, Bacillus stearothermophilus, Bacillus subtilis), Escherichia (e.g., Escherichia coli), Lactobacillus (e.g., Lactobacillus acidophilus, Lactobacillus bulgaricus), Lactococcus (e.g., Lactococcus lactis, Lactococcus lactis Lancefield Group N, Lactobacillus reuteri), Leuconostoc (e.g., Leuconostoc citrovorum, Leuconostoc dextranicum, Leuconostoc mesenteroides), Micrococcus (e.g., Micrococcus lysodeikticus), Rhodococcus (e.g., Rhodococcus opacus, Rhodococcus opacus strain PD630), Spirulina, Streptococcus (e.g., Streptococcus cremoris, Streptococcus lactis, Streptococcus lactis subspecies diacetylactis. Streptococcus thermophilus), Streptomyces (e.g., Streptomyces chattanoogensis, Streptomyces gnseus, Streptomyces natalensis, Streptomyces olivaceus, Streptomyces olivochromogenes, Streptomyces rubiginosus), Tetrahymena (e.g., Tetrahymena thermophile, Tetrahymena hegewischi, Tetrahymena hyperangularis, Tetrahymena malaccensis, Tetrahymena pigmentosa, Tetrahymena pyriformis, Tetrahymena vorax ), and Xanthomonas (e.g., Xanthomonas campestns).
[0110] Non-limiting examples of suitable yeast include members of any of the following genera, and derivatives and crosses thereof: Blastobotrys, Candida (e g., Candida albicans, Candida etchellsii, Candida guilliermondii, Candida humilis, Candida lipolytica, Candida orthopsilosis, Candida palmioleophila, Candida pseudotropicalis, Candida sp., Candida utilis,
38
SUBSTITUTE SHEET ( RULE 26)
Candida versatilis), Cladosporium, Cryptococcus (e.g., Cryptococcus terricolus, Cryptococcus curvatus), Debaryomyces (e.g., Debaryomyces hansenii), Endomyces (e.g., Endomyces vemalis), Endomycopsis (e.g., Endomycopsis vemalis), Eremothecium (e.g., Eremothecium ashbyii), Hansenula (e.g., Hansenula sp., Hansenula polymorpha), Kluyveromyces (e.g., Kluyveromyces sp., Kluyveromyces lactis, Kluyveromyces marxianus var. lactis, Kluyveromyces marxianus, Kluyveromyces thermotolerans), Lipomyces (e.g., Lipomyces starkeyi, Lipomyecs lipofer), Ogataea (e.g., Ogataea minuta), Pichia (e.g., Pichia sp., Pichia pastoris, Pichia finlandica, Pichia trehalophila, Pichia koclamae, Pichia membranaefaciens, Pichia minuta, Pichia lindnen), Pichia opuntiae, Pichia thermotolerans, Pichia salictaria, Pichia guercuum, Pichia pijperi, Pichia stiptis, Pichia methanolica), Rhodosporidium (e.g., Rhodosporidium toruloides), Rhodotorula (e.g., Rhodotorula sp., Rhodotorula gracilis, Rhodotorula glutinis, Rhodotorula graminis), Saccharomyces (e.g., Saccharomyces sp., Saccharomyces bayanus, Saccharomyces beticus, Saccharomyces cerevisiae, Saccharomyces chevalieri, Saccharomyces diastaticus, Saccharomyces ellipsoideus, Saccharomyces exiguus, Saccharomyces florentinus, Saccharomyces fragilis, Saccharomyces pastorianus, Saccharomyces pombe, Saccharomyces sake, Saccharomyces uvarum), Sporobolomyces (e.g., Sporobolomyces roseus), Sporidiobolus (e.g., Sporidiobolus johnsonii, Sporidiobolus salmonicolor), Trichosporon (e.g., Trichosporon cacaoliposimilis, Trichosporon oleaginosus sp. nov., Trichosporon cacaoliposimilis sp. nov., Trichosporon gracile, Trichosporon dulcitum, Trichosporon jirovecii, Trichosporon insectorum), Xanthophyllomyces (e.g., Xanthophyllomyces dendrorhous), Yarrowia (e.g., Yarrowia lipolytica), and Zygosaccharomyces (e.g., Zygosaccharomyces rouxii).
[OHl] Non-limiting examples of suitable filamentous fungi include any holomorphic, teleomorphic, and anamorphic forms of fungi, including members of any of the following genera, and derivatives and crosses thereof: Acremonium (e.g., Acremonium alabamense), Aspergillus (e.g., Aspergillus aculeatus, Aspergillus awamori, Aspergillus clavatus, Aspergillus flavus, Aspergillus foetidus, Aspergillus fumigatus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, Aspergillus niger var. awamori, Aspergillus ochraceus, Aspergillus oryzae, Aspergillus sojae, Aspergillus terreus, as well as Emericella, Neosartorya, and Petromyces species), Aureobasidium, Canariomyces, Chaetomium, Chaetomidium, Corynascus, Chrysosporium (e.g., Chrysosporium botr oides. Chrysosporium carmichaeli, Chrysosporium crassitunicatum, Chrysosporium europae, Chrysosporium evolceannui, Chrysosporium farinicola, Chrysosporium fastidium, Chrysosporium filiforme, Chrysosporium georgiae, Chrysosporium globiferum,
39
SUBSTITUTE SHEET ( RULE 26)
Chrysosporium globiferum var. articulatum, Chrysosporium globiferum var. niveum, Chrysosporium hirundo, Chrysosporium hispanicum, Chrysosporium holmii, Chrysosporium indicum, Chrysosporium iops, Chrysosporium keratinophilum, Chrysosporium kreiselii, Chrysosporium kuzurovianum, Chrysosporium lignorum. Chrysosporium obatum, Chrysosporium lucknowense, Chrysosporium lucknowense Garg 27K, Chrysosporium medium, Chrysosporium medium var. spissescens, Chrysosporium mephiticum, Chrysosporium merdarium, Chrysosporium merdarium var. roseum, Chrysosporium minor, Chrysosporium panmcola, Chrysosporium parvum, Chrysosporium parvum var. crescens, Chrysosporium pilosum, Chrysosporium pseudomerdarium, Chrysosporium pyriformis, Chrysosporium queenslandicum, Chrysosporium sigleri, Chrysosporium sulfureum, Chrysosporium synchronum, Chrysosporium tropicum, Chrysosporium undulatum, Chrysosporium vallenarense, Chrysosporium vespertilium, Chrysosporium zonatum), Coonemeria, Cunninghamella (e.g., Cunninghamella ehinulata), Dactylomyces, Emericella, Filibasidium, Fusarium (e.g., Fusarium moniliforme, Fusarium venenatum, Fusarium oxysporum, Fusarium graminearum, Fusarium proliferatum, Fusarium verticiollioides, Fusarium culmorum, Fusarium crookwellense, Fusarium poae, Fusarium sporotrichioides, Fusarium sambuccinum, Fusarium torulosum, as well as associated Gibberella teleomorphic forms thereof), Gibberella, Humicola, Hypocrea, Lentinula, Malbranchea(e.g., Malbranchea filamentosa), Magnaporthe, Malbranchium, Melanocarpus, Mortierella (e.g., Mortierella alpina 1S-4, Mortieralla isabelline, Mortierrla vinacea, Mortieralla vinaceae var. raffinoseutilizer), Mucor (e.g., Mucor miehei Cooney et Emerson (Rhizomucor miehei (Cooney & R. Emerson)) S chipper, Mucor pusillus Lindt, Mucor circinelloides Mucor mucedo), Mycehophthora (e.g., Myceliophthora thermophila), Myrothecium, Neocallimastix, Neurospora (e.g., Neurospora crassa), Paecilomyces, Penicillium (e.g., Penicillium chrysogenum, Pennicillium iilacinum, Penicillium roquefortii), Phenerochaete, Phlebia, Piromyces, Pythium, Rhizopus (e.g., Rhizopus niveus), Schizophyllum, Scytalidium, Sporotrichum (e.g., Sporotrichum cellulophilum), Stereum, Talaromyces, Thermoascus, Thermomyces, Thielavia (e.g., Thielavia terrestris), Tolypocladium, and Trichoderma (e.g., Trichoderma harzianum, Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei, Trichoderma atroviride, Trichoderma virens, Trichoderma citrinoviride, Trichoderma viride).
[0112] Non-limiting examples of suitable plants include cycads, ginkgo biloba, conifers, cypress, junipers, thuja, cedarwood, pines, angelica, caraway, coriander, cumin, fennel, parsley, dill, dandelion, helichrysum, marigold, mugwort, safflower, camomile, lettuce,
40
SUBSTITUTE SHEET ( RULE 26)
wormwood, calendula, citronella, sages, thyme, chia seed, mustard, olive, coffee, capsicum, eggplant, paprika, cranberry, kiwi, vegetables (e.g., carrot, celery), tagetes, tansy, tarragon, sunflower, wintergreen, basil, hyssop, lavender, lemon verbena, marjoram, melissa, patchouli, pennyroyal, peppermint, rosemary, sesame, spearmint, primroses, samara, pepper, pimento, potato, sweet potato, tomato, blueberry, nightshades, petunia, morning glory, lilac, jasmin, honeysuckle, snapdragon, psyllium, wormseed, buckwheat, amaranth, chard, quinoa, spinach, rhubarb, jojoba, cypselea, chlorella, marula, hazelnut, canola, kale, bok choy, rutabaga, frankincense, myrrh, elemi, hemp, pumpkin, squash, curcurbit, manioc, dalbergia, legume plants (e.g., alfalfa, lentils, beans, clovers, peas, fava coceira, frijole bola roja, frijole negro, lespedeza, licorice, lupin, mesquite, carob, soybean, peanut, tamarind, wisteria, cassia, chickpea/garbanzo, fenugreek, green pea, yellow pea, snow pea, lima bean, fava bean), geranium, flax, pomegranate, cotton, okra, neem, fig, mulberry, clove, eucalyptus, tea tree, niaouli, fruiting plants (e.g., apple, apricot, peach, plum, pear, nectarine), strawberry, blackberry, raspberry, cherry, prune, rose, tangerine, citrus (e.g., grapefruit, lemon, lime, orange, bitter orange, mandarin, tangerine), mango, citrus bergamot, buchu, grape, broccoli, brussels sprout, camelina, cauliflower, rape, rapeseed (canola), turnip, cabbage, cucumber, watermelon, honeydew melon, zucchini, birch, walnut, cassava, baobab, allspice, almond, breadfruit, sandalwood, macadamia, taro, tuberose, aloe vera, garlic, onion, shallot, vanilla, yucca, vetiver, galangal, barley, com, curcuma aromatica, ginger, lemon grass, oat, palm, pineapple, rice, rye, sorghum, tnticale, turmeric, yam, bamboo, barley, cajuput, canna, cardamom, maize, oat, wheat, cinnamon, sassafras, lindera benzoin, bay laurel, avocado, ylang- ylang, mace, nutmeg, moringa, horsetail, oregano, cilantro, chervil, chive, aggregate fruits, grain plants, herbal plants, leafy vegetables, non-grain legume plants, nut plants, succulent plants, land plants, water plants, delbergia, millets, drupes, schizocarps, flowering plants, nonflowering plants, cultured plants, wild plants, trees, shrubs, flowers, grasses, herbaceous plants, brushes, lianas, cacti, tropical plants, subtropical plants, temperate plants, moss (e.g., Physcomitrella patens), and derivatives and crosses thereof.
[0113] The recombinant milk protein may be purified (i.e., be substantially separated from chemicals (e.g., carbohydrates, lipids, ash, metabolites, signaling molecules, other proteins), cellular components (e.g., cell walls, membrane lipids, chromosomes), and cells (e.g., other cells in an organism) of the source material from which the recombinant milk protein originated) comprised in a source material [e.g., a plant material, a fermentation broth]). For example, the recombinant milk protein may be purified to a purity of greater than 30%, greater than 35%, greater than 40%, greater than 45%, greater than 50%, greater than 55%, greater
41
SUBSTITUTE SHEET ( RULE 26)
than 60%, greater than 65%, greater than 70%, greater than 75%, greater than 80%, greater than 85%, greater than 90%, greater than 95%, greater than 97%, or greater than 99% relative to other components comprised in the source material, or to at least 2-fold, at least 3 -fold, at least 4-fold, at least 5-fold, at least 6-fold, at least 7-fold, at least 8-fold, at least 9-fold, or at least 10-fold greater abundancy relative to other components comprised in the source material, or to a purity of greater than 30%, greater than 35%, greater than 40%, greater than 45%, greater than 50%, greater than 55%, greater than 60%, greater than 65%, greater than 70%, greater than 75%, greater than 80%, greater than 85%, greater than 90%, greater than 95%, greater than 97%, or greater than 99% by weight.
[0114] The method may further comprise the step of polymerizing the recombinant milk protein. Methods for polymerizing milk proteins are disclosed, for example, in U.S. patent publication US20060057131, published March 16, 2006; PCT publication WO2019213155, published November 7, 2019; and PCT publication WO2022031941, published February 10, 2022.
[0115] The method may further comprise the step of producing a coacervate comprising the recombinant milk protein and a polysaccharide. Methods for producing a coacervate comprising a recombinant milk protein and a polysaccharide are known in the art.
[0116] A variety of recipes known in the art may be used to prepare cosmetic or personal care product. The recombinant milk may be used in such recipes in purified/isolated form or comprised in a fermentation broth to produce a cosmetic or personal care product according to any of the above.
Method for Beautifying or Hygienizmg
[0117] In various aspects, provided herein is a method for beautifying or hygienizing, wherein the method comprises the step of applying to a body surface a cosmetic or personal care composition according to any of the above.
EXAMPLES
[0118] The following examples are included to illustrate specific aspects of this disclosure. The techniques disclosed in the examples represent techniques discovered by the inventors to function well in the methods and processes of this disclosure; however, those of skill in the art should, in light of the present disclosure, appreciate that many changes can be made in the specific aspects that are disclosed and still obtain a like or similar result without departing from
42
SUBSTITUTE SHEET ( RULE 26)
the spirit and scope of the disclosure. Therefore, all matter set forth or show n in the examples is to be interpreted as illustrative and not in a limiting sense.
Example 1 : Skin lightening activity of recombinant B-lactoglobulin in melanoderm skin model [0119] The skin lightening activity of recombinantly produced B-lactoglobulin (diluted to various concentrations in PBS) was evaluated using a MelanoDerm 24 tissue kit (MELB-300; MatTek, Ashland. MA). To each well of hanging top 12 well plates, 5 mL of EPI-100-NMM- 113 culture medium (pre-warmed at 30-37C) was added. The MEL-300B tissue was removed from packaging using sterile forceps and transferred into the 12 well hanging top plates. After overnight incubation at 37°C and 5% CO2, both the lid and the hanging top lid of the plates were removed, the inserts were carefully removed and blotted, and the medium was replenished. To each insert, 25 pL of test sample was added, and the plates were further incubated. Additional dosing was done every alternate day. On day 14, the tissues were rinsed with PBS and blotted, and then cut and transferred into 1.5 mL Eppendorf tubes. To each tube, 300 pL of solvable was added, and the tubes were incubated overnight at 65°C in a thermoshaker, before the samples were analyzed in a melanin assay. Spectrophotometric measurements were performed to assess the skin lightening efficacy. The positive control (PC) consisted of 2% Kojic acid in ultrapure water.
[0120] As shown in Table 1, the highest melanin concentration was detected in the negative control (NT), followed by various test concentrations of recombinant P-lactoglobulin. The positive control (PC) exhibited the most significant melanin reduction compared to NT and the test samples.
[0121] As show n in Table 2, the positive control (PC) exhibited the brightest skin (highest L* value). Lower concentrations of recombinant B-lactoglobulin (0.63mg/ml, 0.2mg/ml, and 0.06mg/ml) showed higher L*values, indicating lighter skin. At even higher concentrations (20mg/ml, 6.33mg/ml, and 2mg/ml), the recombinant B-lactoglobulin showed lower L*values, suggesting less effective skin lightening.
Table 1: Melanin Estimation
(pg /ml) Reduction
NT - 59.96 100.00 0.00
PC 2% Kojic 37.88 63.17 36.83
Al 20 mg/mL 58.10 96.90 3.10
A2 6.33 mg/mL 56.46 94.16 5.84
A3 2 mg/mL 56.67 94.51 5.49
A4 0.63 mg/mL 56.58 94.37 5.63
SUBSTITUTE SHEET ( RULE 26)
A5 0.2 mg/mL 56.38 94.02 5.98
A6 0.06 mg/mL 56.44 94.13 5.87
Table 2: Spectrophotometric Values for Skin Tissue Concentrations
Sample Concentration L* Value
NT 44.29
PC 2% Kojic acid 46.04
Al 20 mg/mL 44.03
A2 6.33 mg/mL 44.11
A3 2 mg/mL 44.93
A4 0.63 mg/mL 45.48
A5 0.2 mg/mL 45.54
A6 0.06 mg/mL 45.60
Example 2: Anti-oxidant and anti-aging activity of recombinant B-lactoglobulin in epiderma skin model
[0122] The anti-oxidant and anti-aging activity of recombinantly produced P-lactoglobulin (diluted to various concentrations in PBS) was evaluated using a EpiDerm - Full Thickness 24 tissue kit (EFT-400; MatTek, Ashland, MA). To each well of 6 well plates, 5 mL of EFT-400- MM maintenance medium (pre-warmed to 20-25 °C) was added. The EFT-400 tissue was removed from packaging using sterile forceps and transferred into the 6 well plates. After overnight incubation at 37°C and 5% CO2, the inserts were carefully removed from the plates and blotted, and the media replenished. To each insert, 42 pL of test sample was added, and the plates were further incubated. Additional dosing was done every alternate day. On day 9, the tissues were rinsed with PBS and blotted, and then cut and transferred into 1.5 mL Eppendorf tubes. To each tube, 750 pL of cold lysis buffer with protease inhibitor cocktail was added. The tissues were homogenized with Pellet Pestle for approximately 30 seconds on ice, and the lysates were collected. Levels of analytes were determined by ELISA. The positive control (PC) consisted of ascorbic acid in ultrapure water.
[0123] As shown in Table 3, compared to NT, levels of glutathione peroxide (GPX), superoxide dismutase (SOD), and LPO were increased, and levels of prostaglandin were decreased, in the test samples, a molecular profile that is indicative of anti-oxidant activity.
[0124] As shown in Table 4, compared to NT, levels of COL3A1, COL1A1, hyaluronic acid, and filaggrin were increased in the test samples, a molecular profile that is indicative of anti-aging activity.
45
SUBSTITUTE SHEET (RULE 26)
Claims
1. A cosmetic or personal care composition comprising a milk protein component, wherein the milk protein component comprises or consists essentially of a recombinant milk protein.
2. The cosmetic or personal care composition of claim 1 comprising between 0.1% and 100%, by mass of the milk protein component.
3. The cosmetic or personal care composition of claim 1 or 2, wherein the cosmetic or personal care composition is a liquid.
4. The cosmetic or personal care composition of claim 1 or 2, wherein the cosmetic or personal care composition is an emulsion.
5. The cosmetic or personal care composition of claim 4, wherein the emulsion comprises between 5% and 80% by mass of lipid.
6. The cosmetic or personal care composition of claim 1 or 2, wherein the cosmetic or personal care composition is a gel.
7. The cosmetic or personal care composition of claim 1 or 2, wherein the cosmetic or personal care composition is a powder.
8. The cosmetic or personal care composition of claim 1 or 2, wherein the cosmetic or personal care composition is an aerosol.
9. The cosmetic or personal care composition of claim 1 or 2, wherein the cosmetic or personal care composition is a semi-solid.
10. The cosmetic or personal care composition of claim 1 or 2, wherein the cosmetic or personal care composition is a solid.
11. The cosmetic or personal care composition of any of claims 1 through 10, wherein the cosmetic or personal care composition is essentially free of a component found in a mammal- produced milk, or comprises a lower concentration of at least one component found in a mammal-produced milk.
12. The cosmetic or personal care composition of any of claims 1 through 11, wherein the cosmetic or personal care composition is essentially free of a component obtained from an animal, or comprises 2% or less by mass of such component.
13. The cosmetic or personal care composition of any of claims 1 through 12, wherein the cosmetic or personal care composition is hypoallergenic.
14. The cosmetic or personal care composition of any of claims 1 through 13, wherein the recombinant milk protein is a single recombinant milk protein.
47
SUBSTITUTE SHEET ( RULE 26)
15. The cosmetic or personal care composition of claim 14, wherein the single recombinant milk protein is a recombinant P-lactoglobulin.
16. The cosmetic or personal care composition of claim 14, wherein the single recombinant milk protein is a recombinant a-lactalbumin.
17. The cosmetic or personal care composition of claim 14, wherein the single recombinant milk protein is a recombinant GMP.
18. The cosmetic or personal care composition of claim 14, wherein the single recombinant milk protein is a recombinant lactotransferrin.
19. The cosmetic or personal care composition of claim 14, wherein the single recombinant milk protein is a recombinant bovine serum albumin.
20. The cosmetic or personal care composition of claim 14, wherein the single recombinant milk protein is a recombinant lactoperoxidase.
21. The cosmetic or personal care composition of claim 14, wherein the single recombinant milk protein is a recombinant K-casein.
22. The cosmetic or personal care composition of claim 14, wherein the single recombinant milk protein is a recombinant P-casein.
23. The cosmetic or personal care composition of claim 14, wherein the single recombinant milk protein is a recombinant a-Sl -casein.
24. The cosmetic or personal care composition of claim 14, wherein the single recombinant milk protein is a recombinant a-S2-casein.
25. The cosmetic or personal care composition of any of claims 1 through 13, wherein the recombinant milk protein is a mixture of two or more recombinant milk proteins.
26. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises a recombinant P-lactoglobulin.
27. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant P- lactoglobulin and a recombinant a-lactalbumin.
28. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant P- lactoglobulin and a recombinant GMP.
29. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant P- lactoglobulin and a recombinant lactotransferrin.
48
SUBSTITUTE SHEET ( RULE 26)
30. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin and a recombinant bovine serum albumin.
31. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin and a recombinant lactoperoxidase.
32. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin and a recombinant K-casein.
33. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin and a recombinant 0-casein.
34. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin and a recombinant a-Sl-casein.
35. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin and a recombinant a-S2-casein.
36. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant a-lactalbumin, and a recombinant GMP.
37. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant a-lactalbumin, and a recombinant lactotransferrin.
38. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant a-lactalbumin, and a recombinant bovine serum albumin.
39. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant a-lactalbumin, and a recombinant lactoperoxidase.
40. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant a-lactalbumin, and a recombinant K-casein.
49
SUBSTITUTE SHEET ( RULE 26)
41. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant a-lactalbumin, and a recombinant 0-casein.
42. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant a-lactalbumin, and a recombinant a-Sl-casein.
43. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant a-lactalbumin, and a recombinant a-S2-casein.
44. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant GMP, and a recombinant lactotransferrin.
45. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant GMP, and a recombinant bovine serum albumin.
46. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant GMP, and a recombinant lactoperoxidase.
47. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant GMP, and a recombinant K-casein.
48. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant GMP, and a recombinant 0-casein.
49. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant GMP, and a recombinant a-Sl -casein.
50. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant GMP, and a recombinant a-S2-casein.
51. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant lactotransferrin, and a recombinant bovine serum albumin.
50
SUBSTITUTE SHEET ( RULE 26)
52. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant lactotransferrin, and a recombinant lactoperoxidase.
53. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant lactotransferrin, and a recombinant K-casein.
54. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant lactotransferrin, and a recombinant 0-casein.
55. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant lactotransferrin, and a recombinant a-Sl -casein.
56. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant lactotransferrin, and a recombinant a-S2-casein.
57. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a bovine serum albumin, and a recombinant lactoperoxidase.
58. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant bovine serum albumin, and a recombinant K-casein.
59. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant bovine serum albumin, and a recombinant 0-casein.
60. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant bovine serum albumin, and a recombinant a-Sl -casein.
61. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant bovine serum albumin, and a recombinant a-S2-casein.
62. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant lactoperoxidase, and a recombinant K-casein.
51
SUBSTITUTE SHEET ( RULE 26)
63. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant lactoperoxidase, and a recombinant 0-casein.
64. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant lactoperoxidase, and a recombinant a-Sl -casein.
65. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant lactoperoxidase, and a recombinant a-S2-casein.
66. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant K-casein, and a recombinant 0-casein.
67. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant K-casein, and a recombinant a-Sl -casein.
68. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant K-casein, and a recombinant a-S2-casein.
69. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant 0-casein, and a recombinant a-Sl -casein.
70. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant 0-casein, and a recombinant a-S2-casein.
71. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0- lactoglobulin, a recombinant a-Sl -casein, and a recombinant a-S2-casein.
72. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises a recombinant a-lactalbumin.
73. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumin and a recombinant GMP.
52
SUBSTITUTE SHEET ( RULE 26)
74. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumm and a recombinant lactotransferrin.
75. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumin and a recombinant bovine serum albumin.
76. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumin and a recombinant lactoperoxidase.
77. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumm and a recombinant K-casein.
78. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumm and a recombinant P-casein.
79. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactal bumin and a recombinant a-Sl -casein.
80. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalburmn and a recombinant a-S2-casein.
81. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumm, a recombinant GMP, and a recombinant lactotransferrin.
82. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumin, a recombinant GMP, and a recombinant bovine serum albumin.
83. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumin, a recombinant GMP, and a recombinant lactoperoxidase.
84. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumm, a recombinant GMP, and a recombinant K-casein.
53
SUBSTITUTE SHEET ( RULE 26)
85. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumm, a recombinant GMP, and a recombinant 0-casein.
86. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactal bumin, a recombinant GMP, and a recombinant a-Sl -casein.
87. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumin, a recombinant GMP, and a recombinant a-S2-casein.
88. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumm, a recombinant lactotransferrin, and a recombinant bovine serum albumin.
89. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumm, a recombinant lactotransferrin, and a recombinant lactoperoxidase.
90. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumin, a recombinant lactotransferrin, and a recombinant K-casein.
91. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalburmn, a recombinant lactotransferrin, and a recombinant 0-casein.
92. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumm, a recombinant lactotransferrin, and a recombinant a-Sl -casein.
93. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumin, a recombinant lactotransferrin, and a recombinant a-S2-casein.
94. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumin, a recombinant bovine serum albumin, and a recombinant lactoperoxidase.
95. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumm, a recombinant bovine serum albumin, and a recombinant K-casein.
54
SUBSTITUTE SHEET ( RULE 26)
96. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumm, a recombinant bovine serum albumin, and a recombinant P-casein.
97. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactal bumin, a recombinant bovine serum albumin, and a recombinant a-Sl -casein.
98. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumin, a recombinant bovine serum albumin, and a recombinant a-S2-casein.
99. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumm, a recombinant lactoperoxidase, and a recombinant K-casein.
100. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumm, a recombinant lactoperoxidase, and a recombinant P-casein.
101. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactal bumin, a recombinant lactoperoxidase, and a recombinant a-Sl -casein.
102. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalburmn, a recombinant lactoperoxidase, and a recombinant a-S2-casein.
103. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumm, a recombinant K-casein, and a recombinant P-casein.
104. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactal bumin, a recombinant K-casein, and a recombinant a-Sl -casein.
105. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumin, a recombinant K-casein, and a recombinant a-S2-casein.
106. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumm, a recombinant P-casein, and a recombinant a-Sl -casein.
55
SUBSTITUTE SHEET ( RULE 26)
107. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactalbumm, a recombinant -casein, and a recombinant a-S2-casein.
108. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a- lactal bumin, a recombinant a-Sl -casein, and a recombinant a-S2-casein.
109. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises a recombinant GMP.
110. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP and a recombinant lactotransferrin.
111. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP and a recombinant bovine serum albumin.
112. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP and a recombinant lactoperoxidase.
113. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP and a recombinant K-casein.
114. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP and a recombinant -casein.
115. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP and a recombinant a-Sl -casein.
116. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP and a recombinant a-S2-casein.
117. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant lactotransferrin, and a recombinant bovine serum albumin.
56
SUBSTITUTE SHEET ( RULE 26)
118. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant lactotransferrin, and a recombinant lactoperoxidase.
119. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant lactotransferrin, and a recombinant K-casein.
120. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant lactotransferrin, and a recombinant P-casein.
121. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant lactotransferrin, and a recombinant a-Sl -casein.
122. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant lactotransferrin, and a recombinant a-S2-casein.
123. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant bovine serum albumin, and a recombinant lactoperoxidase.
124. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant bovine serum albumin, and a recombinant K-casein.
125. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant bovine serum albumin, and a recombinant P-casein.
126. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant bovine serum albumin, and a recombinant a-Sl -casein.
127. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant bovine serum albumin, and a recombinant a-S2-casein.
128. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant lactoperoxidase, and a recombinant K-casein.
57
SUBSTITUTE SHEET ( RULE 26)
129. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant lactoperoxidase, and a recombinant P-casein.
130. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant lactoperoxidase, and a recombinant a-Sl -casein.
131. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant lactoperoxidase, and a recombinant a-S2-casein.
132. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant K-casem, and a recombinant P-casein.
133. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant K-casem, and a recombinant a-Sl -casein.
134. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant K-casein, and a recombinant a-S2-casein.
135. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant P-casein, and a recombinant a-Sl -casein.
136. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant P-casem, and a recombinant a-S2-casein.
137. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant GMP, a recombinant a-Sl -casein, and recombinant a-S2-casein.
138. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises a recombinant lactotransferrin.
139. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin and a recombinant bovine serum albumin.
58
SUBSTITUTE SHEET ( RULE 26)
140. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin and a recombinant lactoperoxidase.
141. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin and a recombinant K-casein.
142. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin and a recombinant P-casein.
143. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin and a recombinant a-Sl -casein.
144. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin and a recombinant a-S2-casein.
145. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin, a recombinant bovine serum albumin, and a recombinant lactoperoxidase.
146. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin, a recombinant bovine serum albumin, and a recombinant K-casein.
147. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin, a recombinant bovine serum albumin, and a recombinant P-casein.
148. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin, a recombinant bovine serum albumin, and a recombinant a-S 1 -casein.
149. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin, a recombinant bovine serum albumin, and a recombinant a-S2-casein.
150. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin, a recombinant lactoperoxidase, and a recombinant K-casein.
59
SUBSTITUTE SHEET ( RULE 26)
151. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin, a recombinant lactoperoxidase, and a recombinant P-casein.
152. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin, a recombinant lactoperoxidase, and a recombinant a-Sl -casein.
153. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin, a recombinant lactoperoxidase, and a recombinant a-S2-casein.
154. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin, a recombinant K-casein, and a recombinant P-casein.
155. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin, a recombinant K-casein, and a recombinant a-Sl -casein.
156. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin, a recombinant K-casein, and a recombinant a-S2-casein.
157. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin, a recombinant P-casein, and a recombinant a-Sl -casein.
158. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin, a recombinant P-casein, and a recombinant a-S2-casein.
159. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactotransferrin, a recombinant a-Sl -casein, and a recombinant a-S2-casein.
160. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises a recombinant bovine serum albumin.
161. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant bovine serum albumin and a recombinant lactoperoxidase.
60
SUBSTITUTE SHEET ( RULE 26)
162. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant bovine serum albumin and a recombinant K-casein.
163. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant bovine serum albumin and a recombinant P-casein.
164. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant bovine serum albumin and a recombinant a-Sl -casein.
165. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant bovine serum albumin and a recombinant a-S2-casein.
166. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant bovine serum albumin, a recombinant lactoperoxidase, and a recombinant K-casein.
167. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant bovine serum albumin, a recombinant lactoperoxidase, and a recombinant p-casein.
168. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant bovine serum albumin, a recombinant lactoperoxidase, and a recombinant a-Sl -casein.
169. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant bovine serum albumin, a recombinant lactoperoxidase, and a recombinant a-S2-casein.
170. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant bovine serum albumin, a recombinant K-casein, and a recombinant P-casein.
171. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant bovine serum albumin, a recombinant K-casein, and a recombinant a-Sl -casein.
172. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant bovine serum albumin, a recombinant K-casein, and a recombinant a-S2-casein.
61
SUBSTITUTE SHEET ( RULE 26)
173. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant bovine serum albumin, a recombinant P-casein, and a recombinant a-Sl -casein.
174. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant bovine serum albumin, a recombinant P-casein, and a recombinant a-S2-casein.
175. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant bovine serum albumin, a recombinant a-Sl-casein, and a recombinant a-S2-casein.
176. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises a recombinant lactoperoxidase.
177. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactoperoxidase and a recombinant K-casein.
178. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactoperoxidase and a recombinant P-casein.
179. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactoperoxidase and a recombinant a-Sl -casein.
180. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactoperoxidase and a recombinant a-S2-casein.
181. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactoperoxidase, a recombinant K-casein, and a recombinant P-casein.
182. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactoperoxidase, a recombinant K-casein, and a recombinant a-Sl -casein.
183. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactoperoxidase, a recombinant K-casein, and a recombinant a-S2-casein.
62
SUBSTITUTE SHEET ( RULE 26)
184. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactoperoxidase, a recombinant P-casein, and a recombinant a-Sl -casein.
185. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactoperoxidase, a recombinant P-casein, and a recombinant a-S2-casein.
186. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant lactoperoxidase, a recombinant a-Sl -casein, and a recombinant a-S2-casein.
187. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises a recombinant K-casein.
188. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant K-casein and a recombinant P-casein.
189. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant K-casein and a recombinant a-Sl -casein.
190. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant K-casein and a recombinant a-S2-casein.
191. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant K-casein, a recombinant P-casem, and a recombinant a-Sl -casein.
192. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant K-casein, a recombinant P-casem, and a recombinant a-S2-casein.
193. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of recombinant K-casein, a recombinant a-Sl -casein, and recombinant a-S2-casein.
194. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises a recombinant P-casein.
195. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant P-casein and a recombinant a-Sl -casein.
63
SUBSTITUTE SHEET ( RULE 26)
196. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant -casein and a recombinant a-S2-casein.
197. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant 0-casein, a recombinant a-Sl -casein, and recombinant a-S2-casein.
198. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises a recombinant a-Sl -casein.
199. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises or consists essentially of a recombinant a-Sl -casein and a recombinant a-S2-casein.
200. The cosmetic or personal care composition of claim 25, wherein the mixture of two or more recombinant milk proteins comprises a recombinant a-S2-casein.
201. The cosmetic or personal care composition of any of claims 1 through 200, wherein the recombinant milk protein is produced using a recombinant host cell.
202. The cosmetic or personal care composition of claim 201 , wherein the recombinant host cell is a recombinant bacterial host cell.
203. The cosmetic or personal care composition of claim 201 , wherein the recombinant host cell is a recombinant plant host cell.
204. The cosmetic or personal care composition of claim 201 , wherein the recombinant host cell is a recombinant fungal host cell.
205. The cosmetic or personal care composition of claim 204, wherein the recombinant fungal host cell is a recombinant yeast.
206. The cosmetic or personal care composition of claim 204, wherein the recombinant fungal host cell is a recombinant filamentous fungal host cell.
207. The cosmetic or personal care composition of claim 204, wherein the recombinant fungal host cell is derived from Saccharomyces, Kluyveromyces, Pichia, Tetrahymena, Yarrowia, Hansenula, Blastobotrys, Zygosaccharomyces, Debaryomyces, Aspergillus, Candida, Trichoderma, Fusarium, Chrysosporium, Physcomitrella, or Neurospora.
208. The cosmetic or personal care composition of any of claims 1 through 207, wherein the milk protein component comprises or consists essentially of a multimer or polymer of recombinant milk protein monomers.
64
SUBSTITUTE SHEET ( RULE 26)
209. The cosmetic or personal care composition of any of claims 1 through 208, wherein the milk protein component consists of whey protein and casein at a mass ratio of between about 10 to 0 and about 0 to 10.
210. The cosmetic or personal care composition of any of claims 1 through 209, wherein the milk protein component is comprised in a cosmetically or physiologically acceptable medium.
211. The cosmetic or personal care composition of any of claims 1 through 210, wherein the milk protein component is comprised in a coating layer around a core of the cosmetic or personal care composition.
212. The cosmetic or personal care composition of claim 211, wherein the core comprises an active agent.
213. The cosmetic or personal care composition of any of claims 1 through 212, wherein the recombinant milk protein is undenatured.
214. The cosmetic or personal care composition of any of claims 1 through 213, wherein the recombinant milk protein is hydrolyzed.
215. The cosmetic or personal care composition of claim 214, wherein the hydrolyzed recombinant milk protein consists essentially of peptides having a molecular weight of between 200 to 5,000.
216. The cosmetic or personal care composition of any of claims 1 through 215, wherein the recombinant milk protein is covalently or non-covalently associated with a lipid to form an amphiphilic complex.
217. The cosmetic or personal care composition of claim 216, wherein the lipid is selected from the group consisting of fatty acids or acyls having a carbon atom number of between 4 and 30.
218. The cosmetic or personal care composition of claim 216, wherein the lipid is selected from the group consisting of heptanoic acid, octanoic acid, decanoic acid, lauric acid, myristic acid, palmitic acid, stearic acid, ricinoleic acid, oleic acid, linoleic acid, linolenic acid, caprylic acid, capric acid; corresponding fatty alcohols and fatty amines; derivatives of said fatty acids, fatty alcohols, and fatty amines; and mixtures thereof.
219. The cosmetic or personal care composition of any of claims 216 through 218, wherein the recombinant milk protein comprises such lipid at a mass ratio of between about 1,000 to 1 and about 1 to 10.
220. The cosmetic or personal care composition of any of claims 216 through 219, wherein the lipid is covalently linked to the recombinant milk protein via a monofunctional agent or a multifunctional grafting agent.
65
SUBSTITUTE SHEET ( RULE 26)
221. The cosmetic or personal care composition of any of claims 1 through 220, wherein the recombinant milk protein is covalently or non-covalently associated with a coloring agent.
222. The cosmetic or personal care composition of claim 222, wherein the recombinant milk protein is covalently or non-covalently associated with a UVA and/or UVB light filtering or UVA and/or UVB light scattering agent.
223. The cosmetic or personal care composition of any of claims 1 through 222, wherein the recombinant milk protein is comprised in a coacervate with a polysaccharide.
224. A method for producing a cosmetic or personal care composition of any of claims 1 through 223, wherein the method comprises: obtaining a recombinant milk protein.
225. The method of claim 224, wherein the recombinant milk protein is produced using a recombinant host cell.
226. The method of claim 225, wherein the recombinant host cell is a recombinant bacterial host cell.
227. The method of claim 225, wherein the recombinant host cell is a recombinant plant host cell.
228. The method of claim 225, wherein the recombinant host cell is a recombinant fungal host cell.
229. The method of claim 228, wherein the recombinant fungal host cell is a recombinant yeast.
230. The method of claim 228, wherein the recombinant fungal host cell is a recombinant filamentous fungal host cell.
231. The method of claim 228, wherein the recombinant fungal host cell is derived from Saccharomyces, Kluyveromyces, Pichia, Tetrahymena, Yarrowia, Hansenula, Blastobotrys, Zygosaccharomyces, Debaryomyces, Aspergillus, Candida, Trichoderma, Fusarium, Chrysosporium, Physcomitrella, orNeurospora.
232. The method of any of claims 224 through 231, wherein the method further comprises polymerizing the recombinant milk protein.
233. The method of any of claims 224 through 232, wherein the method further comprises producing a coacervate comprising the recombinant milk protein and a polysaccharide.
234. A method for beautifying or hygienizing, wherein the method comprises: applying to a body surface a cosmetic or personal care composition of any of claims 1 through 223.
66
SUBSTITUTE SHEET ( RULE 26)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202263391511P | 2022-07-22 | 2022-07-22 | |
US63/391,511 | 2022-07-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024020592A1 true WO2024020592A1 (en) | 2024-01-25 |
Family
ID=89618540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2023/070793 WO2024020592A1 (en) | 2022-07-22 | 2023-07-23 | Cosmetic or personal care composition comprising recombinant milk protein |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024020592A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040170590A1 (en) * | 2003-02-20 | 2004-09-02 | Fahnestock Stephen R. | Water-soluble silk proteins in compositions for skin care, hair care or hair coloring |
WO2020219596A1 (en) * | 2019-04-22 | 2020-10-29 | Perfect Day, Inc. | Recombinant milk proteins and compositions comprising the same |
WO2022031941A1 (en) * | 2020-08-05 | 2022-02-10 | Perfect Day, Inc. | Fusion proteins comprising milk proteins and compositions thereof |
WO2022104227A1 (en) * | 2020-11-13 | 2022-05-19 | Perfect Day, Inc. | Methods and compositions for producing recombinant components for use in food and other products |
-
2023
- 2023-07-23 WO PCT/US2023/070793 patent/WO2024020592A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040170590A1 (en) * | 2003-02-20 | 2004-09-02 | Fahnestock Stephen R. | Water-soluble silk proteins in compositions for skin care, hair care or hair coloring |
WO2020219596A1 (en) * | 2019-04-22 | 2020-10-29 | Perfect Day, Inc. | Recombinant milk proteins and compositions comprising the same |
WO2022031941A1 (en) * | 2020-08-05 | 2022-02-10 | Perfect Day, Inc. | Fusion proteins comprising milk proteins and compositions thereof |
WO2022104227A1 (en) * | 2020-11-13 | 2022-05-19 | Perfect Day, Inc. | Methods and compositions for producing recombinant components for use in food and other products |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1322532C (en) | Trehalose containing cosmetic composition and method of using it | |
ES2198662T3 (en) | USE OF RETINOIDS AS AN INDUCTIVE AGENT OF SKIN PIGMENTATION. | |
JPWO2016067688A1 (en) | Skin barrier function improving agent and skin barrier function improving composition | |
JP2008538769A (en) | Personal care compositions containing dipeptides | |
JP4252460B2 (en) | Skin preparation for external use | |
WO2002072040A1 (en) | Comsetics or external preparaiotns for skin | |
US11116708B2 (en) | Personal care compositions including naringin:zinc complexes and methods for the same | |
JP5550863B2 (en) | Cosmetics | |
JP2000309521A (en) | Skin lotion | |
JP7044229B2 (en) | Cellular β-catenin production promoting composition | |
JP4970805B2 (en) | Topical skin preparation | |
KR102486936B1 (en) | Cosmetics compositions for skin whitening | |
JP2008195651A (en) | Humectant | |
WO2024020592A1 (en) | Cosmetic or personal care composition comprising recombinant milk protein | |
JPH02111714A (en) | Cosmetic | |
JP2009274968A (en) | Hairdye composition containing protein nanoparticles | |
JP6173362B2 (en) | Skin barrier function improving agent, intercellular adhesion structure formation promoter, tight junction formation promoter, TRPV4 activator, intracellular Ca concentration increase promoter and sebum production promoter | |
KR102083325B1 (en) | Cosmetics compositions for skin whitening | |
KR102502511B1 (en) | Cosmetics compositions for prevention and improvement of wrinkle | |
JP2011042613A (en) | Anti-aging skin care preparation and anti-aging cosmetic | |
US10406086B2 (en) | Moisturizer and cosmetic including the same | |
KR102491995B1 (en) | Cosmetics compositions for skin whitening | |
KR102006951B1 (en) | Cosmetics compositions for prevention and improvement of dandruff or itching | |
CN105963166A (en) | Lipstick prepared form lycium ruthenicum mill | |
KR102491996B1 (en) | Cosmetics compositions for prevention and improvement of wrinkle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23843953 Country of ref document: EP Kind code of ref document: A1 |